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Abstract 
 
Natural products, produced as secondary metabolites by plants and microbes, have been 
used for thousands of years to treat human ailments and still form the basis of drug 
discovery efforts. Terpenes form the largest category of natural products. Terpenes such as 
the antimalarial compound artemisinin and the anticancer compound taxol are potent 
medicines. Furthermore, terpenes are active ingredients in perfumes, nutraceuticals and 
biofuels. The fact that these products are produced in very small quantities in their natural 
host, from sources that are potentially exhaustible and prone to environmental fluctuations, 
have fuelled interest in sustainable, affordable and environmentally friendly means of 
production. Genetic engineering has proved an invaluable tool in producing considerable 
amounts of terpenes in heterologous hosts such as Escherichia coli and yeast. In this thesis, 
genetic/metabolic engineering and –omics strategies have been applied for the more 
efficient production of the anti-tumour compound β-elemene. Heterologous expression of 
sesquiterpene synthase from Nostoc sp. PCC 7120 in E. coli resulted in the successful 
production of β-elemene. Final β-elemene titres of up to 178 mg/L were quantified using 
targeted metabolomics strategies. Simultaneous monitoring of regulation of metabolic flux 
in recombinant E. coli producing β-elemene was carried out by applying isobaric tags for 
relative and absolute quantification (iTRAQ), a proteomics tool for relative quantification. 
A systematic evaluation of recombinant E. coli strains identified pathways that can be 
further optimised using metabolic engineering for commercially viable synthesis of β-
elemene. This is the first report of an iTRAQ aided metabolic engineering study of terpene 
production in E. coli. This study demonstrates the importance of systems level –omic 
analyses in shedding light on bottlenecks that prevent commercially viable synthesis of 
highly beneficial natural products like terpene with E. coli as a biological chassis.
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Natural products have had significant impact on human development. The hunt for the 
Earth’s pool of natural resources have in turn impacted significantly on the natural 
environment, with sustainable environmental issues topping current discussions(Goudie, 
2013). Many natural products such as the potent antitumor compound taxol from the 
Pacific Yew tree produced by living organisms are known to be produced in very small 
quantities. As such would require sacrificing huge portions of the natural host for any 
meaningful usage. Unfortunately, many of the products are have unique chemistries and as 
such are very difficult and not very cost effective for total chemical synthesis.  
One such host of natural products that has received significant interest are the 
cyanobacteria.  These products are synthesized through secondary metabolism giving rise 
to polyketides, non-ribosomal peptides and terpenes amongst others (Barrios-Llerena et al., 
2007; A. M. Burja et al., 2001; Neilan et al., 1999; Tan, 2007; Welker and Von Döhren, 
2006). Of all the classes of terpenes, the carotenoids are known to be widely produced by 
cyanobacteria (Hirschberg and Chamovitz, 2004), but not significantly much is known 
about other classes of terpene in this phylum. Efforts are currently ongoing to discover and 
characterize the non-carotenoid terpenes in cyanobacteria, many of which have 
demonstrated pharmacological properties (Agger et al., 2008; Gutiérrez et al., 2008; Jaki et 
al., 2000a, 2000b; Liu et al., 2007; Mo et al., 2009; Nagarajan et al., 2012). A sesquiterpene 
synthase from Nostoc sp.PCC7120 has been cloned and characterized by Agger et al. 
(2008). This sesquiterpene produces the anticancerous compound β-elemene.  
Unfortunately, harvesting these useful cyanobacterial natural products for commercially 
viable and renewable manner is a herculean task and considering the slow growth of these 
organisms and specialized media requirement. Fortunately, with the characterization of 
many of these metabolites, biosynthesis in a cheap and tractable secondary host such as 
Escherichia colirepresents the most commercially viable, sustainable and renewable option.  
However, using a secondary host as a production factory for a foreign protein or metabolite 
produces a significant amount of stress on the host metabolism with system wide effects 
which may affect the final product titres. Understanding the metabolic impact of these 
products in its production factory will provide a tool box for engineering better strains. 
1.2 Aims of this study 
The aim of this study is to gain an understanding of the global metabolic changes and 
systemic effects of a heterologous sesquiterpene synthetic pathway in an E. coli host 
This thesis is laid out in 7 chapters as follows: 
Chapter 2 sets the tone for the rest of the chapters by giving the necessary background 
information and rationale for the thesis. It discusses natural products with emphasis on 
terpene natural products and mechanisms of synthesis. It also discusses the cytochrome 
P450 which are known to act as downstream modifiers in terpene synthetic pathway and 
many other synthetic pathways as well as metabolic engineering and analytical tools used 
in the thesis. 
 
Chapter 3 deals with the amplification and cloning of the sesquiterpene and cytochrome 
P450 from Nostoc sp.PCC7120 and verification of the insert.  
 
In Chapter 4, the sesquiterpene synthase is expressed in an expression strain of E. coli and 
the terpene product is qualitatively and quantitatively assayed. The effect of an exogenous 
precursor supply to the terpene titres is also assessed and quantified using gas 
chromatography- mass spectrometry (GC-MS).  
 
Chapter 5 uses an isobaric tag for relative and absolute quantification (iTRAQ)-based 
proteomics technique to study the effect of the sesquiterpene synthase on E. coli.  
 
Chapter 6 also uses iTRAQ-based proteomics to evaluate the systemic changes that are 
produced in E. coli when the sesquiterpene synthase is expressed with a cytochrome P450 
as well as an added source of terpene precursors. 
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Chapter 7 gives a summary of the major findings in this thesis and plans for future work 
arising from this work.  
This thesis presents the production and quantitative assay ofβ-elemene,the antitumor 
sesquiterpene in an E. coli host and went further to increase the product titre by more than 
34 fold by adding an exogenous source of biosynthetic precursors. The gobal metabolic 
changes in these strains were elucidated and could provide a template for rational metabolic 
engineering and further strain improvements. 
 
  
  
  
 
CHAPTER 2 
 
Literature review 
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2.1 Introduction 
This chapter reviews the literature on natural products with emphasis on terpenes. The 
chapter is organized into 4 sections. The review starts with a brief introduction of 
cyanobacteria followed by (section 2.3) an introduction into natural products with emphasis 
on the terpenes while section 2.4 deals with the cytochrome P450s that also play significant 
roles in natural product synthesis. The evolution of metabolic engineering terpene 
production as well as some analytical tools used for engineering terpenes is discussed in 
section 2.5 and section 2.6 concludes with an outlook for this PhD thesis. 
 
2.2 Cyanobacteria 
Cyanobacteria are arguably one of the oldest known organisms on earth and are found in 
diverse habitats ranging from the oceans to fresh water bodies and to desert rocks (Harel et 
al., 2004). They are also found in such extreme environments as ice shelves, hot springs, 
and in the Arctic and Antarctic lakes as well as endosymbionts in lichens amongst others 
(Laybourn-Parry and Pearce, 2007; Steunou et al., 2006; Ward et al., 1998). Cyanobacteria 
are the only group of organisms that are able to reduce nitrogen and carbon in aerobic 
conditions and thus play a significant role in the nitrogen and carbon cycles as well as a 
major role in the evolution of life, by contributing to the oxygenation of the Earth (Herrero 
and Flores, 2008). They are photoautotrophic prokaryotes with a Gram-negative cell wall 
and contain chlorophyll a, phycobiliproteins, as well as photosystem I and II molecules 
(Stanier and Bazine, 1977; Woese, 1987).Cyanobacteria are a rich source of natural 
products comprising both primary and secondary metabolites including nonribosomal 
proteins, polyketides, terpenes and alkaloids and several of these are known to have 
anticancer, antiviral, UV protective activities as well as hepatotoxicity and neurotoxicity 
(Herrero and Flores, 2008).For example, Nostoc species have been employed 
therapeutically for pathologies such as renal stones, anal fistulas and many malignancies 
(Pietra, 1990). However, terpene synthetic pathways elucidation has been concentrated in 
plants and fungi, but recent efforts in bacteria have shown that cyanobacterial strains just 
like the Streptomyces are capable of producing terpenes(Agger et al., 2008) 
 
2.3 Natural Products  
Natural products have found use in health and disease for thousands of years. Healers have 
known the usefulness of these natural products since the dawn of civilization, and still form 
a major corner stone of modern therapeutics (Butler, 2005; Newman et al., 2000). These 
products fall into several therapeutic classes such as anti-neoplastic, antioxidant, antibiotic, 
cytotoxic, photo-protective and anti-parasitic, and anti-viral (Adam M. Burja et al., 2001; 
Schwarzer et al., 2003). These natural products have not only served as drugs in their own 
right, but have also been as primers for the discovery and synthesis of new drugs (Newman 
et al., 2000). It was reported that between 1981 and 2010, 4% of the 1355 new chemical 
entities approved by the FDA were natural products and another 22% natural–product–
derived, molecules,  15% as biologics with only 29% as totally synthetic molecules 
(Newman and Cragg, 2012). It is worthy of note that an estimated 80% of the world 
population according to the World Health Organisation (WHO) depend on traditional 
remedies for their primary health care needs (Newman et al., 2000). These natural products 
are classified structurally into polyketides (PKS), nonribosomal peptides (NRPS), 
alkaloids, lipoproteins, phenylpropanoids and terpenes (Adam M. Burja et al., 2001; Clardy 
and Walsh, 2004; Hanson, 2003). Most of these natural products are secondary metabolites 
that are produced by organisms from conditional pathways that are activated in certain 
situations such as stress, developmental needs, signaling, starvation and defense amongst 
others (Edwards and Ericsson, 1999). These products which are mainly sourced from 
plants, fungi and microbes have served therapeutics purposes for several millennia for the 
treatment of diverse and wide ranging conditions from infectious diseases to cancer to pain 
(Butler, 2005). Indigenous knowledge has played a significant role in many modern drug 
discovery efforts. A few examples include the antimalarial compound artemisinin, which 
was discovered as a result of collaborative efforts between modern scientists and traditional 
Chinese healers (Hsu, 2006). Vinblastines (Madagascar periwinkle), codeine (opium 
poppy), digitalis (purple foxglove) have been used for the treatment of diabetes, pain and 
cardiovascular conditions respectively for thousands of years (Newman et al., 2000). 
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2.3.1 Polyketides and non-ribosomal peptides (PKS/NRPS) 
The polyketides and the non-ribosomal peptides are a large group of natural products that 
are produced through ubiquitous multi-domain synthases referred to as non-ribosomal 
peptide synthetase (NRPS) and polyketide synthase (PKS) (Ansari et al., 2004; Walsh, 
2004). These diverse groups of compounds with many important pharmacological 
properties are produced mainly from fungi and bacteria. Cyanobacterial species in 
particular have been shown to produce a large and wide variety of these compounds with 
varied activities ranging from antibiotics, immunosuppressant to anticancerous (Wase and 
Wright, 2008). Many of the known cyanobacterial bioactive compounds that have been 
characterised are known to be produced via the NRPS/PKS route (Hoffmann et al., 2003; 
Trimurtulu et al., 1994a). Some of these compounds include the antitumor compound 
GSV224 from Nostoc sp. (Smith et al., 1994; Trimurtulu et al., 1994a) ;  the antiretroviral 
Cyanovirin-N which is active against HIV-1 and HIV-2 from N. ellipsosporum (Tsai et al., 
2004), the boron containing  anticancer Borophycin-11 useful in drug resistant prostate, 
breast, cervical and lung cancer from Nostoc linkia (Scorei and Popa, 2010). However, 
several other non-NRPS/PKS synthetic pathways leading to the production of secondary 
metabolites with the active participation of cytochrome P450 (CYP) are being   
appreciated, with the discovery of many CYP coding genes in their genome (Agger et al., 
2008; Ikawa et al., 2001; Ke et al., 2005; Robert et al., 2010). 
 
2.3.2 Alkaloids 
The alkaloids are a diverse group of nitrogen-containing molecules that have been 
exploited by man for medicinal purposes, hunting, and poison as well as in warfare for 
thousands of years (De Luca and St Pierre, 2000). 
These compounds are found mostly in plants and cyanobacteria but are also known to be 
sequestered by amphibians on their skin to deter predators (Daly, 1998). The amphibians, 
unlike plants and cyanobacteria, do not have the biosynthetic machinery for alkaloids 
synthesis but are sequestered from their diet and more than 800 bioactive alkaloid 
compounds have been extracted from them (Daly et al., 2005). 
Several alkaloidal biosynthetic pathways have been elucidated with CYPs playing active 
role in many of them. The pathway for the L-tyrosine derived biosynthesis of the 
medicinally important tetrahydrobenylisoquinoline group of alkaloids such as the analgesic 
morphine, the anti-microbial berberine, the anti-tussive codeine, the muscle relaxant 
tubocurarine, marcapine, and berbamurine require many cytochrome P450 especially 
CYP80B family members (Bird and Facchini, 2001; Chou and Kutchan, 1998; Pauli and 
Kutchan, 1998a). 
 
2.3.3 Terpenes 
Terpenes, terpenoids or isoprenoids (Table 2.1) are one of the major structural classes of 
natural products and are produced by all organisms either as primary or secondary 
metabolites.  They are reputed to be the most structural diverse group of natural products, 
with an estimated 30, 000 to 50,000 compounds already discovered to date (Keasling, 
2010).  Terpenes are mainly produced by plants, fungi and microbes and are known to have 
a wide range of biological functions (Kirby and Keasling, 2009) for which many have been 
exploited for mainly medical and agricultural purposes. Medically, they have been applied 
to treat cancers such as the diterpene taxol (paclitaxel) from Taxus brevifola (Jennewein 
and Croteau, 2001), and malaria via the antimalarial drug artemisinin a sesquiterpene from 
Artemisia annua(Liu et al., 2006). These molecules have also found use as insect 
antifeedants (azadirachtin from Azadirachta indica) (Brahmachari, 2004),  nutraceuticals 
(carotenoids, lycopene, astaxanthin), as well as  flavours and fragrances (limonene, 
geraniol). These molecules are mostly produced in very small quantities in the natural host. 
For example, 1 kg of taxol would need at least 2,000 pacific yew trees (Hartzell, 1991) and 
at a recommended dose of 135mg/m
2
every three weeks may only be sufficient for about 
two hundred patients with an average weight of 70kg in one year. 
Additionally, terpenes are also produced as primary metabolites in all organisms such as 
gibberellic acid, steroids which serve to maintain membrane fluidity and as precursors of 
such steroid hormones as progesterone, oestrogen and testosterone, which serve very 
essential functions in these organisms (Hanson, 2003; Harrison, 1990). Other primary 
terpenes include the electron transport chain proteins, ubiquinone, plastoquinone and 
menaquinone as well as dolichol which is involved in glycosylation of membrane proteins 
and carotenoids in photosynthetic plants (Barkovich and Liao, 2001a). They also serve as 
pollinator attractants molecules and as signaling molecules (Edwards and Ericsson, 1999; 
Isman et al., 1990). All terpenes are synthesized from two basic linear building blocks 
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namely Isopentenyl diphosphate (IPP) and its structural isomer dimethylallyldiphosphate 
(DMAPP) (Withers and Keasling, 2007a). 
These monomers are synthesized from simple carbon molecules through two independent 
biosynthetic pathways namely the mevalonate-dependent pathway (MVA) and the non-
mevalonate pathway or the 2-C-methyl-D-erythritol 4-phosphate/1-deoxy-D-xylulose 5-
phosphate pathway (MEP/DXP). DMAPP is combined with one, two or three  molecules of 
IPP using prenyl transferases as catalysts to produce different carbon chain lengths of linear 
isoprene diphosphate backbones referred to as geranyl diphosphate (C10), farnesyl 
diphosphate (C15) and geranylgeranyl diphosphate (C20) and geranylfarnesyl diphosphate 
(C25), respectively (Lesburg et al., 1997). The chain length of the precursor isoprene 
backbone determines the class of isoprenoids produced based on the isoprene rule which 
states that terpenes are formed by the repetitive joining of isoprene units linked head to tail 
(Roberts, 2007; Ruzicka, 1953).  
 
 
 
Table 2.1 some important terpenes classified according to chain length  
Name 
Carbon 
chain 
length 
Class Structure 
Isopentenyl 
diphosphate 
5 
Isoprene 
monomer 
 
(−)-Menthol 10 Monoterpene 
 
(−)-β-
elemene 
15 Sesquiterpene 
 
Name 
Carbon 
chain 
length 
Class Structure 
(+)-
Artemisinic 
acid 
15 Sesquiterpene 
 
Taxol 
 
20 Diterpene 
 
Oleanolic 
acid 
30 Triterpene 
 
β-carotene 40 Carotenoid 
 
Source: Chemical Entities of Biological Interest (ChEBI) 
 
These further undergo cyclization, rearrangement and modification to produce the various 
classes of isoprenoids. The cyclization reaction is carried out by a group of enzymes 
referred to as terpene synthases or cyclases (Rynkiewicz et al., 2001). The terpenes are 
classified based on the number of carbon atoms in their backbone into monoterpenes (C10), 
sesquiterpenes (C15), diterpenes (C20), triterpenes (C30) and carotenoids (C40) (Trapp and 
Croteau, 2001). Additionally, there is a separate composite terpene derived group referred 
to as the meroterpenes. These are  compounds made up of a terpene-derived unit bound to a 
non terpene unit such as chlorophyll, plastoquinone, some indole alkaloids and prenylated 
proteins (Chappell, 1995). The terpenes produced from the cyclization reactions could be 
subsequently tailored by modifying enzymes such as P450, aryl transferases and several 
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others to produce the final terpenoid in most cases (Walker and Croteau, 2001). The basic 
pathway for the final synthesis of most of these terpenoid requires the active participation 
of cytochrome P450s. The monoterpenes peppermint, perilla and spearmint are produced 
from the regiospecific hydroxylation of (-)-limonene at the C3, C7 and C6 respectively by 
CYP71D13/CYP71D15, CYP71D15 (Ito, 2008; C. J. Mau and Croteau, 2006). The highly 
effective antimalarial drug artemisinin is produced in the leaves of Artemisia annua by 
series of oxidative reaction catalysed by CYP71AV1, on the precursor amorpha-4,11-diene 
(Bertea et al., 2005; Kirby and Keasling, 2009). A host of other very important isoprenoids 
with CYP playing significant roles in their biosynthetic pathway include the anticancer 
drug, taxol, gibberellic acid, and oleanolic acid (Aharoni et al., 2005; Montellano, 2005). 
 
2.3.3.1 Biosynthetic pathways  
 
2.3.3.1.1 Mevalonate-dependent pathway (MVA) 
 
The MVA pathway (Figure 2.1)uses two molecules of acetyl-CoA as starting substrates to 
synthesize IPP and DMAPP in the cytosol of cells. Eukaryotic cells as well as archaea and 
a few bacterial species (Table 2.2)such as Borrelia burgdorferi, Staphylococcus aureus, 
Streptococcus pyogenes, use the MVA pathway almost exclusively to make IPP and 
DMAPP from acetyl-CoA (Boucher and Doolittle, 2000; Chappell, 1995; Lichtenthaler et 
al., 1997). The pathway (Fig 2.1) is a seven enzyme pathway with an upstream 3 enzyme 
segment leading to mevalonate and a downstream 4 enzyme component leading to 
DMAPP. The pathway starts with sequential condensation of acetyl-CoA molecules 
catalyzed successively by acetoacetyl-CoA thiolase and 3-hydroxymethyl-3-glutaryl-CoA 
synthase (HMGS) to form 3-hydroxymethyl-3-l glutaryl-CoA (HMG-CoA).  
 
 Figure 2.1 The mevalonate (MVA) pathway leading to the synthesis of IPP and 
DMAPP 
 
This is then converted to mevalonic acid by HMG-CoA reductase (HMGR). This enzyme 
which catalyzes the rate limiting step in the synthesis of IPP/DMAPP is inhibited by 
specific inhibitors which forms the basis for the cholesterol lowering statins (Istvan and 
Deisenhofer, 2001; Lichtenthaler et al., 1997). The subsequent steps involve two sequential 
phosphorylation by mevalonate kinase (MK) and phosphomevalonate kinase (PMK) to 
yield mevalonate-5-phosphate and mevalonate-5-pyrophosphate. A final decarboxylation 
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reaction by mevalonate-5-pyrophosphate decarboxylase to yield IPP, which is then 
converted to the more reactive isomer DMAPP by the eukaryotic isomerase isopentenyl 
pyrophosphate isomerase (IdiI). This is an essential step in the biosynthetic pathway of 
isoprenoids and its derivatives(Bach, 1995). 
 
2.3.3.2 Mevalonate independent pathway  
It was assumed that all terpenes were made through the MVA pathway for decades until it 
was shown in the early 1990s through isotopic labeling using glyceraldehyde 3-phosphate 
(G3P) and pyruvate as precursors that there was an alternative pathway for IPP and 
DMAPP (Rohmer et al., 1993). 
The non-mevalonate or 2-C-methyl-D-erythritol 4-phosphate/1-deoxy-D-xylulose 5-
phosphate pathway (MEP/DXP) (Fig 2.3) is used by most bacteria and plants plastids, 
algae and some protozoa such as the Plasmodium falciparum (Table 2.2). Even in plants 
with both pathways, the cytosolic MVA pathway and the plastidial DXP are physically 
segregated but with some limited communication and mostly responsible for different 
synthetic processes (Bouvier et al., 2005). While the cytosolic MVA pathway is responsible 
for sterol biosynthesis, the plastidial DXP pathway is responsible for biosynthesis of the 
both primary metabolites such as carotenoids and chlorophyll components but also 
secondary metabolites such as terpenes while a few metabolites share precursors from both 
pathways (Eisenreich et al., 2004; Mandel et al., 1996; Nagata et al., 2002).   
Unlike the MVA pathway however, the DXP pathway uses pyruvate and glyceraldehyde-3-
phosphate as the starting substrates for IPP and DMAPP synthesis (Rohmer et al., 1996) . 
The synthetic pathway starts with the Mg
2+
-ion dependent 1-deoxy-D-xylulose 5-phosphate 
synthase (dxs) as the starting and rate-limiting enzyme in a transketolase-like reaction that 
transfers a pyruvate derived acetaldehyde group to glyceraldehyde-3-phosphate to generate  
1-deoxy-D-xylulose 5-phosphate (Eisenreich et al., 2004; Xiang et al., 2013). The 
subsequent step is a reductoisomerase reaction catalyzed by 1-deoxy-D-xylulose 5-
phosphate reductase (dsr or ispC) which also requires a divalent cation in the form of Mg
2+
 
or Mn
2+ 
to form a branched aldose that is reduced with NADPH to 2-C-methyl-D-erythritol 
4-phosphate (Koppisch et al., 2002; Takahashi et al., 1998).  
 Figure 2.3 Representation of the mevalonate-independent pathway (DXP) for 
IPP and DMAPP synthesis 
 
This enzyme (IspC) is inhibited by the antibiotic fosmidomycin and shows one 
example of the potential of this pathway as a drug target (Kuzuyama et al., 1998). 
The subsequent three steps require IspD (4-diphosphocytidyl-2-C-methyl-D-
erythritol synthase) , IspE (4-diphosphocytidyl-2-C-methyl-D-erythritol kinase) and 
IspF (2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase) proteins that 
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transform 2-C-methyl-D-erythritol 4-phosphate to form 2-C-methyl-D-erythritol 2, 
4-cyclodiphosphate by consecutive transfer of a cytidyl phosphate, ATP-dependent 
phosphorylation and molecular rearrangement with loss of the cytidyl 
monophosphate CMP (Herz et al., 2000; Lüttgen et al., 2000). The last two steps of 
this pathway are catalyzed by the iron–sulfur proteins IspG (4-hydroxy-3-methyl-
but-2-enyl pyrophosphate synthase) and IspH (E)-4-hydroxy-3-methyl-but-2-enyl 
pyrophosphate reductase) to produce IPP and DMAPP at a molar ratio of 6 :1 
through 4-hydroxy-3-methyl-but-2-enyl pyrophosphate (Gräwert et al., 2011a; 
Rohdich et al., 2002). 
Unlike the eukaryotic IdiI, the IPP isomerase (idiII) is not found in most DXP 
utilizing bacteria and not essential in Escherichia coli (Cunningham et al., 2000; 
Hahn et al., 1999), however, it is known to be important for the biosynthesis of 
plants carotenoids and chlorophyll (Page et al., 2004).  Importantly, some major 
disease causing protozoas such as Plasmodium falciparum as well as the 
tuberculosis causing mycobacterium use the DXP pathway to synthesis IPP which 
can serve as a useful drug target (Eisenreich et al., 2004b). In E. coli these 
precursors are used for the prenylation of tRNAs  and synthesis of FPP which is 
then used to synthesize quinone and for cell wall biosynthesis (Connolly and 
Winkler, 1989; Martin et al., 2003a). 
 
 
 
 
 
 
 
 
 
Table 2.2 IPP/DMAPP synthetic pathway used by different organisms   
Organism 
Non-mevalonate 
pathway 
Mevalonate 
pathway 
Idi I idiII 
Aquifales Yes No No No 
Chlamydia group Yes No No No 
Cyanobacteria Yes No No Yes 
B. subtilis Yes No No Yes 
M. genitalium No No No No 
S. aureus No Yes No Yes 
S. carnosus No Yes No Yes 
S. coelicolor Yes No Yes No 
L. monozytogenes Yes Yes No Yes 
E. coli Yes No Yes No 
R. prowazeckii No No No Yes 
T. pallidum Yes No No No 
B. burgdorferi No Yes No Yes 
Archaea No Yes No Yes 
Animals No Yes Yes No 
Plants Yes Yes Yes No 
P. falciparum Yes No No No 
Yeast No Yes Yes No 
 
Source (Eguchi et al., 1998; Eisenreich et al., 2004; Gräwert et al., 2011b; Horbach 
et al., 1993; Kakinuma et al., 1988; Moldoveanu and Kates, 1988) 
 
2.3.3.1.3 Terpene synthases and prenyl transferases 
Terpene synthases or cyclases are responsible for converting the acyclic terpene 
olefin derived from the action of  prenyl synthases (geranyl pyrophosphate, farnesyl 
pyrophosphate, geranylgeranyl pyrophosphate) into the respective mono-, sesqui- 
and diterpenes (Starks et al., 1997). Physically, they are divalent metal ions (Mg
2+
or 
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Mn
2+
)-dependent, soluble and acidic enzymes with native size ranging from 35-80 
kDa (Leeper and Vederas, 2000). The primary structure of these enzymes do not 
show any significant sequence homology across plant, fungal and bacterial species 
despite their catalytic similarity even though the plant enzymes do show significant 
similarities (Starks et al., 1997). However, there are conserved features in the 
secondary structure that cuts across the terpene synthases and the prenyl synthases.  
These enzymes contain characteristic class I terpenoid cyclase fold with an aspartate 
rich motif DDXXDD on the C-terminus of helix D and a conserved NSE/DTE on 
the C-terminus of the H helix of the cyclases and are both implicated in magnesium 
ion binding for the initiation of catalysis (Aaron et al., 2010; Cane et al., 1996; 
Chappell, 1995; Christianson, 2006; Shishova et al., 2007; Starks et al., 1997). The 
prenyl synthases and the terpene cyclases both have similar catalytic activities but 
while the prenyl synthases produce chain elongation, the cyclases convert the 
acyclic prenyl olefin to mono, di or tricyclic compounds with some level of product 
degeneracy (Davis and Croteau, 2000).  
The prenyl synthases produce a sequential head to tail condensation of IPP and 
DMAPP and subsequent addition of  IPP to the products to generate longer chain 
olefins polymers of IPP and DMAPP. They do this through an intermolecular 
electrophilic attack of the allylic carbocation on the terminal double bond of the IPP 
molecule with subsequent coupling and stabilisation by deprotonation (Ogura and 
Koyama, 1998; Withers and Keasling, 2007b). The cyclization reaction proceeds in 
a similar manner. In this case, the reaction is an intramolecular electrophilic attack 
on a double bond down the terpene chain to cause a ring closure with subsequent 
involvement of hydride shift, methyl migration and final deprotonation (Chappell, 
1995; Starks et al., 1997). The diversity of these compounds is primarily due to the 
terpene synthases which are capable of producing multiple products from a single 
substrate which could be further elaborated by downstream processing enzymes 
(Misawa, 2011). In this regard, even though the terpene synthases are substrate 
specific, they have the potential to produce many different products from a single 
substrate such as γ-humulene synthase which can produce up to 52 different 
products (Chappell, 1995; Christianson, 2006). 
 2.3.3.2 Classes of terpenes  
2.3.3.2.1Monoterpenes 
Monoterpenes are 10 carbon containing terpenes are synthesized by terpene synthases 
using geranyldiphosphate as universal precursors with some exceptions (Schilmiller et al., 
2009; Yu and Utsumi, 2009). The geranyldiphosphate is derived from the condensation of 
one molecule of IPP with one molecule of DMAPP in a head to tail manner that are mainly 
produced through the plastidial DXP pathway (Yu and Utsumi, 2009).These molecules are, 
colorless, volatile organics with characteristic smell that make up the major constituents of 
plant essential oils (Geron et al., 2000; Gershenzon and Croteau, 1990). Structurally, they 
mostly have cyclic carbon skeleton such as the thujanes, pinanes, p-menthanes, bornanes, 
caranes, camphanes and fenchanes, while some are acyclic and both classes can be further 
modified by downstream enzymes such as cytochrome P450 which serve to increase the 
diversity (Mau and Croteau, 2006). The monoterpene synthases fall into two categories; 
those produced by gymnosperm synthases require a monovalent cation such as K
+
 in 
addition to a divalent cation Mn
2+
 or Fe
2+
 and an alkaline pH for optimal activity while the 
angiosperm require only the divalent cation Mg
2+
 or Mn
2+
 and a neutral pH (Leeper and 
Vederas, 2000). 
The essential oils are a complex mix of terpenes and non-terpenes with one or two 
monoterpenes making up a major component which also forms the basis for the naming of 
these oils (Hanson, 2007). More than 3400 of these compounds are known and they form 
the cornerstone of the perfumery and flavour industry and widely used in aromatherapy 
(Mau and Croteau, 2006). Menthol is the one of the most important monoterpenes and is 
produced mainly by plants of mentha species were it is the predominant constituent of 
peppermint oil in the mature plant (Croteau et al., 2005; Gómez-Galera et al., 2007). 
Menthol has a cooling-anaesthetic effect and pleasant aroma and is used extensively in 
toothpaste, cosmetics, teas and pharmaceuticals for which more than 7,000 metric tons are 
consumed  with an annual market value of more than $300 million (Croteau et al., 2005). 
The biosynthetic pathway for menthol biosynthesis comprises of 8 enzymes with limonene 
synthase catalysing the committed step of the pathway by cyclization of GPP and several 
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engineering strategies to increase yield of menthol and reduce undesirable side products 
such as menthofuran in transgenics have been reported (Croteau et al., 2005; Gómez-Galera 
et al., 2007; Mahmoud and Croteau, 2002). 
Other important monoterpenes include myrcene, α-pinene, α-terpinolene, camphene, 2-
methylisoborneol and camphor.  
 
2.3.3.2.2 Sesquiterpenes 
The sesquiterpenes are 15- carbon hydrocarbon compounds that that are widely distributed 
in plants as constituents of essential oils and some fungi as well some bacteria as well as 
marine organisms (Capon, 1995; Pham et al., 1991). These compounds are synthesized by 
sesquiterpene synthases using farnesyl diphosphate as substrate  into more than 300 known 
hydrocarbon skeletons and  also exist as oxygenated derivatives of their respective 
sesquiterpene olefin as alcohols, acids, ketones or as lactones (Agger et al., 2008b; Martin 
et al., 2001; Merfort, 2002). The sesquiterpenes unlike the monoterpenes are mostly 
produced from the mevalonate pathway in plants and the sesquiterpene synthases do not 
require a monovalent cation as seen in some monoterpene synthases (Davis and Croteau, 
2000). 
Many sesquiterpenes with wide ranging applications are known such as patchoulol in  
perfumery, the antibiotic pentalenolactone, the plant growth hormone abscisic acid, the 
antimalarial artemisinin, the biodiesel bisabolene as well as the brewery ingredient α-
humulene (Cane et al., 1990; Connolly and Hill, 1991; Davis and Croteau, 2000; Leung and 
Giraudat, 1998; Peralta-Yahya et al., 2011a). 
Artemisinin from the Artemisia annua plant and several semisynthetic derivatives have 
been adopted as frontline drug to treat drug resistant malaria and is unique in the sense that 
it kills young ring stage parasite and therefore a more rapid reduction in parasitemia  
(Meshnick et al., 1996). The reliance on cultivation of the Artemisia annua plant made 
global prices of artemisinin to fluctuate between US$350 and US$1700 per kilogram but 
the advent of microbial production, prices are expected to reduce significantly to US$100 
per kilogram (White, 2008). Another sesquiterpene with great pharmaceutical potential is 
the β-elemene. This compound has been shown to have anti-cancer activities across several 
cancers such as brain, lung, prostate , cervical, ovarian and breast cancers as well as 
melanoma and leukemia (Chen et al., 2011; Li et al., 2010, 2005; Tao et al., 2006; Wang et 
al., 2005; Yu et al., 2011). It is naturally foundalongside germacrene-A as the main 
constituent of the oils from the leave of the cedar  Cedrela odorata and also produced by 
the cheese associated fungi  Penicillium roquefortiand has also been extracted from over 50 
chinese herbs and plants(Larsen, 1997; Maia et al., 2000; Tan et al., 2011).  
 
2.3.3.2.3 Diterpenes 
The diterpenes are 20-carbon compounds that are made from the 20-carbon geranylgeranyl 
diphosphate precursor but unlike the sesquiterpenes are made through the plastidial DXP 
pathway in plants (Gómez-Galera et al., 2007). There are several important diterpenes 
including the phytohormone gibberellic acid, the antimicrobial casbene and the anticancer 
taxol (Davis and Croteau, 2000). Gibberellic acid produced from the fungus Gibberella 
fujikuroi is useful as a plant growth hormone and also used in the malting step in the 
brewing of beer (Hanson, 2007). Taxol from the bark of Taxus brevifola is perhaps the best 
known diterpene. Taxol marketed as paclitaxel and its several structural derivatives are 
touted as the most potent and commercially successful anticancer drugs (Kingston and 
Newman, 2007). It is active against a wide array of cancers such as breast, ovarian, 
cervical, lung and head and neck cancers (Jennewein and Croteau, 2001). 
 
2.4 Cytochrome P450 superfamily 
2.4.1 Discovery and spectral characteristics 
The cytochrome P450s (CYPs) were discovered as a result of the pioneering work of 
several researchers in the late 1940s to the early 1960s who greatly benefitted from the 
development at that time of three key scientific instruments namely, the mass spectrometer, 
the double beam rapid scanning spectrophotometer and the oxygen electrode (Estabrook, 
2003). It was Hayaishi et al (1951) in 1950, who discovered the oxidation of catechol to 
muconic acid by the incorporation of one atom of oxygen by an enzyme contained in soil, 
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which he named pyrocatechase. He subsequently went on to show that the oxygen atom 
that was incorporated into the substrate was from molecular oxygen and not water as 
previously believed and this group of enzymes were then named dioxygenases (Hayaishi 
and Stanier, 1951; Hayaishi, 2005). In 1958, Klingenberg first reported the presence of an 
unusual pigment in rat liver microsomes which was capable of binding carbon monoxide 
when reduced with a characteristic absorption peak at 450 nm (Garfinkel, 1958; 
Klingenberg, 2003). This pigment was later shown to be a heme protein, containing 
protoheme IX and was given the name cytochrome P450 (Omura, 1999). Buoyed by this 
discovery, Estabrook and colleagues confirmed the hydroxylation capacity of cytochrome 
P450 (Estabrook et al., 1963). They realised that the adrenal cortex microsomes which 
catalysed the C-21 hydroxylation of 17-hydroxyprogesterone had exactly the same carbon 
monoxide binding properties of the cytochrome P450 hemoprotein. Further confirmation 
that the cytochrome P450 served as a terminal oxidase of several other reactions came soon 
after, when it was shown that carbon monoxide also inhibited the liver microsome 
catalysed oxidative demethylation of aminopyrine (Orrenius et al., 1964). Indication that 
the enzyme was indeed ubiquitous with multiplicity of forms was shown by Alvares et al 
(1967). They observed in their experiments that there was a shift of the absorption 
maximum from 448 nm to 450 nm of the CO-complex of reduced P450 present in liver 
microsomes from animals treated with methylcholanthrene as compared to those from 
animal liver microsomes treated with phenobarbital (Alvares et al., 1967). Since the first 
paper on cytochrome P450 was published in 1962, the volume of knowledge and 
publications have increased dramatically with more than a thousand papers per annum 
since the late 80s (Estabrook, 2003). A survey of publications containing “cytochrome 
P450” in their title in the Web of knowledge database (accessed: 18/07/13) reveals that a 
least five hundred publications per annum has been maintained since the mid 1990s. This is 
seen in Figure 2.4 
 
 Figure 2.4 Number of cytochrome P450 publications since the 1980s (Source: Web of 
Knowledge) 
Cytochrome-P450s are characterised by their vivid orange-yellow pigment on 
complexation with carbon monoxide. An intense soret absorption maximum band at 450 
nm in the UV spectrum which is reversible by light, and hypothesised to be due to the trans 
configuration between the cysteinate and carbon monoxide ligands of the prosthetic heme 
group (Dawson and Sono, 1987; Klingenberg, 2003). This characteristic soret peak is a 
feature that is shared only with the chloroperoxidases, and nitric oxide synthases (Griffin, 
1991; Stuehr and Ikeda-Saito, 1992). 
 
2.4.2 Occurrence and distribution 
The cytochrome P450s are a group of ubiquitous hemoproteinoxygenases that are found in 
all branches of the tree of life (Nebert et al., 1989). More than 11,000 genes encoding 
P450s have been identified in all kingdoms of life distributed in approximately 977 families 
to date and these are collected and updated by David Nelson 
(http://drnelson.uthsc.edu/P450.statistics.Aug2009.pdf). The cloning and characterisation 
of a cytochrome P450 in the archaeon, Sulfolobus solfataricus(McLean et al., 1998) and 
with at least 18 sequences discovered in the archaeabacteria to date, suggest that these 
enzymes are very ancient. The great diversity, occurrence and distribution of cytochrome 
P450 suggests that they could be involved in essential or critical metabolism such as 
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defense against environmental pollutants, drugs detoxification, synthesis of important 
molecules amongst others even though a few primitive forms of bacteria like E. coli do not 
have the enzyme (McLean et al., 1998). Cytochrome P450s are found as soluble proteins in 
prokaryotic cytosols, while in eukaryotes, they are mostly found in the endoplasmic 
reticulum as well as in the mitochondria, and all except the bacterial cytochrome P450s are 
membrane proteins anchored on the endoplasmic reticulum or the inner mitochondrial 
membrane by a transmembrane amino terminus(Nelson and Strobel, 1988). 
In mammals, P450s are expressed in most tissues such as kidneys, prostate, brain and 
placenta (Waterman, 1992; Williams et al., 2000). However, it is in the liver that they are 
most abundant where they are found in the smooth endoplasmic reticulum, occupying more 
than 1% of the total weight of the liver hepatocytes (Williams et al., 2000). 
 
2.4.3 Nomenclature and Structure  
The intense interest in cytochrome P450 system as a result of its intriguing properties and 
characteristics has yielded significant results over the decades as fallout of the efforts of 
chemists, biophysicists, pharmacologist, biochemists and molecular biologists (Denisov et 
al., 2005). The cytochrome P450 superfamily nomenclature is based on sequence similarity 
in which sequences with a 40% amino acid sequence identity are collected into a single 
family and subfamilies are grouped based on more than 55% similarity with subfamily 
members designated by capital letters (Nelson et al., 1993).  The cytochrome P450s are 
also classified based on their electron carrier protein and system of electron delivery that 
they use to supply the required electrons into ten classes (Hannemann et al., 2007). These 
are illustrated in Table 2.3 
 
 
 
 
 
Table 2.3 Classes of P450 systems based on electron transport protein 
Class/source Electron transport chain Localization 
Class I 
Bacterial  NAD(P)H►[FdR]►[Fdx]►[P450 cystosolic, soluble 
Mitochondrial  NADPH►[FdR] ►[Fdx]►[P450] P450: inner mitochondrial 
membrane                                                                                                                       
FdR: membrane associated                                                                                                                       
Fdx: mitochondrial matrix, soluble 
Class II 
Bacterial  NADH►[CPR]►[P450]                                      cystosolic, soluble;  
Sulfolobuscarbophilus 
Microsomal A NADPH►[CPR]►[P450]    membrane anchored, ER 
Microsomal B NADPH►[CPR]►[cytb5]►[P450
]                 
membrane anchored, ER 
Microsomal C NADPH►[cytbRed]►[cytb5]►[P
450] 
membrane anchored, ER 
Class III 
Bacterial  NA (P)H►[FdR]►[Fdx]►[P450]                   cystosolic, soluble, 
Citrobacterbraakii 
Class IV 
Bacterial  Pyruvate, 
CoA►[OFOR]►[Fdx]► P450]             
cystosolic, soluble, 
Sulfolobustokadaii 
Class V 
Bacterial  NADH►[FdR]►[Fdx-P450]   Cystosolic, soluble, 
Methylococcuscapsulatus 
Class VI 
Bacterial  NAD(P)H►[FdR]►[Fldx-P450]                              Cystosolic, soluble                                                                                                                         
R. rhodococcusstrain 11Y 
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Class/source Electron transport chain Localization 
Class VII 
Bacterial  NADH► [PFOR-P450]                                            Cystosolic, soluble,                                                                                                                        
Rhodococcussp strain NCIMB 
9784,                                                                                                                             
Ralstoniametallidurans 
Class VIII 
Bacterial,  
fungi 
NADPH►[CPR-P450]     Cystosolic, soluble                                                                                                                       
Bacillusmegaterium, 
Fusariumoxysporum 
Class IX 
Only NADH 
dependent, 
fungi    
NADH►[P450] Cystosolic, soluble, 
Fusariumoxysporum 
Class X 
Independent in 
plants/mamma
ls        
       [P450]                                                   membrane bound, ER 
 
Fdx (iron-sulfur-cluster); FdR (ferredoxinreductase (FAD)); CPR (cytochrome P450 reductase, (FAD, 
FMN)); Fldx (flavodoxin, (FMN)); OFOR (2-oxoacid:ferredoxinoxireductase (thiamine pyrophosphate, [4Fe-
4S] cluster)); PFOR (phthatate-family oxygenasereductase (FMN, [2Fe-2S] cluster)). Reproduced from 
(Hannemann et al., 2007) 
 
With an average mass of 50 kDa (Spatzenegger and Jaeger, 1995), the enzyme is made up 
of a protein component and a heme prosthetic group around which the catalytic properties 
are built. The conserved domain of cytochrome P450 is made up of a three parallel helices 
called D , L and I and an antiparallel helix, E and a prosthetic heme which is sandwiched 
between the proximal L and distal I helices respectively (Montellano, 2005, 1995; Poulos et 
al., 1987). The proximal L helix contains the absolutely conserved cysteine that serves as 
the proximal or fifth ligand of the heme iron (Nelson and Strobel, 1988). The cysteine- 
heme ligand loop contains the signature sequence of the cytochrome P450s 
FxxGx(H/R)xCxG (Denisov et al., 2005). In addition, cytochrome P450s contain regions 
within the protein that are responsible for substrate recognition and channelling referred to 
as substrate recognition sites (SRS) (Gotoh, 1992; Roussel et al., 2000). These SRS which 
are six in number are responsible for the specificities and selectivity exhibited by these 
enzymes and mutations can drastically affect substrate specificity of any enzyme (Gotoh, 
1992). 
A greater insight into the uniqueness of cytochrome P450 was revealed when the first 
crystal structure from CYP101 (P450cam) of the enzyme was published (Montellano, 1995). 
Subsequently, several other structures have been solved and deposited in the protein data 
bank. With over 51 unique structures either substrate bound or free enzyme crystallized (for 
example see 3G5F, 3E5J, 3B4X, 3DAM, 2Q9G in the PDB: 
http://www.pdb.org/pdb/home/home.do), this has given sufficient evidence of the unique 
fold of cytochrome P450 which is yet to be seen in any other enzyme system (Montellano, 
2005). Despite less than 15% protein sequence homology across families, the structural 
core remains essentially conserved suggesting that the tertiary structure evolved to bring all 
the essential components together irrespective of source or location (Degtyarenko and 
Archakov, 1993)  which perhaps explains the common mechanism of oxygen activation. 
Despite this conservation of tertiary structure across families, the observation that many 
cytochrome P450s especially the drug metabolising ones in humans have a very wide range 
of substrates specificities suggests some element of variability. This is indeed the case, as 
the most variable regions in the structure across families have been confirmed to be the F 
and G helices (SRS2 and SRS3) and their connecting loop which can change from open to 
close conformation (Poulos, 2005) favouring an induced-fit mechanism for substrate 
binding (Pylypenko and Schlichting, 2004). 
 
2.4.4 Reactions catalyzed by cytochrome P450  
The Earth’s atmosphere changed from a reducing one to an oxidising one about 2 billion 
years ago, as evidenced by the dating of banded iron formations as a result of the 
photosynthetic activities of cyanobacteria (Lewis, 2001; Marguilis et al., 2000). This 
increase in atmospheric oxygen was essential for evolution from simple forms to more 
Literature review 
31 
 
complex multi-cellular organisms that invariably required oxygen for their metabolism. In 
order to utilize the oxidative properties of oxygen, which is normally chemically inert to 
organic compounds, nature had to evolve key enzymes with the capacity to activate oxygen 
from its triplet ground state to the active singlet excited state needed for essential 
metabolism such as biosynthesis, growth and respiration, of these organisms (Hamdane et 
al., 2008; Lewis, 2001). The cytochrome P450s are involved in three fundamental 
functional roles in organisms. Firstly, they are needed for the synthesis of essential primary 
metabolites such as synthesis of steroid hormones in mammals required for growth and 
development and homeostatic regulation (Ioannides, 1996). Secondly, they are responsible 
for metabolism and detoxification of exogenous molecules for removal from the organism 
as a protective measure such as the phase I biotransformation of drugs in humans by liver 
cytochrome P450 (Spatzenegger and Jaeger, 1995). Lastly, they are major players in the 
biosynthesis of many secondary metabolites whose role to the organisms may not yet be 
evident but which are highly sought for their useful roles as medicines amongst others 
(Montellano, 2005). The role of cytochrome P450 as detoxifiers in animals is thought to be 
a co-evolutionary response to the production of potentially toxic plant P450 metabolites 
(Gonzalez and Nebert, 1990) and in general, cytochrome P450s present in non-animal 
species have a role in the metabolism of endogenous substrates primarily (Lewis, 2001). 
As with all other enzymes, cytochromes P450s are able to catalyse reactions at 
physiological conditions by reducing the activation energies of the reactions. Uniquely 
however, cytochrome P450s do this principally by gradually increasing the oxygen-oxygen 
bond length with resultant reduction of the oxygen-oxygen bond energy that eventually 
leads to splitting of the dioxygen bond for substrate monooxygenation (Lewis and Pratt, 
1998). The interest in these enzymes is not only due to this, but also due to their unique 
spectral properties, wide range of substrate classes, selectivity and specificity, and 
significantly also by the diverse range of reactions that they catalyse (Coon et al., 1996; 
Groves, 1997).The one electron reduction of the heme moiety changes the oxidation state 
of iron to a high spin ferrous state which enables binding of molecular oxygen to produce a 
ferrous cytochrome P450-dioxygen complex. A second one electron reduction of the 
ferrous cytochrome P450-dioxygen complex and protonation produces a low spin ferric 
hydroperoxy state. 
A second protonation and subsequent cleavage of the dioxygen bond gives the highly 
reactive compound I which is a Fe (IV)=O compound. The second oxygen atom is reduced 
to water. The oxygen atom from compound I is transferred to the bound substrate with 
subsequent dissociation to form the oxygenated products as seen in Figure 2.5 
 
Figure 2.5 Cytochrome P450 catalytic cycle 
 
2.4.5 Cytochrome P450 metabolic pathways 
The cytochromes P450s have been employed by nature to catalyze numerous synthetic and 
catabolic processes in organisms for the overall wellbeing of these organisms. The 
metabolic pathways that utilize cytochrome P450s either for synthetic, catabolic or 
biotransformation are very numerous and diverse. 
 
2.4.5.1 Primary metabolism of cytochrome P450 
2.4.5.1.1 Endogenous metabolism of cytochrome P450 
           Cytochrome P450s are critically involved in many essential endogenous metabolic aspects 
of cells that are required for growth and development, homeostatic regulation, signalling, 
embryogenesis and defences (Lamb et al., 2006; Stoilov et al., 2001; Zerbe et al., 2002). 
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They are involved in the biosynthetic pathway of several molecules that are essential for 
the physiological functions of many organisms from simple prokaryotes to the complex 
multi-cellular mammals. In mammals, cytochrome P450 play critical roles in the synthetic 
pathway for the synthesis of prostaglandins, fatty acids, steroids, bile acids, fat soluble 
vitamins and sex hormones. These synthetic P450 are generally product specific i.e. they 
yield one product as opposed to the multipurpose xenobiotic metabolising cytochrome 
P450 (Schenkman, 1992; Stoilov et al., 2001). Many steroids and steroid hormones in 
mammals use cholesterol as the precursor which is produced by the action of CYP51 and 
the actions of several other cytochrome P450 such as CYP11A1, CYP17A1, CYP11B1, 
CYP19A1, CYP21A1 at various points leading to the production or interconversion of 
several steroid hormones such as progesterone, corticosteroids, oestrogen, and testosterone 
(Lewis, 2001; Payne and Hales, 2004). This has resulted in the suggestion of targeting 
some of these CYPs for cholesterol control (Pikuleva, 2006). 
In plants, cytochrome P450 activities are even more essential as they inherently rely on 
CYPs for most of their biological functions (Bolwell et al., 1994; Morant et al., 2007; 
Nelson, 2006). The highest number of CYP genes are found in plants, and since the cloning 
of the first plant CYP gene in 1990 (Bozak et al., 1990), at least 4200 other CYP genes 
have been discovered to date (http://drnelson.uthsc.edu/P450.statistics.Aug2009.pdf)and 
these genes constitutes up to 1% of the total protein coding genes (Nelson et al., 2008). In 
addition to using CYPs for synthesis of several secondary metabolites, plants use CYPs for 
the synthesis of primary metabolites such as plant hormones/signalling compounds 
(gibberellins, absicic acid, and brassinosteroid), cytokinins, lignin, defence compounds, 
UV-protectants, fruit and flower colour (Bolwell et al., 1994; Choe et al., 1998; Clouse et 
al., 1996; Durst and Nelson, 1995; S.D Clouse and Sasse, 1998), these are classified into 
four basic classes as summarised in Table 2.4 
The evolutionary phylogeny of plants CYPs shows that the earliest P450 families are 
needed for such primary function as biochemistries of sterol and carotenoid synthesis, 
followed by those CYPs families apparently needed for their roles in adaptations to a land 
environment, while the newest CYPS families are thought to be mainly responsible for 
synthesis of pigments, flavours and specie specific secondary metabolites (Nelson et al., 
2008). 
 
 Table 2.4 substrate classes of plant cytochrome P450s. Reproduced from (Lewis, 2001). 
 
Class Example P450 enzyme 
Phenylpropanoids 
     Lignin 
     Pigments 
  UV-protectant 
 
Cinnamic acid 
 
CYP73 
Terpenoids 
   Steroids 
   Hormones 
   Defence molecules 
   Aroma/odorant molecules 
 
Geraniol 
 
CYP71 
Fatty acids 
Cutin precursors 
Suberin precursors 
Defence molecules 
 
Oleic acid 
 
CYP94 
Diverse substrates Tyrosine CYP79 
 
Microbial species, unlike higher species of plants and animals are not yet known to require 
CYPs for essential metabolism except for CYP51 which is found in animals, plants, fungi, 
protists and some bacteria, and is required in the synthetic pathway for steroid biosynthesis 
(Lepesheva and Waterman, 2007). Their roles in secondary metabolism and natural product 
biosynthesis will be examined in later sections.  
 
2.4.5.2 Secondary metabolism and P450 based natural products 
Most of the reactions that are catalysed by cytochrome P450 that are of most use to man in 
plants and microbes are from the so called secondary metabolic pathways with cytochrome 
P450 involved in key products such as codeine, morphine and erythromycin (Cupp-Vickery 
and Poulos, 1995; Schwab, 2003a; Unterlinner et al., 1999). Secondary metabolites are 
usually not produced constitutively by organisms but may be produced during periods of 
Literature review 
35 
 
stress and may not be essential for normal physiological functions (Mann, 1987), as such 
many serve as natural products, harvested for their medicinal and other applications. 
Cytochrome P450 in microbes as in plants, are numerous and very diverse. This is 
demonstrated by cataloguing of the abundance of CYP genes in their genomes, with 2570 
fungal, 905 bacterial, 22 archaeal and 247 protists 
(http://drnelson.uthsc.edu/P450.statistics.Aug2009.pdf), collated to date (18/07/2013). 
There is, though as yet no delineated structural or physiological role reported to date apart 
from CYP51 (Kelly et al., 2001). It can be inferred from this that they are mostly employed 
in secondary metabolism. Despite this abundance of CYPs in microbial genomes, there are 
still several such organisms as E. coli without CYP genes (Montellano, 2005), which 
further buttresses the point that CYPs may not be necessary for primary metabolism. CYPs 
in plants, fungi and bacteria are responsible for the biosynthesis of important products 
(Table 2.5) and with more than 100,000 natural products produced in plants, CYPs are 
known to be active in most of the pathways (Montellano, 1995; Schwab, 2003b). The 
classes of secondary metabolites produced by plants and microbes that have significant 
CYP activity in their synthetic pathway include isoprenoids, alkaloids, phenylpropanoids, 
and fatty acids as well as in the polyketide synthetic pathway (Edwards et al., 2004; Lewis, 
2001). In the synthesis of macrolide antibiotics such as methymycin, amphotericin and 
erythromycin, the cytochrome P450 is responsible for imparting functionality and 
specificity through their site- specific modifying reactions (Carmody et al., 2005; Donadio 
et al., 1993). Several other therapeutic agents produced in microbes such as the antibiotics 
vancomycin from Streptomyces orientalis, amphotericin B from Streptomyces nodosus, 
erythromycin from Saccharopolysporaerythraea, the anticancer, adriamycin have CYPs 
actively involved in their biosynthetic pathway (Hopwood, 2007; Levine, 2006). The 
antimitotic indole alkaloids vincristine and vinbalstine used in cancer chemotherapy is 
biosynthesised by Catharanthus rosea (Madagascar periwinkle) using CYP71D12 
(Schröder et al., 1999). 
 
 
 
 
 
 
 Table 2.5 Examples of cytochrome P450 catalysed bioactive natural products 
Source organism Compound Activity References 
Lyngbya majuscula Hectochlorin Antifungal 
(Ramaswamy et al., 
2007) 
Saccharopolypspora 
erythraea 
Erythromycin Antibacterial 
(Cupp-Vickery and 
Poulos, 1995) 
Streptomyces 
nodosus 
Amphotericin Antifungal (Lamb et al., 2006) 
Streptomyces 
avermitilis 
Avermectin Antiparasitic (Lamb et al., 2003) 
Aspergillus 
fumigatus 
Fumitremorgin C Anticancer 
(Grundmann et al., 
2008) 
Catharanthus rosea Vincristine Anticancer 
(Schröder et al., 
1999) 
Taxus brevifola Taxol Anticancer 
(Walker and 
Croteau, 2001) 
Artemisia annua Artemisinin 
Antiparasitic/anti-
malarial 
(Bertea et al., 2005) 
Papaver somniferum Morphine Opiate, analgesic 
(Pauli and Kutchan, 
1998b) 
Streptomyces 
avermitilis 
Filipin Antifungal (Xu et al., 2010) 
 
2.4.6 Cyanobacterial P450s 
Several cytochrome P450 and cytochrome P450-like genes have been identified in 
cyanobacterial genomes but little attention has been given to their functional 
characterisation. Cyanobacteria, especially those from the marine environment have been 
implicated as prolific producers of natural products (Adam M. Burja et al., 2001; Faulkner, 
1988; Herrero and Flores, 2008; Hoffmann et al., 2003; Simmons et al., 2005; Trimurtulu 
et al., 1994b), and as evidence for the importance of cytochrome P450s in production of 
secondary metabolites in many organisms has been presented above, it would be beneficial 
to investigate any linkage between them. There is ample evidence that cytochrome P450 in 
cyanobacteria participate in specific metabolic processes and did not arise as a result of 
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isolated gene transfer and the crystal structure of CYP120A1 has proved that it indeed 
participate in retinoid metabolism (Alder et al., 2009; Ke et al., 2005; Kühnel et al., 2008). 
However, most of the presently known natural products from cyanobacteria are produced 
through the NPRS, PKS or NRPS/PKS pathway (Jones et al., 2009; Wase and Wright, 
2008). It is a little surprising that the first cloning, heterologous expression and functional 
characterisation of a cytochrome P450 in a cyanobacterial specie was only done as recently 
as 2005(Ke et al., 2005) despite the importance of both the organism and the molecule. It is 
emerging that cyanobacteria have several CYPs in their genomes. A BLASTp search in the 
NCBI cyanobacterial genome database using the characterised protein NP_488726 from 
Nostoc sp. strain PCC 7120 (Agger et al., 2008b) or CYP120A1 from  Synechocystis sp. 
PCC 6803 (Kühnel et al., 2008) gives 100 putative cytochrome  P450s sequences 
distributed in most of the known cyanobacterial species as seen in Figure 2.6, 63 of these 
proteins have been characterised and named with most (30) belonging to the CYP110 
family, 12 fall into CYP213 family while CYP120 family currently has 10 members. 
CYP110 from Nostoc sp. strain PCC 7120 unlike most bacterial CYPs is not a cytosolic 
enzyme but membrane bound just like eukaryotic CYPs; not induced by alkanes or 
participates in alkane biodegradation but is involved in ω-hydroxylation of long chain fatty 
acid and play a role in nitrogen fixation (Wase and Wright, 2008). 
 
 Figure 2.6 Phylogenetic tree of cytochrome P450 in cyanobacteria generated through 
BLASTP search in NCBI cyanobacterial database using NP_488726.  
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2.5 Metabolic Engineering 
The availability of natural products for potential therapeutic and other uses is often limited 
by the ability of the primary producers to yield enough products and in renewable 
quantities (Chang and Keasling, 2006). Natural products are endowed with complex 
structures with many chiral centers that are essential for their unique biological roles 
(Koehn and Carter, 2005). However, total chemical synthesis of these complex structures 
have proved quite difficult and when successful, the yield may be poor or may not be as 
effective (Chemler and Koffas, 2008; Koehn and Carter, 2005). Extraction of these very 
important natural products from their natural host is not without problems. Firstly, they are 
produced at unappreciable levels (Kirby and Keasling, 2009). Secondly, they may be 
produced in a complex mixture with other less useful products, making downstream 
separation quite difficult (Koehn, 2008; Martin et al., 2003a). Thirdly, many of these 
products are mined from rare and exotic species that raise very serious issues of 
conservation in addition to the prohibitive cost of production in their natural host and 
unpredictable impact on the environmental. It has been shown that it requires a minimum 
of six 100-year Pacific yew trees to yield adequate quantities of taxol for the treatment of a 
single patient and although total chemical synthesis is now possible, there are associated 
issues of product yield and cost to consider (Horwitz, 1994; Wessjohann, 1994). 
The development of metabolic engineering has been spurred not only by the major 
challenges of the 21
st
 century such as climate change, renewable energy, food security, 
pollution and health but also by development of new technologies (Betenbaugh and 
Bentley, 2008; Lindberg et al., 2010). Metabolic engineering was first defined by James 
Bailey as “the improvement of cellular activities by manipulation of enzymatic, transport, 
and regulatory functions of the cell with the use of recombinant DNA technology”(Bailey, 
1991). James Bailey who was a pioneer in the field saw the cell as a production line only, 
and he proposed the recruitment of heterologous activities for strain improvement and the 
redirecting of metabolic flow at branch points as the essential strategies for metabolic 
engineering. Stephanopoulos (1999) went a bit further in 1994 when he defined metabolic 
engineering as “the design of biochemical reaction network to accomplish a certain 
objective”. His definition, though less constrained, was still limited. However, with the 
advent of the post genomic era, availability of new tools and technologies and development 
of system biology/synthetic biology, there has been a paradigm shift from seeing the cell as 
a production line to that of a production factory (Cortassa, 2002; Kholodenko and 
Westerhoff, 2004; Smolke, 2009). This shift in focus from reductionist view to a system 
wide view of the cell as a system of elements with complex regulatory network operating at 
different levels, has given impetus to the development of synthetic biology which is a 
subject that aims to design and construct novel biological entities or modify already 
existing ones for enhanced productivity (Fu and Panke, 2009). Hence metabolic 
engineering has been recently defined as a systemic approach to the problem of 
remodelling and reconfiguring the many pieces of the cell through careful understanding 
and measurement of how small changes affect the network as a whole (Tyo et al., 2007). 
The ultimate aim is to achieve strain improvement and cell engineering using 
transcriptomics, proteomics, metabolomics, computational systems biology, protein 
engineering and synthetic biology. Metabolic engineering as depicted in Figure 2.7 can be 
seen as a product pathway that is fed by other stand-alone pathways with a common 
general theme. 
 
 
 
Figure 2.7 Metabolic engineering in relation to other complementary fields. 
Reproduced from (Tyo et al., 2007) 
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The success of metabolic engineering has been astounding so far with many useful 
compounds already produced through metabolic engineering in the two decades of the 
discipline. In therapeutics, several drugs or drug leads such as the antimalarial compound 
artemesinin and the anticancerous drug taxol which hitherto were produced exclusively by 
cultivation have either been wholly heterologously synthesized or a biosynthesis of their 
direct precursor achieved (DeJong et al., 2006a; Dietrich et al., 2009a; Ro et al., 2006a). In 
addition several other molecules such as isoprenes, flavonoids, dihydroxyacetone and 
ethanol have been produced in high titre (20.8 mg/l of naringenin, 700 mg/l 
dihydroxyacetone, 0.46 g/g of ethanol) through metabolic engineering (Nguyen and 
Nevoigt, 2009; Trantas et al., 2009; Watts et al., 2004). Many of these pathways have 
multiple cytochrome P450 enzymes at critical points of the pathway. In this project a 
proteomics based approach is proposed to evaluate the systemic changes in a terpene 
producing E. coli mutant. This could provide a rational basis for engineering an improved 
strain. 
 
2.5.1 Proteomics 
The proteome of a cell is the total protein complement expressed by the genome of that cell 
(Wilkins et al., 1996); and the proteome unlike the genome is dynamic and subject to 
environmental influences and conditions. As opposed to the gene expression focus of 
transcriptomics which is ‘blind’ to post translational modifications, proteomics gives a 
more biological representation of cellular activities of the cell at any time point (Han and 
Lee, 2006). Proteomics looks at the proteins not as single separate entities but as part of 
dynamic interacting system that change with time and conditions (Liebler, 2002). To this 
end, proteomics has shown significant rapid development from the traditional 2-
dimensional electrophoresis 2DE gel based methods to the present day mass spectrometry 
based gel–free (shotgun) proteomics (Evans et al., 2012; Ow and Wright, 2009; Peng and 
Gygi, 2001; Wilkins et al., 1996). While 2DE gel saw to the birth of proteomics, it soon 
became obvious that it was very labor intensive, low abundance proteins were mostly 
missed and also excluded very acidic/basic proteins, very large and small proteins as well 
as membrane proteins (Aebersold and Mann, 2003; Gygi et al., 2000; Peng and Gygi, 
2001). For these reasons other methods of protein separation without the use of 2DE gels 
were developed and optimized. These methods aim to reduce the complexity of the 
protein/peptide mixture typically through liquid chromatography before MS analysis. MS-
based proteomics can be used to identify and quantify relative and absolute protein 
expression profile of a cell, the post translational modifications that these proteins have 
undergone as well as the protein interactions (Cox and Mann, 2011). Not only is MS-based 
proteomics useful for ‘shotgun’ system wide investigations and application but as seen in 
the work of Redding-Johanson et al. (2011a) can be applied to specific small-scale projects 
as ‘targeted proteomics’ with significant outcome. Targeted proteomics uses the same basic 
proteomic pipeline as shotgun proteomics, but in this case focus is placed on a small set of 
known protein targets for fast analysis and with a significantly greater dynamic range and 
sensitivity (Picotti et al., 2009). 
There have been significant improvements in proteomics and as such the proteome 
coverage has also shown significant leap from about 50% in unicellular organism 
(Bantscheff et al., 2007)to almost 100% for the yeast proteome as reported by Mann et al. 
(2013). These improvements have been achieved through a combination of liquid 
chromatographic improvements through high pressure-high performance liquid 
chromatography with long column and gradient and high resolution mass spectrometry 
(  cher et al., 2011  ann et al., 2013). 
The modern quantitative proteomic tool box has two basic paradigms: the stable isotope 
label and label-free methods. Several stable isotope labeling methodologies from in vivo 
metabolic labels such as stable isotope label of amino acid in cell culture (SILAC) to in 
vitro labeling techniques such as enzymatic labelling, isotope-coded affinity tagging 
(ICAT, tandem mass tag (TMT) and isobaric tag for relative and absolute quantification 
(iTRAQ) each of which has its advantages and disadvantages (Evans et al., 2012; Gygi et 
al., 1999; Miyagi and Rao, 2007; Ong et al., 2002; Ross et al., 2004; Schmidt et al., 2005; 
Thompson et al., 2003). This high-throughput method of looking at the cell would give a 
pictorial view of the functional dynamics of the cell and the consequences of any external 
or internal stimuli or stresses. This would also enable a better understanding of the 
metabolic and regulatory adjustments that a cell makes in order to continue to survive in 
the face of a stressful input. Understanding the metabolic and regulatory perturbation of a 
cell (through iTRAQ-based proteomics) as a result of a single or multiple stimuli or stresses 
could potentially provide a tool box to redirect or tailor the organism towards a desired 
productive end.  
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2.5.1.1 iTRAQ-bases proteomics 
iTRAQ was first described in 2004 as a multiplexed quantitation strategy for relative and 
absolute quantification of proteins in a complex mixture (Ross et al., 2004). This method as 
the name implies uses isobaric chemical labels to derivatize the peptides or proteins for 
subsequent MS analysis. The label is a molecule of three parts; a methylpiperazine reporter 
group and an N-hydroxysuccinimide ester (NHS) primary amine reactive group linked by a 
balancing carbonyl group (Fig 2.4). It forms covalent bonds by attaching to the N-terminus 
and to the epsilon-amine group of lysine side-chain residues of proteins or peptides. During 
the labelling reaction, the NHS-ester acts as a leaving group, whilst the reporter and the 
normalizer groups are attached to the peptide or protein. By distributing strategically stable 
isotopes of carbon or nitrogen or oxygen (light and heavy 
12
C/
13
C, 
14
N/
15
N and 
16
O/
18
O) 
across the reporter and normalizer groups, reporter ions of different masses are generated 
without altering the total mass of reagents. The mass of the reporter and balance groups are 
maintained at 144 Da for the 4-plex (Figure 2.8) and 304 Da for the 8-plex with the 
piperazine group ranging in mass from 114.1, 115.1, 116.1 and 117.1m/z for a 4-plex and 
113.1, 114.1, 115.1, 116.1,117.1 118.1, 119.1 and 121.1 m/z for an 8-plex (Pichler et al., 
2010).The isobaric nature of the labels ensures that they are indistinguishable when bound 
to peptides from different samples such as mutant or wild type and can then be used to 
quantify peptides when they undergo collision-induced dissociation to release the reporter 
ion which populate the low mass region of the MS/MS spectrum. The multiplex capabilities 
allows for analysis of up to 8 samples derived from different conditions in one experiment. 
The relative peak intensities of these reporter ions directly correlate to the relative 
abundance of the peptide and hence the protein from which the peptide is from. Since 
quantitative information in iTRAQ is obtained from tandem MS,  the same peptide from 
each sample appears as a single peak in the MS spectrum with reduced complexity with 
significant reduction in the chemical noise and therefore increase in sensitivity compared to 
ICAT(Aggarwal et al., 2006; Evans et al., 2012). When compared to 2DE,  iTRAQ permits 
multiplexing and biological/technical replication of samples for better statistical analysis, 
gives more reproducible results and is versatile enough to quantify proteins across 
functional categories cellular location as well as abundance level (Aggarwal et al., 2006; 
Leitner and Lindner, 2006). iTRAQ-based quantification have been shown to have good 
precision due to the equal distribution of errors across the low mass quantification region. 
The detection of regulated proteins (up and down) is usually not compromised (Li et al., 
2012; Pichler et al., 2010; Udeshi et al., 2012). 
Accuracy is reduced by the existence of isotopic contamination. However, the isotopic 
impurities in the iTRAQ reagents can be corrected when the manufacturer provides 
correction coefficients (this is usually the case for iTRAQ 4-plex). Non-reporter ions, such 
as immonium ions, can also be a source of interference with the reporter ions in the low-
mass region. For example, interference of M+1 peak of the phenylalanine (F) immonium 
ion (with m/z 120.03) interferes with the m/z 121.1 iTRAQ reporter ion. The specific 
interference of the F immonium can be eliminated using correction coefficients (S. Y. Ow 
et al., 2009). Usually, ion contamination is weaker than the reporter ions but this can still 
have a dramatic effect in reporter ion intensities affecting the accuracy of the ratios 
measurements and quantification. Note, that if high resolving power MS platforms are 
used, it becomes possible to confidently differentiate between them and the reporter ions 
(Evans et al., 2012) 
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Figure 2.8 A 4-plex iTRAQ label showing the configuration of the 3 components. 
Modified from (Ross et al., 2004) 
 
Since its discovery, iTRAQ has been employed to study a wide range of systemic 
perturbations in many different cell types such as E. coli, yeast, cyanobacteria,  human cell 
lines (Castrillo et al., 2007; Fuszard et al., 2013; Glen et al., 2008; Mukherjee et al., 2011; 
Ow et al., 2008a). 
 
2.5.2 Analytical methods 
2.5.1.1 SCX/HILIC Chromatography 
The obvious advantages of shotgun proteomics over 2DE based methods have principally 
been due to the power of the separation ability of liquid chromatography. In addition to the 
preferred reasons for using the LC-MS based proteomics outlined above, the efficiency of 
this system is significantly greater and more high-throughput in view of the fact that it can 
be directly coupled to the mass spectrometer either as an online or offline with offline 
offering more advantages (Peng et al., 2003). Multi-dimensional liquid chromatography 
applications employing orthogonal separation significantly reduces the complexities of 
peptide mixture, enhance the resolution with attendant increase in both the proteome 
coverage and dynamic range (Motoyama and Yates III, 2008; Washburn et al., 2001). In 
our lab, a 2-dimensional separation comprising of an offline separation employing either 
strong cation exchange (SCX) or hydrophilic interaction liquid chromatography (HILIC) 
and an online reverse phase (RP) is mostly used in the proteomics workflow.  Both these 
methods take advantage of different physico-chemical properties of the peptides for 
separation.  
SCX chromatography has been widely employed as a first dimensional offline fraction 
method for quantitative proteomics. The separation of peptides takes advantage of the 
electrostatic interaction between the negatively charged polysulfonate stationary phase and 
the positively charged amino acid (caused by low pH of binding buffer). This interaction is 
then modulated by a graded change in ionic strength of the mobile phase with elution of 
peptides across the salt gradient depending on the strength of the ionic interactions (itself a 
function of net charge of peptide, charge distribution/density, peptide length and 
conformation) (Lorne Burke et al., 1989). Some organic solvent is usually added to the 
mobile phase in order to reduce the effect of hydrophobic interaction between the 
stationary phase and the peptides. Ross et al. (2004) have demonstrated that an SCX-HPLC 
is well suited for iTRAQ based quantitative proteomics without any undue influence on the 
labeled peptides. However, the high salt content of eluted peptide fractions may require an 
additional clean up step before RP-MS analysis. 
HILIC unlike SCX uses a hydrophilic stationary phase (polysulfoethyl) with a high 
percentage of hydrophobic organic mobile phase (usually more than 70%) (Alpert and 
Andrews, 1988). The high percentage of organic in the binding buffer causes an enrichment 
of an aqueous layer on the hydrophilic stationary phase in which the hydrophilic peptides 
can partition between the hydrophobic mobile phase and hydrophilic stationary phase 
(Alpert, 1990). The high organic content of HILIC and minimal salt (unlike SCX) means 
that it is more compatible with RP-MS. In HILIC, the gradient is based on gradual 
reduction of the organic solvent and a proportionate increase in the water causing the 
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elution of more hydrophobic (less hydrophilic) first while the more hydrophilic (less 
hydrophobic) are eluted later as the organic solvent is reduced and water increased 
(Naidong, 2003; Zhu et al., 1991). 
HILIC has been reported to have superior separation performance to SCX and is more 
orthogonal to RP (Gilar et al., 2005). HILIC has been successfully applied to iTRAQ based 
proteomics and as shown by Ow et al., (2011a) and Longworth et al., (2012), is superior to 
SCX in reducing under-estimation well as proteome coverage.  
 
2.5.2.2 Tandem Mass spectrometry  
Analysis of molecules by mass spectrometric techniques has seen tremendous development 
spanning several decades but this powerful analytical tool was not available to answer 
biological questions until the early 1990s when both electrospray ionization (ESI) and 
matrix-assisted laser desorption ionization (MALDI) were developed (Hoffmann and 
Stroobant, 2013) and brought with it the era of MS-based quantitative proteomics. This 
development was so significant that the 2002 Nobel Prize in chemistry was awarded in part 
to John B. Fenn and  oichi Tanaka for ‘their development of soft desorption ionization 
methods for mass spectrometric analyses of biological macromolecules’ In proteomics, the 
ESI is usually coupled to a Quadrupole Time-of-flight (Q-ToF) and measures the 
mass/charge (m/z) of eluting peptides fromthe coupled LC. The eluting positively charged 
(using a very low pH carrier buffer of formic acid) peptides from the electrospray are 
‘dried’ using a counter current high temperature gas in a process of  desolvation before 
analysis (Fenn et al., 1989). A survey mass spectrum (MS) is acquired and selected 
peptides are then subjected to further fragmentation (MS
2
) typically under CID conditions 
to produce either N-terminal fragments (b series) or the C-terminal fragments (y series) 
upon which peptide identification is based.  
 In recent years, quantitative MS-based proteomics has benefitted from development of 
very high resolution instrument enabling near total proteome coverage (Mann et al., 2013). 
The resolution of a mass spectrometer defined as the peak width at half maximum height 
divided by mass is a dimensionless quantity with great significance. Instruments with high 
resolutions have made it possible for increased mass accuracies and with the ability to 
differentiate peptides with similar masses and significantly increase the confidence level of 
peptide identification(Cox and Mann, 2011, 2008).  Another factor in mass spectrometer 
performance is the significant increase in speed of acquiring a survey mass spectrum and 
fragmentation of the selected peptides (Andrews et al., 2011; Michalski et al., 2011) 
 
2.5.2.3 Gas chromatography-mass spectrometry (GC-MS) analysis 
Gas phase chromatography connected to a mass spectrometer (quadrupole analyser) has 
been applied to study low molecular weight compounds which have high thermal stability 
and high volatility. Thus GC-MS provides a method for both qualitative and quantitative 
assay of the metabolome of a cell or of specific metabolites and is applied to measure 
volatile, semi-volatile or non-volatile compounds that can be derivatized (Mashego et al., 
2007).  
Metabolites are low-molecular weight organic compounds of less than 1000 Da that are 
produced by the cell and participate in cell metabolism or product  cell metabolism (ter 
Kuile and Westerhoff, 2001).  Some these metabolites as stated earlier are not necessarily 
involved in primary metabolism but are secondary metabolites without defined functions in 
the cell (van der Werf et al., 2005). 
Since one of the goals of metabolic engineering is to achieve reliable, sustainable and 
cheap cell factories for fine chemicals, a robust and reliable method of qualitative and 
quantitative assay of these chemicals would be a necessity.  
The GC-MS (Figure 2.9) is made up of a gas chromatograph attached to a mass 
spectrometer which serves as a detector. The analyte is injected into the injector port either 
in the gas phase or as a liquid which is then vaporized by the high temperature of the 
injection port and carried by an inert carrier gas through to the capillary column in the 
oven. The column provides a platform for interaction between the gaseous mobile phase 
(analyte) and the stationary phase which can be modulated by changes in temperature. The 
chemical properties of the stationary phase as well as the length, diameter and thickness 
determines the interactions between the analyte and the column as well as the binding 
capacity of the column (Hoffmann and Stroobant, 2013). The operation of a temperature 
gradient in the oven enables the constituent to be eluted through the column and reach the 
mass spectrometer.  
In the source of the mass spectrometer, these compounds are then ionised upon 
bombardment with high energy electrons released from a tungsten filament, typically 70 
eV, a Process known as electron ionization (EI).  At the same time they are also fragmented 
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and both molecular ion and fragments are separated by the mass analyser. Once they reach 
the detector electrical signals are generated which are proportional to the abundance of the 
ions in m/z values (Fiehn et al., 2000). 
 
 
 
Figure 2.9 Schematic representation of a GC-MS showing the oven and the mass 
analyser.  
 
However a fast and convenient method of qualitative assay of volatile or semi-volatile 
organic compounds employs the head space sampling and direct injection into the GCMS 
(Zambonin et al., 2004). This solid phase micro extraction (SPME)-GCMS method uses an 
SPME fibre to selectively adsorb and concentrate specific groups of volatile organics from 
environmental samples as well as culture head space (Grimm et al., 2001; Larsen, 1997; 
Nilsson et al., 1996). This provides a convenient way of screening culture samples for the 
presence of an expected metabolite before subsequent extraction and quantitative assay. 
The combined information provided by the gas chromatographic retention time and the 
mass spectra is used to identify the compound(s) or the spectra can be matched through a 
(national institute for standard and technology (NIST) database search.  
 
2.5.3 Engineering of mevalonate pathway 
Due to the wide ranging applications of terpenes in medicine and industry and agriculture 
combined with the limitations imposed by sustainable and commercially viable natural 
sources, heterologous expression in tractable hosts such as E. coli and yeast have proved an 
excellent alternative. These organisms could provide a steady, reliable and cheaper source 
of these terpenes. E. coli has been employed for heterologous expression of terpenes 
because it is a fast growing, cheap to cultivate and has been well-studied with a host of 
wide ranging molecular genetics and bioinformatics resources available (Han and Lee, 
2006).  
Harada et al. (2009) used the mevalonate pathway from yeast starting from HMG-CoA 
with idi 2 with mevalonolactone supplementation to give more than 13 fold (958 µg/mL) of 
α-humulene over a control strain (using native DXP) expressing humulene synthase gene 
using acetoacetate as the carbon source. 
Martin et al., (2003a) engineered a strain of E. coli  containing the seven the MVA pathway 
genes from yeast and the FPP synthase and showed a 40 fold increase yield of 
amorphadiene yield to 110 mg/L with a codon optimized  amorphadiene synthase 
compared to synthesis with native DXP pathway.  This increased to 400 mg/L in a biphasic 
reactor (Newman et al., 2006). Pitera et al. (2007) and Kizer et al. (2008) went further to 
show using a combination of microarray analysis and targeted metabolic profile that further 
strain improvement was compromised by the accumulation of HMG-CoAwhich causes  
inhibition of fatty acid synthesis and this could be relieved by feeding the cells with 
paltmitic acid. An imbalance of single or multiple enzymes could result in the accumulation 
of a precursor(s) and thus compromise pathway carbon flux with negative implications as 
shown by these authors. Further, using targeted proteomic methodologies, it was revealed 
that there was reduced expression of two of the mevalonate pathway enzymes namely 
mevalonate kinase (MK) and phosphomevalonate kinase (PMK) and on that basis, the two 
enzymes were codon optimized and expressed using a stronger promoter and this led to a 
more than 500 mg/L amorphadiene titres  (Redding-Johanson et al., 2011a).  
The mevalonate pathway template or modified forms of it has also been employed with 
other terpene synthases to increase productions of terpenes. Notable examples include a 
more than 900 mg/L production of the biodiesel bisabolene when this was coupled with 
bisabolene synthase (Peralta-Yahya et al., 2011a). Using this pathway, the acyclic 
sesquiterpenefarnesol was produced at a titre of 136 mg/L (Wang et al., 2010). Wang et al. 
(2011) were also able to increase the yield of the bio-jet fuel α-farnesene from a baseline 
production of 1.2 mg/L to 380 mg/L.  
The taxol biosynthetic pathway starting from the Isopentenyl diphosphate/dimethylallyl 
diphosphate precursor is made up of twenty steps, with the first committed step catalysed 
by taxadiene synthase (a terpene synthase) converting gerynylgerynyl diphosphate to taxa-
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4(5), 11(12)-diene. Taxa-4(5), 11(12)-diene subsequently undergoes a series of eight 
cytochrome P450 catalysed reactions and two acylation steps to produce a molecule of 10-
deacetyl baccatin III, which is a direct precursor of taxol (Chau et al., 2004; Hefner et al., 
1996; Jennewein and Croteau, 2001; Wildung and Croteau, 1996). DeJong and colleagues 
(2006b) have described the first metabolic expression for the synthesis of baccatin III in 
yeast cells with some limited success. They succeeded in functionally expressing five genes 
leading to the production of the committed taxadiene and also eight taxoid downstream 
genes, but baccatin III yield was speculatively hampered at the first hydroxylation step 
because they relied on endogenous cytochrome P450 reductase for electron transfer from 
NADPH. However, Engels et al have been able to increase taxadiene production by 40 fold 
to more than 8mg/l in yeast (Engels et al., 2008).This was done by increasing flux toward 
taxadiene synthesis by combining the expression of a truncated version of HMG-CoA 
reductase to increase supply of isopentenyldiphosphate with the expression of a regulatory 
mutant allele of upc2.1 that helps to reduce flux towards competitive steroid biosynthesis. 
On the other hand, Ajikumar et al. (2010) were able to use combinatorial methodologies 
(promoter strength and plasmid copy number) and the native DXP pathway of E. coli  to 
increase titres of taxadiene to 1g/L with limited accumulation of the toxic indole.  
 
 
 
2.6 Conclusions 
Engineering a desired pathway either in the native host or in a heterologous organism is 
never an isolated event whether the process is hypothesis driven or not. 
Every organism has inherent regulatory and metabolic properties which can potentially 
interfere with the expression of an exogenous protein which could cause a wholesale 
targeted degradation, mis-folding or formation of insoluble aggregates because the right 
chaperones are not available, poorly expressed. 
 Any pathway or network that serves as a template for in situ constructive metabolic 
engineering or heterologous inverse metabolic engineering would necessary be a part of an 
existing network or system within that organism or could potentially form part of or affect 
an existing network in the secondary hosts. These secondary networks are linked to other 
networks or pathways which may not be known and which could potentially exert a 
significant control on the engineered pathway. In effect, the consequence of a single 
exogenous gene product may not be localized to a single pathway or an adjacent pathway 
but may actually be felt far afield which may be the cause of failure in such a project 
(Bailey et al., 1996). 
Therefore, for a successful metabolic engineering of any synthetic pathway either 
heterologously, or in the native host, requires a thorough elucidation of the pathway, the 
enzymes involved, their mechanism of action, the structural genes that encode these 
enzymes,  rate limiting steps and the regulatory networks controlling it. Knowledge of all 
the parameters involved in any synthetic pathway will enable the metabolic engineer to 
decide on the system perturbation, iterative/refinement steps and optimization protocol. 
The use of –omics technologies to investigate and direct the rational engineering of 
terpenes is not widespread with the few examples using transcriptomics and targeted 
proteomics have given very encouraging results. A systemic study of a terpene producing 
system in E. coli using iTRAQ-based shotgun proteomics would therefore add a significant 
layer of understanding and thus facilitate further metabolic engineering.  There is however 
no known application of iTRAQ-based proteomics exploration of terpene producing E. coli 
system to my knowledge. This project therefore aims to evaluate the metabolic changes in a 
terpene producing cell factory upon which further strain improvement and refinement can 
be explored. 
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 3.1 Introduction 
In Nostocsp. PCC 7120, a single terpene synthase gene has been identified alongside an 
adjacent cytochrome P450 (Agger et al., 2008). This gene lies in a gene cluster that 
comprise a downstream cytochrome P450 separated by a 21 bp intergenic segment and a 
5.7 Kb sensor (serine/threonine kinase) gene downstream of the cytochrome P450. 
Advances in methodologies for the biosynthesis of important terpenoids from 
cyanobacteria require identification, cloning and expression of these genes a in suitable 
host that is cheap and cost effective. Expression of the terpene synthase and cytochrome 
P450 proteins in a genetically tractable organism such as E. coli provides the advantages of 
low cost, high level of heterologous protein expression, lack of post-translational protein 
modification, scalability and fast turnover (Edwards and Palsson, 2000; Peti and Page, 
2007; Studier, 2005). This ensures that sufficient proteins for biochemical and biophysical 
characterization as well as in vivo production of the terpenoid product. Additionally, and 
more importantly, it provides a platform for evidence-based strain improvement through 
systemic biology analysis and metabolic engineering. Cloning of these genes into an 
appropriate plasmid with an inducible promoter for expression in E. coli therefore provides 
the necessary tools for this project. The Novagen duet vectors (pCDFDuet -1 and pETDuet 
-1) provide suitable vehicles for cloning by having two multiple cloning sites, compatible 
replicons and drug resistance cassettes for co-expression as well as an inducible T7lac 
promoter. The lacI gene they carry provides a means of regulating basal expression with an 
N-terminal His Tag sequence for purification of fusion protein. Additionally, they are also 
compatible with other co-expressed plasmids that provide for a complete and enhanced 
terpenoid biosynthetic pathway in E. coli. 
Therefore, the aim of this chapter is to describe the genetic engineering strategies and 
optimizations carried out in order to successfully transfer the genes important for the 
biosynthesis of terpenoids from Nostoc sp. PCC 7120 into E. coli.  
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3.2 Materials and methods 
3.2.1 Culture conditions 
3.2.1.1 Nostoc sp. PCC 7120 
Nostoc sp. PCC 7120 was grown 100 ml of BG11 (Table 3.1) media supplemented with 
trace metal solution (Table 3.2) in a 250 ml flask. The inoculated culture medium was 
grown in a plant growth chamber (Sanyo, Japan) at 25
o 
C, 50 µE m
-2 
sec
-1 
illumination and 
60% humidity in continuous light conditions. Culture was maintained for 6 weeks and 
checked for bacterial contamination using light microscopy at intervals prior to harvest. 
 
3.2.1.2 Plasmid amplification and purification 
E. coli DH5(NEB, UK) used for plasmid amplification were grown in Luria-Bertani (LB) 
medium. 5 ml of freshly autoclaved media in 50 ml tube supplemented with the appropriate 
antibiotics i.e. ampicillin (100 µg/ml), spectinomycin (50 µg/ml), chloramphenicol (34 
µg/ml), kanamycin (30 µg/ml) and tetracycline (12 µg/ml) was inoculated with a single 
colony from agar plate and incubated at 37
o
C for 12-16 hours. The strains and plasmids 
used are listed in Table 3.3 and 3.4  
Table 3.1 BG11 media recipe 
Constituent Concentration (g/L) 
Ammonium ferric citrate 0.006 
Calcium chloride dihydrate 0.036 
Citric acid 0.006 
EDTA 0.001 
Magnesium sulphate heptahydrate 0.075 
Potassium hydrogen phosphate (K2HPO4) 0.04 
Sodium carbonate 0.02 
Sodium nitrate 1.5 
Trace metals solution 1ml 
 
Table 3.2 Recipe for trace metal solution 
Constituent Concentration (g/L) 
Boric acid (H3BO3) 2.86 
Cobalt(II) nitrate (Co(NO3)2.6H2O 0.049 
Copper sulphate (CuSO4.5H2O) 0.079 
Manganese chloride (MnCl2.4H2O 1.81 
Sodium molybdate (Na2MoO4.2H20)  0.390 
Sodium orthovanadate (Na3VO4) 0.593 
Zinc sulphate (ZnSO4.7H2O) 0.222 
 
Trace metal solution was made by dissolving in distilled water, pH adjusted to 7.4 and 
made to 1 litre. 
 
Table 3.3 List of strains used 
 
 
 
 
 
 
Strains Description/genotype source 
Nostocsp. PCC 
7120 
Wild-type strain ATCC 27893 
E. coli DH5a           huA2 lac(del)U169 phoA glnV44 Φ80' lacZ(del)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
 
New England 
Biolabs 
 
E.coli BL21 (DE3) F
-
ompT hsdSB(rB
-
mB)gal dcm (DE3) New England 
Biolabs 
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Table 3.4 Plasmids 
Plasmid Description source 
pCDFDuet-1 Cloning vector, CloDF13, two T7lac promoters, two MCS regions, 
and a single T7 terminator. lacI gene Sm
r
 
Novagen 
pETDuet-1 Cloning vector, ColE1 (pBR322),two T7lac promoters, two MCS 
regions, and a single T7 terminator. lacI gene Amp
R
 
Novagen 
pCDFDuet-NS1 NS1  amplified from Nostoc sp. and cloned into NcoI and NotI 
sites of pCDFDuet-1 
This study 
pCDFDuet-NStag NS1  amplified from Nostoc sp. and cloned into BamHI and 
NotI sites of pCDFDuet-1 
This study 
pCDFDuet-P450 P450 amplified from Nostoc sp. and cloned into NcoI and NotI 
sites of pCDFDuet-1 
This study 
pCDFDuet-P450tag P450 amplified from Nostoc sp. and cloned into BamHI and 
NotI sites of pCDFDuet-1 
This study 
pETDuet-NS1 NS1  amplified from Nostoc sp. and cloned into NcoI and NotI 
sites of pETDuet-1 
This study 
pETDuet-NStag NS1  amplified from Nostoc sp. and cloned into BamHI and 
NotI sites of pETDuet-1 
This study 
pETDuet-P450 P450 amplified from Nostoc sp. and cloned into NcoI and NotI 
sites of pETDuet-1 
This study 
pETDuet-P450tag P450 amplified from Nostoc sp. and cloned into BamHI and 
NotI sites of pETDuet-1 
This study 
pCDFDuet-NS-P450 NS-P450 amplified from Nostoc sp. and cloned into NcoI and 
NotI sites of pCDFDuet-1 
This study 
pETDuet-NS-P450 NS-P450 amplified from Nostoc sp. and cloned into NcoI and 
NotI sites of pETDuet-1 
This study 
pET-NS1-P450NS NS1 and P450 inserted into NcoI-PstI and NdeI-EcoRV sites 
respectively of pETDuet-1 
(H. Harada et al., 
2011) 
pBbA5c-RFP RFP cloned into pBb plasmid using standard BglBrick cloning 
strategy.  
(Lee et al., 2011) 
pBbA5c-MevT(CO)-
T1-MBIS(CO, ispA) 
Mevalonate pathway genes from S. cerevisiae cloned into the 
pBb plasmid using standard BglBrick cloning strategy 
(Peralta-Yahya et 
al., 2011b) 
pBBR1-MCS2 Cloning vector, Kan
R
 (Kovach et al., 
1995) 
pBb Cloning vector, Cm
r
 (Lee et al., 2011) 
 
 
3.2.2 Genomic DNA extraction and purification 
To extract genomic DNA from Nostoc sp. PCC 7120 culture, the 100 ml culture was 
divided into two 50 ml aliquots in sterile tubes and centrifuged to pellet the cells at 4000 
rpm at 4
o
C for 10 minutes in a Multifuge 3 refrigerated centrifuge (Haraeus). Supernatant 
was decanted leaving approximately 200 µl of cell pellet. Cell pellet was washed 3 times 
by resuspending in 1 ml of secret wash buffer (50 Mm Tris-HCl, pH 7.4, 100 mM EDTA, 
pH 8.0, 25% sucrose) and transferred to a sterile 2 ml tube and vortexed for 30 seconds. 
Pellet was again resuspended in 0.5 ml of resuspension buffer (50 mM Tris-HCl, pH 8.0, 
10 mM EDTA) to which 0.6 g of 0.4-0.6 mm diameter glass beads (Sigma, UK), 25 µl of 
10% sodium dodecyl sulphate (SDS), 250 ml of phenol and 250 ml of chloroform were 
added. This was then chilled on ice for 1 minute and vortexed for 30 seconds and chilled on 
ice again for another 1 minute. This was repeated for 4 cycles and then centrifuged at 
14000 rpm for 10 minutes at 4
o
C. The top aqueous layer was carefully aspirated into a fresh 
sterile 2 ml tube and 500 µl of chloroform was added and vortexed to mix. The top aqueous 
layer was aspirated into a new sterile 2 ml tube and DNA precipitated by adding 1/10 
volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of 100% ice-cold ethanol and 
incubated at -20
o
C for 30 minutes. The mixture was then centrifuged at 14000 rpm for 10 
minutes at 4
o
C to pellet the DNA. Supernatant was carefully aspirated and the pellet DNA 
was washed with 500 µl of ice cold 70% ethanol, centrifuged and carefully aspirated. The 
DNA was allowed to dry on the bench after which it was resuspended in 100 µl of nuclease 
free water (Sigma, UK). The concentration of DNA was measured using a 
spectrophotometer (Ultraspec 2100 pro UV/Visible spectrophotometer). Quantified DNA 
was diluted to make 100 ng/µl concentration and further purified using a MoBio Ultraclean 
microbial DNA isolation kit, ( oBio, Carlsbad, CA, USA) according to the manufacturer’s 
protocol as follows:  200 µl of 100 ng/µl DNA solution was loaded to a sterile 2 ml tube 
and 900 µl of MD3 was added and mixed by vortexing for 5 seconds and then loaded onto 
a spin filter and centrifuged at 13000 rpm for 30 seconds. The spin filter was washed with 
300 µl of solution MD4 and centrifuged at 13000 rpm for 30 seconds. DNA was eluted 
from the spin filter using 50 µl of MD5 into a sterile 1.5 ml tube by centrifuging at 13000 
rpm for 30 seconds. DNA was again measured using spectrophotometer and diluted to100 
ng/µl with nuclease free water. 1 µl of RNAse A was added and left at room temperature 
for 1 hour. DNA was verified by running in a 0.8% agarose gel. 
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3.2.3 Agarose gel electrophoresis 
DNA was frequently analyzed by running on a 0.8% agarose gel containing 0.0015% (v/v) 
ethidium bromide solution (Sigma, UK). DNA was resuspended in 6x DNA loading buffer 
(NEB, UK) and run at 80V using 1x TAE buffer until the dye front had travelled ¾ of the 
gel. DNA was visualized under UV light in a gel dock. 
 
3.2.4 PCR Primer design 
The oligonucleotide primers for the Polymerase Chain Reaction (PCR) were designed 
using Clone manager software version 9 (http://www.scied.com/pr_cmbas.htm. The 
primers were designed in such a way as to avoid possible primer dimers, significant hairpin 
loop formation, secondary priming site in template and low specific binding at the 3’ end. 
Also GC content was aimed at 45-60% where possible, melting temperature in the range of 
55-65
o
C and temperature difference between primer pairs within 5
o
C of each other in most 
cases. These primers were synthesized by Integrated DNA Technologies (Leuven, 
Belgium) and supplied at 25 nmole with standard desalting. 100 µM stock solutions were 
made using nuclease free water (Sigma, UK) and stored at -20
o
C. Working concentrations 
of 10 µM were used for PCR mix. The primers used are listed in Table 3.5. 
Table 3.5 List of primers used for PCR 
Name of 
primer 
Primer sequence 
Restriction 
site 
Tm of 
primer 
NSTag_F 
5’-GCGGGATCCTATGGAAAAAATTACTTTCCCAAATTTATATTGG-
3’ 
BamHI 60.6oC 
NS_R 5’-CGC GGCGGCCGCATTCTGGTAACTTTTTCAAGAAG-3’ NotI 67.6oC 
P450Tag_F 
5’-CGCGCGTCCTATGAAATATCAAATACAGAGACCTAATC-3’ 
 
BamHI 63.5oC 
P450_R 5’-GCGGCGGCCGCTACTATGCTGTGAATGTTGTTGAG-3’ NotI 68.5oC 
NS-P450_F 5’-CGCGCCATGGGGAGGCACAAATGACTTATGG-3’ NcoI 65.9oC 
ACYCDuetUP1 5’-GGA TCTCGA TCT CCC T-3’ Nil 58.5oC 
DuetDOWN1 5’-GATTATGCGGCCGTGTACAA-3’ Nil 55.5oC 
pETUpstream 5’-ATGCGTCCGGCGTAGA -3’ Nil 56.7oC 
DuetUP2 5’- TTGTACACGGCCGCATAATC -3’ Nil 55.5oC 
 
3.2.5 Polymerase Chain Reaction (PCR) 
Genes from Nostoc sp. PCC 7120 were amplified from genomic DNA using PCR and 
cloned into the appropriate plasmid for expression in E. coli as seen in Figure 3.1 
 
3.2.5.1 Amplification of Sesquiterpene synthase 
Sesquiterpene synthase (NP_488725, alr4685) was amplified using primers NS-P450_F 
and NS_R. In this instance, the NS-P450_F primer had an added NcoI site for ligation into 
the NcoI site of the corresponding plasmid. All PCR components were bought from Sigma 
and PCR was set up on ice using Taq DNA polymerase. The PCR mix had final 
concentrations of 0.4 µM of each forward and reverse primer, 200 µM of each dNTP, 1x 
PCR buffer and 2.5 mM of magnesium chloride. To this was added 3 µl of 50 ng/µl DNA 
template, 0.5 µl of Taq DNA polymerase and nuclease free water to make 50 µl final 
volumes. The PCR was performed on a Veriti 96 Well Thermal Cycler (Applied 
Biosystems) after gentle mixing and pulse centrifugation. The PCR parameters were as 
follows: initial denaturation at 95
o
C for 1 minute followed by denaturation at 95
o
C for 15 
seconds. Annealing was done at 63
o
C for 15 seconds and extension at 72
o
C for 30 seconds 
all for 30 cycles. A final one cycle extension step at 72
o
C for 7 minutes was done and then 
held at 4
o
C. 
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Fig 3.1 Schematic representation of the cloning of terpene synthase (NS1) and cytochrome 
P450 (P450) genes from Nostoc sp. PCC7120  
 
 
3.2.5.2 Amplification of Sesquiterpene synthase using high fidelity DNA polymerase 
PCR reaction was also performed using a Phusion high fidelity DNA polymerase 
(Finnzymes, UK). The PCR was set up as described in section 3.2.3.1 above with the 
following modifications: there was no additional magnesium chloride as the 5X buffer 
provided 1.5 mM final concentration and 0.02 U/µl final concentration of DNA polymerase 
was used. The reaction parameters were as described above but denaturation was at 98
o
C 
and annealing temperature was at 68.9
o
C (3
o
C above the lower Tm primer as recommended 
by the manufacturer). Following this, a temperature gradient PCR was done with same 
parameters as above using the following annealing temperatures 55
o
C, 57
o
C, 60
o
C, 65
o
C, 
68
o
C and 70
o
C. 
 
3.2.5.3 Amplification of Hexa-histidine tagged sesquiterpene synthase 
Sesquiterpene synthase for protein expression and purification was amplified from Nostoc 
sp. PCC 7120 genomic DNA. In order to add an N-terminal six histidine tag to the 
expressed protein in pCDFDuet-1plasmid (Figure 3.2), a 5’ BamHI sequence was added to 
the forward primer. This strategy would utilize and re-establish the BamHI restriction site 
and produce an expressed protein in-frame with the hexa-histidine producing sequence in 
the plasmid vector. Primers generated were named NSTag_F and NS_R for forward and 
reverse primers respectively. The PCR was set up as done in section 3.2.3.2 using phusion 
high fidelity DNA polymerase but with an annealing temperature of 60.6
o
C. 
 
3.2.5.4 Amplification of Hexa-histidine tagged Cytochrome P450  
Cytochrome P450 (NP_488726, alr4686) was amplified using primers P450Tag_F with a 
BamHI restriction site and P450_R and set up as described in section 3.2.3.2 with an 
annealing temperature of  65.9
o
C and extension at 72
o
C for 40 seconds.  
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3.2.5.5 Subcloning of genes from pCDFDuet-1 into pETDuet-1 
Sesquiterpene synthase and cytochrome P450 genes in pCDFDuet-1 (Figure 3.2) parents 
were sucbloned into pETDuet-1 (Figure 3.3) for co-expression with other plasmids. This 
was because the terpene synthase (NS1) and P450 were cloned into a pETDuet-1 plasmid 
(305) the pCDFDuet-1 has a streptomycin resistance marker which was not compatible 
with some of the other co-expressed plasmids. Since these inserts were cloned into MCS1 
of the plasmid (Figure 3.2), MCS1 plasmid primers, ACYCDuetUP1 and DuetDOWN1 
were used as forward and reverse primers respectively. The PCR was set up as in section 
3.2.3.2 but using 50ng of mutant plasmid with negative control containing wild type 
plasmid. Annealing temperature was set at 55.5
o
C for 30 seconds. 5 µl of the reaction was 
visualized on a 0.8% agarose gel as described in section 3.2.3. The rest was purified using 
SureClean (Bioline, U ) according to the manufacturer’s protocol and quantified 
spectrophotometrically using an Ultrospec 2100 pro UV/Visible spectrophotometer 
(Amersham Bioscience). 
 
Figure 3.2 Plasmid map of pCDFDuet-1 showing with restriction sites and multiple cloning 
sites (MCS1 and MCS2). Reproduced from Novagen duet vector user manual. 
 3.2.5.6 Amplification of terpene synthase and cytochrome P450 (NS-P450) 
To amplify the 2.5 kb long adjacent terpene synthase and cytochrome P450 genes from 
Nostoc sp. PCC 7120, magnesium chloride gradient PCR reactions was set up. The PCR 
mix was set up to give final magnesium chloride concentrations of 0.5mM, 1mM, 1.5mM, 
2mM, 2.5mM, 3mM, 4mM and 5mM. Set up was as done as in section 3.2.3.1 with NS-
P450_F and P450_R as forward and reverse primers respectively, using Taq DNA 
polymerase. Annealing temperature was set at 63
o
C for 30 seconds and extension was 72
o
C 
for 1 minute. 
 
 
 
Figure 3.3 Plasmid map of pETDuet-1 showing with restriction sites and multiple cloning 
sites (MCS1 and MCS2). Reproduced from Novagen duet vector user manual. 
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3.2.5.7 High fidelity amplification of NS-P450 
PCR was also done using high fidelity DNA polymerase as done in section 3.2.3.2 using 
NS-P450_F and P50_R as forward and reverse primers with annealing temperature set at 
65.9
o
C for 15 seconds and extension at 72
o
C for 1 minute 30 seconds.  
 
3.2.6 Purification of PCR product 
The PCR reactions were purified by either by agarose gel extraction or by using a column 
free purification method. 
 
3.2.6.1 PCR gel extraction 
The entire PCR reaction was separated on a 0.8% agarose gel as described in section 3.2.3. 
Purification was done by cutting out the correct sized bands using a scalpel blade under 
minimal low intensity UV light. The excised product was placed in pre-weighed 1.5 ml 
microcentrifuge tubes and extraction of amplified DNA was done using an Isolate DNA kit 
(Bioline, U ) according to the manufacturer’s protocol.  All tubes were then pooled and 
final concentration and purity measurements done with Ultrospec 2100 pro UV/Visible 
spectrophotometer (Amersham Bioscience). 
 
3.2.6.2 Column free PCR product purification 
For column free PCR product purification, 5 µl of the PCR reaction was removed for 
agarose gel visualization and the remaining 45 µl was purified using SureClean Plus 
reagent (Bioline, UK) according to the manufacturer’s protocol. The recovered PCR 
products were dissolved in nuclease free water and concentration and purity measurements 
done using an Ultrospec 2100 pro UV/Visible spectrophotometer (Amersham Bioscience). 
 
 3.2.7 Digestion and purification of PCR product 
Sticky ends for ligation into plasmid were produced by double restriction enzyme digest. 
The double digest in each case was done using high fidelity versions of the enzymes (New 
England Biolabs, UK). About 500 ng of purified PCR product was digested in a 50 µl final 
volume using 20 units of each enzyme and compatible buffer in each case. The buffer 
compatibility for the double enzyme digest was obtained through the New England Biolabs 
online buffer chart tool at 
http://www.neb.com/nebecomm/tech_reference/restriction_enzymes/buffer_activity_restric
tion_enzymes.asp#.UNtzWoXN5kg. Each digest was supplemented with 0.5 µl of BSA 
mixed and incubated at 37
o
C for 1 hour. The reaction was then purified to remove 
restriction enzymes and to concentrate the doubly digested PCR fragments using SureClean 
(Bioline, U ) according to the manufacturer’s protocol and pellet dissolved in 20 µl of 
nuclease-free water (Sigma).  
 
3.2.8 Digestion of Plasmid and purification 
The double digestion was set up in PCR tubes on ice using 500 ng of plasmid. The set up 
was mixed and incubated at 37
o
C for 1 hour. A small digest using each of the enzymes 
separately were also set up to check for linearization of the plasmid The digest was purified 
by SureClean (Bioline, U ) using the manufacturer’s protocol.  2.5 µl of the purified 
double digest and the linearization reactions were run on a 0.8% agarose gel as previously 
described.  
 
3.2.9 Dephosphorylation of digested plasmid 
The doubly digested plasmid was dephosphorylated prior to ligation reaction using Calf 
Intestinal Phosphatase (NEB, U ) according to the manufacturer’s protocol and incubated 
at 37
o
C for 1 hour. The mixture was purified using SureClean and dissolved in 20 ul of 
nuclease-free water (Sigma, UK). The concentration of the doubly digested, 
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dephosphorylated and purified plasmid was measured using an Ultrospec 2100 pro 
UV/Visible spectrophotometer (Amersham Bioscience). 
3.2.10 Ligation reactions 
Ligation of purified PCR products into their respective plasmid was done using T4 DNA 
ligase (NEB, UK) by using different ratios of vector to insert ranging from 6:1 to 1:3. 50 ng 
of the plasmid vector was used in each instance and reactions were set up on ice in PCR 
tubes. The amount of insert needed in each ligation was worked out according to the 
following formula: 
                                       
               
                            
The tubes were mixed and incubated at room temperature for 1 hour. The ligase enzyme 
was inactivated by heating at 65
o
C for 10 minutes. To check the background of 
spontaneous re-ligation/uncut plasmid, a control using the digested and dephosphorylated 
plasmid with dH2O in place of an insert was employed.   
 
3.2.11 Ligation PCR 
To ensure that transformation was done using only successfully ligated plasmid, a ligation 
PCR was done as a screening test by using 2 µl of the ligation reaction. A time saver 
MyTaq
TM
 Red DNA Polymerase and buffer (Bioline, UK) was used. The 5 x buffer already 
contained dNTPs, MgCl2 and loading dye for direct loading after the PCR. A master mix 
for eight reactions including negative and positive controls was set up and 48 µl of the 
master mix was aliquoted into PCR tubes and 2 µl of each ligation reaction was added, 2 µl 
of nuclease free water was used for negative control and 2 µl of uncut plasmid vector 
(pCDFDuet-1/pETDuet-1) was used as a positive control. The forward and reverse primers 
were the plasmid specific primers for MCS1 (Figure 3.2 and 3.3) which are 
ACYCUP1/pETUPStream and DUETDOWN1 respectively. The tubes were mixed and 
loaded into the PCR machine. Program was as follows: initial denaturation at 95
o
C for 2 
minutes and subsequent denaturation at 95
o
C for 15 minutes for 30 cycles. Annealing 
temperature was set at 53
o
C for 15 seconds and extension was 72
o
C for 1 minute for 30 
cycles. A final extension at 72
o
C for 4 minutes and held at 4
o
C. 10 µl of the reaction was 
separated on a 0.8% agarose gel as described in section 3.2.3 
3.2.12 Transformation into cloning strain 
Based on the result of the PCR screening test for the ligation reaction, transformation using 
positive ligation reactions were set up using 1 µl of the ligation reaction into 50 ul of 
chemically competent DH5α cells (NEB, U ) according to the manufacturer’s instructions. 
1 µl of double digested plasmid was also used to transform to check for background 
(plasmid re-ligation and uncut plasmid) and a negative control.   
 
3.2.13 Colony screen PCR 
Colony PCR was used to screen colonies for positive clones containing the gene insert prior 
to sequencing. This was done by making a master mix for several reactions (10-30) with 
the time saver MyTaq
TM
 Red DNA Polymerase and buffer (Bioline, UK). The master mix 
had 10 µl of 5 x buffer, 2 µl of each primer, 1 µl of polymerase and 33 µl of nuclease-free 
water. This was mixed and 48 µl aliquoted into each PCR tube. Colonies were picked with 
sterile tips, dipped in labelled PCR tube containing 20 µl of nuclease-free water and same 
tip was used to inoculate 5 ml LB broth in correspondingly labelled 50 ml falcon tubes. The 
inoculated PCR tubes were heated to 95
o
C for 10 min, spun at 5, 000 x g for 5 minutes and 
2 µl of supernatant used as DNA template for PCR reaction. The 50 ml tubes were 
incubated at 37
o
C while the PCR tubes were set up. The PCR reactions had a negative 
control of nuclease free water in place of DNA and a positive control of wild type plasmid 
vector. The PCR program was run as follows: initial denaturation at 95
o
C for 2 minutes and 
subsequent denaturation at 95
o
C for 15 minutes for 30 cycles. Annealing temperature was 
set at 53
o
C for 15 seconds and extension was 72
o
C for 1 minute for 30 cycles. A final 
extension at 72
o
C for 4 minutes and held at 4
o
C. The PCR reactions were separated on a 
0.8% agarose gel and visualized as described in section 3.2.3.  
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3.2.14 Plasmid mini-prep 
The culture tubes corresponding to positive clones from the colony PCR screen were 
retained and the negative ones were discarded. After overnight growth, the cells were 
harvested by centrifuging at 5, 400 x g for 10 min at 4
o
C and supernatant discarded. 
Plasmid DNA was extracted from the cell pellet using a QIAGEN plasmid mini prep kit 
according to the manufacturer’s protocol. DNA quantification was done directly by UV 
spectrophotometry and through agarose TAE gel estimation using hyperLadder I (Bioline, 
UK). 
 
3.2.15 DNA sequencing 
20 µl of purified plasmid vector containing the cloned inserts from all positive clones were 
sent for sequencing at the University of Sheffield Medical School Core Genetic facility. 20 
µl of 10 µM forward and reverse primers (insert specific and plasmid specific flanking 
primers) were used and sequencing was done on an ABI 3730 capillary sequencer.  
 
3.2.16 Analysis of DNA sequence results 
The chromatogram of the DNA sequencing results were viewed and manually curated 
using FinchTV version 1.4 (http://www.geospiza.com/Products/finchtv.shtml).  The 
sequences were analyzed on clone manager software version 9 
(http://www.scied.com/pr_cmbas.htm). Inserts were checked for nucleotide deletion, 
insertion, mutation. The sequences were also checked for translational frame shifts and 
alignment with the N-terminal hexa-histidine tagging sequence. Insert sequences were then 
used as query in a BLASTX (Altschul et al., 1997) in both the non-redundant and Nostoc sp. 
7120 database at NCBI. 
 
 
 
3.2.17 Competent cell preparation  
 The expression of cloned genes was done using E. coli BL21 (DE3) and chemically 
competent Rosetta-gami 2 (Novagen). The E. coli BL21 (DE3) cells were made chemically 
competent using Z-competent
TM
E. coli Transformation kit (Zymoresearch) according to the 
manufacturer’s protocol.  
 
3.2.18 Transformation 
Plasmid containing correct gene insert as well as wild type plasmid vector were 
transformed into chemically competent E. coli BL21 (DE3) and Rosetta-gami 2 (Novagen) 
according to the manufacturers’ protocol.  
 
3.2.19 Glycerol stocks 
Single colonies from transformants were picked and used to inoculate 5 ml of LB media 
containing the appropriate antibiotics in a 50 ml tube. Culture was incubated overnight and 
the next morning, 200 µl of culture in late exponential phase was placed in a fresh sterile 
1.5 ml microcentrifuge tube. 800 µl of sterile 80% glycerol was added, vortexed and flash 
frozen in liquid nitrogen and stored at -70
o
C.   
 
3.3 Results 
3.3.1 Genomic DNA extraction 
Genomic DNA extracted from Nostoc sp. PCC7120 biomass was purified using MoBio 
Ultraclean microbial DNA isolation kit (MoBio, Carlsbad, CA, USA) and the absorbance 
results of the initial extract compared to the purified DNA seen in Table 3.6. The genomic 
DNA extracted and purified with the MoBio kit had better purity as seen by the A260/A230 
and A260/280 values despite the significant reduction in concentration.    
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Table 3.6 Measurements of Genomic DNA extracted from Nostoc sp. 7120  
Sample 
DNA conc 
(µg/ml) 
A230 A260 A280 A260/230 A320 A260/280 
Nostoc sp. 
7120 
 1355 1.841 2.846 1.706 1.59 0.130 1.76 
Nostoc sp. 
7120 
MoBio kit 
451 0.394 0.891 0.464 2.23 -0.010 1.90 
 
The significant improvement in A260/A230 ratio may be attributed to residual carbohydrate 
contamination as well as possible phenolic/ethanol contamination used in the extraction 
process. In all, a significantly good concentration and level of purity was achieved as 
impurities such as phenol are known to affect PCR amplification negatively (Al-Soud and 
Rådström, 1998). 
 
3.3.2 PCR Amplification 
The required open reading frame from extracted genomic DNA from Nostoc sp. PCC 7120 
was amplified by PCR. Successfully cloned genes were also amplified by PCR from their 
parent for subcloning into another host. 
 
3.3.2.1 Sesquiterpene synthase amplification using Taq DNA polymerase  
The open reading frame coding sesquiterpene synthase (NS1) from Nostoc sp. PCC 7120 
was amplified by PCR. Several PCR reactions were done using genomic DNA extract. 
PCR optimization steps where instituted as a result of failure of initial PCR runs. These 
optimizations included temperature and MgCl2 concentration gradients as well as BSA and 
DMSO supplementation as well as changes in dNTP and primer concentrations without 
success. It was thought that inhibiting factors may be present in the DNA extract as 
substances such as ethanol, phenol, salts, detergent, EDTA and proteinases are known to 
inhibit PCR (Davalieva and Efremov, 2010; Eilert and Foran, 2009). As seen in Figure 3.4, 
subsequent amplification using genomic DNA from kit purification yielded good product. 
This confirmed the presence of inhibitory contaminants in the initial DNA extract as 
addition of the original extract and kit purified DNA did not give any amplification. 
Following this, all subsequent PCR amplification from genomic DNA was done using the 
kit purified DNA as template. 
 
 
 
Figure 3.4 Agarose gel visualization of amplified sesquiterpene synthase from genomic DNA 
of Nostoc sp. PCC 7120 with kit purified DNA (3, 4 & 6). Lane 1 and 2 are from unpurified and 
lane 7 is mix of purified and unpurified DNA extract with no amplicon indicating the 
presence of PCR inhibitors in the unpurified DNA extract.Lane 5 is DNA size marker. 
 
3.3.2.2 Sesquiterpene synthase amplification using high fidelity DNA polymerase  
 Sequencing results of amplified genes using Taq DNA polymerase showed significant 
number of mutations and deletions. For this reason, a high fidelity DNA polymerase was 
used subsequently in all PCR amplification for cloning purposes.  However, as 
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recommended by the manufacturer, an annealing temperature that was 3
o
C (68.9
o
C) higher 
than the lower Tm primer (65.9
o
C) was used for the PCR but yielded no product. A 
temperature gradient PCR run was then used to ascertain the optimal annealing 
temperature. As seen in Figure 3.5, amplification was achieved with temperatures as low as 
57
o
C which was almost 9
o
C lower than the Tm of the lower Tm primer. The optimum 
annealing temperature was seen to be 65
o
C which was just about the Tm of the lower 
primer. The upper annealing temperature for amplification was seen at 68
o
C.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Agarose gel electrophoresis showing PCR amplification of NS1 at 
different annealing temperatures using Phusion high fidelity polymerase. Lane 1 
was at 57oC, lane 2 is DNA size marker, lane 3 was at 60oC, lane 4 was at 65oC and 
lane 5 was at 68oC. 
 
3.3.2.3 Sesquiterpene synthase amplification from pCDFDuet-NS1  
Sesquiterpene synthase (NS1) was amplified from the pCDFDuet-NS1 parent for 
subcloning into pETDuet-1. PCR amplification using pCDFDuet-NS1 as template was 
therefore done. Since the insert was originally cloned into NcoI and BamHI restriction sites 
in MCS1 of the parent plasmid (Fig 3.2), the PCR primers used were the plasmid specific 
primers for MCS1. As seen in Figure 3.6, the amplified product was larger than the 
expected 1 Kb size since the forward primer anneals at a site 168 bp upstream of the insert 
and the reverse primer anneals 58 bp downstream thereby adding more than 200 bp to the 
original amplicon. As shown in Figure 3.6, the genomic amplicon is run alongside to show 
the disparity in size. 
 
 
Figure 3.6 Agarose visualization of amplified sesquiterpene synthase from 
pCDFDuet-NS parent (lanes 1, 2, 3) using plasmid specific primers. The amplified 
product is slightly larger than 1 Kb due to primers annealing outside the insert and 
adding about 200 bp to the amplicon. Lane 4 amplified product from Nostoc sp. 
7120 genomic DNA and lane 5 is the DNA size marker 
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3.3.2.4 Amplification of cytochrome P450 
As discussed in the chapter introduction, the open reading-frame coding for a cytochrome 
P450 (P450NS1) is located immediately downstream of the sesquiterpene synthase gene. 
This gene was amplified from kit purified genomic DNA from Nostoc sp. PCC 7120 and 
visualized by running on a 0.8% agarose gel. Figure 3.7 demonstrates the amplification of 
the 1.4 Kb long genes. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 shows 1.5 Kb amplified PCR products seen in lanes 2 and 3 that 
correspond to the size of the cytochrome P450 from Nostoc sp. PCC 7120 
 
3.3.2.5 Amplification of sesquiterpene synthase (NS1) and cytochrome P450 (P450) 
The sesquiterpene synthase (NS1) and cytochrome P450 (P450) from Nostoc sp. PCC7120 
are in an apparent gene cluster in series with each other separated by 21 nucleotide long 
segment. The two contiguous genes are 2.4 Kb long and Figure 3.8 shows a confirmation of 
successful amplification using high fidelity DNA polymerase. 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Visual confirmation of amplified sesquiterpene synthase plus cytochrome 
P450 (NS1+P450) from Nostoc sp. PCC 7120 are seen in lanes 1-4 corresponding to 
the expected 2.5 Kb. Lane 5 is DNA size marker. 
 
3.3.3 Restriction enzyme digestion of plasmid 
Plasmid digestion was done and the digest was visualized on an agarose gel and compared 
to the undigested plasmid as seen in Figure 3.9 
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Fig 3.9 Agarose gel view of restriction enzyme digest of pCDFDuet-1  showing the 
uncut plasmid in lane 1 compared to the one linearised with NotI (lane 3) and double 
cut (lane 2 cut with BamHI/NotI  and lane 4 cut with NcoI/NotI). There is a slight 
difference in size between the linearised and double cut plasmid   
 
 Evidence of successful double digestion of plasmid is revealed by the slight difference in 
size between the doubly digested plasmids as seen in lanes 2 and 4 compared to the 
linearized plasmid in lane 3 which was singly cut by NcoI. This was necessitated by the 
fact that the double plasmid digest did not produce a DNA segment long enough for 
accurate visualization on the gel used.  
 
3.3.4 Restriction enzyme digestion PCR products 
An indirect method of validating digestion of PCR products was by digesting the PCR 
products with plasmid. Figure 3.10 shows evidence of digestion of plasmid pCDFDuet-1 
with NcoI and PacI as shown by the 400 bp fragment in the presence of  the 2.4 Kb 
NS+P450 PCR fragment.    
 
Fig 3.10 Agarose gel visualization of enzyme digestion of pCDFDuet-1 and PCR 
products (NS+P450 and P50tag). Lane 1 is NS + P450 digested with NcoI and NotI, 
lane 2 is P450tag digested with BamHI I and NotI. Lanes 6, 7 and 9 were used to test 
for efficacy of digestion of PCR products. 
 
However, PCR products amplified from pCDFDuet-1 parent for subcloning into pETDuet-
1 were easily confirmed on agarose gel electrophoresis. As shown in figure 3.11, the PCR 
product amplified from CS1 using plasmid primers added more than 150 bp to the 5’ end 
and is easily visualized. This digested product also showed size difference with the 
undigested product. 
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Fig 3.11  Agarose gel visualization of PCR products (NS1) amplified from pCDFDuet-NS 
parent using MCS1 plasmid primers and digested by NcoI and NotI (lanes 1 and 3) and 
undigested product (lane 2). The digested PCR product shows bands of about 150 bp 
confirming digestion 
 
3.3.3 Ligation PCR screen 
In order to ensure that only successful ligations were transformed and thus reduce the 
number of colonies to be screened as well as check the level of undigested plasmid 
background, ligation PCR was done as an additional screening tool. The result as seen in 
Figure 3.12 shows PCR amplification of insert from ligation mix containing insert to vector 
ratios of 6:1, 3:1, 1:1and 1:3. The figure shows that there was successful ligation in all 
cases as seen by the amplified PCR product corresponding to the desired insert. 
Significantly also, there was a 200 bp amplicon in each case which corresponds to 
amplification of the uncut or re-ligated plasmid, which represents the level of background 
in each case. There was no significant difference in intensity of the 200 bp amplified band 
but there was obvious difference between NS +P450 and the P450tag. This possibly 
implies much less successful ligation between vector and insert for NS+P450. Additional 
evidence of differences in successful ligation is seen in the negative control (uncut wild-
type plasmid) as seen in lanes 5 and 13 which shows the same level of intensity of the 200 
bp band which are just as intense as that from NS+P450 ligation. The use of plasmid 
specific primers ensured that only successful insert of the right size will be at the 1.5 kb and 
2.5 Kb marker lanes.   
 
Fig 3.12 Agarose gel visualization of PCR of different ratios of ligation mix for 
pCDFDuet + P450tag and pCDFDuet + (NS + P450). Lanes 1 to 4 are for pCDFDuet + 
(NS+P450) and lanes 6 to 9 are for pCDFDuet + P450tag. Lanes 5, 11 and 13 are 
negative controls and lane 12 is a positive control using pCDFDuet-NStag 
 
3.3.4 Colony PCR screen 
Colony PCR was employed as a further screening tool to select clones of transformed cells 
that had the correct gene insert before subsequent sequencing. Several colonies had to be 
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screened before getting any positive clone. This indicated a very high level of background 
of cells harbouring plasmids that were not completely digested or have spontaneous re-
ligated without the required insert. As seen in Figure 3.13, about 25% of the clones 
screened had the desired insert and this was significantly increased when the plasmid was 
dephosphorylated before ligation. 
 
 
 
Fig 3.13 colony PCR screen for sesquiterpene synthase of bacteria transformed with 
a 3:1 ligation mix (insert: vector) comparing ligation with un-dephosphorylated to a 
dephosphorylated plasmid. M and C are DNA size marker and negative control 
respectively with top and bottom arrows showing positive and negative clones 
respectively.  
 
Additionally, the ligation ratio was seen to have an effect on the nature of the insert. Figure 
3.15 and 3.16 are colony screen PCR of bacteria transformed with 6:1 and 3:1 ratio of 
insert to vector. While Figure 3.15 shows a very high percentage of successful ligation, an 
unexplained band of about 700 bp was seen in all of the positive colonies except one. On 
the other hand, the 3:1 ligation ratio produced just as good successful ligation but the 700 
bp band was seen in just one clone of those screened.  
 Fig 3.15 Colony PCR screen of bacteria transformed with 6:1 ligation mix (pCDFDuet 
+ P450tag). Notice that all of the lanes except lane 1 had positive clones but in 
addition to the expected 1.5 Kb band they all had an unexplained band 
corresponding to 700 bp.Lane 10 did not contain the unexplained 700 bp band. Lane 
6 is a DNA size marker 
 
 
Fig 3.16 Colony PCR screen of bacteria transformed with a 3:1 ligation mix 
(pCDFDuet + P450tag) showing 7 positive clones (P1 to P7) and one positive clone 
(P0) with an unexplained 700 bp amplicon. C+ is a positive control using verified 
clones of pCDFDuet-NStag 
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The colony PCR screen of the bacteria transformed with 3:1 ratio of ligation mix for 2.5 Kb 
insert showed a greatly reduced number of positive clones. As seen in Figure 3.17, just two 
positive clones were identified in a screen of twenty colonies which is just about 10%. This 
result is in keeping with the ligation screen PCR result seen earlier in Figure 3.12.  
 
 
Fig 3.17 Colony PCR screen of bacteria transformed with 3:1 ligation mix (pCDFDuet 
+ NSP450NS) showing just two positive clones (P1 and P2) with P1 as a very faint 
band. Notice that the entire negative clones have amplicons of 200 bp but the 
positive clones do not. C+ is a positive control from sequence verified pCDFDuet-
NS clone 
 
3.3.5 Analysis of DNA sequencing results 
Analysis of DNA sequence was done using FinchTV version 1.4.0 and clone manager 
version 9 (http://www.scied.com/pr_cmbas.htm. Genes amplified with Taq DNA 
polymerase were seen on analysis to have synonymous and non-synonymous single 
nucleotide mutations as well deletions. For this reason, high fidelity DNA polymerase was 
used and results showed significant reduction in mutations. Further analysis using clone 
manager enabled identification of clones not only with the right insert but for the hexa-
histidne tag to be in-frame with the protein when expressed. Figures 3.18 and 3.19 shows 
restriction maps for the sesquiterpene synthase and the cytochrome P450 respectively. 
Figure A1 and A2 shows annotated plasmid maps with inserts in-frame with the respective 
N-terminal hexa-histidine sequence with the chromatogram traces seen in Figure A3 and 
A4 respectively. 
In-silico amino acid translation of the sequences was done and further confirmed the choice 
of the right clones used for further work. As seen in Figures 3.20 and 3.21, the frame 1 
translation of the cytochrome P450 and sesquiterpene synthaseare seen to produce the 
desired protein in-frame with the required histidine tag.  
 
Fig 3.18 Restriction map of terpene synthase from Nostoc sp PCC 7120 generated 
using Nebcutter V2.0 
 
 
Fig 3.19 Restriction map of cytochrome P450 from Nostoc sp. PCC 7120 generated 
using Nebcutter V2.0 
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Fig 3.20 Translated amino acid sequence of P450tag from pCDFDuet-P450tag 
showing N-terminal 6-histidine sequence (H) in-frame with the protein sequence. M 
shows the start of translation  and m is start of P450 protein  
 
 Fig 3.21 Translated amino acid sequence NStag from pCDFDuet-NStag showing N-
terminal 6-histidine sequence (H) in-frame with the protein sequence. M shows the 
start of translation  and m is start of NS protein with the ribosomal binding site (rbs) 
nucleotide sequence. 
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3.4 Discussion 
PCR amplification of terpene synthase and cytochrome P450 genes from Nostoc sp. PCC 
7120 genomic DNA was initially done without success. As a result, several optimization 
techniques and trouble-shooting protocols were instituted. These included graded MgCl2 
concentration titrations, temperature gradient PCR, variations in the primer concentration, 
as well as using additives such as BSA and DMSO.  Other causes of PCR failure were 
considered including issues with primers (primer dimer formation, miss 
priming/mismatch), PCR program and DNA template issues. Since an in-silico template 
amplification of target using these primers all yielded products, it was thought that the most 
likely cause of failure would be issues with the template such as inhibitors. A further clean 
up and subsequent PCR confirmed that the amplification failure was due to inhibitors in the 
template. This is also seen in the significant increase of the A260/A230 value. A further proof 
was demonstrated by the failure of amplification in a mix of both the initial DNA extract 
and the kit purified DNA as template.  
For faithful amplification of target and to reduce the amount of time, energy and resources 
for successful cloning, a few strategies were included in the workflow. These included the 
substituting the Taq DNA polymerase with a high fidelity phusion polymerase, 
dephosphorylating the digested plasmid to reduce re-ligation and the use of ligation PCR 
screening. In particular, dephosphorylations of the cut plasmid greatly reduced the 
background of self-re-ligated plasmid and thereby increase the number of positive clones 
per transformation. This was further enhanced by doing a PCR screen of the ligation mix 
before transformation. The level of background in each case was proportional to the 
intensity of the 200 bp band which measured how much of the uncut plus the re-ligated 
plasmid was in the ligation mix. Since the ligation mix was done in ratios of 6:1, 3:1, 1:1 
and 1:3, it enabled a choice of which ratio gave the least background as well as to avoid 
those that had multiple inserts. The 6:1 ligation ratio evidently produced less background of 
non-recombinants and more positive clones but also had evidence of multiple inserts. The 
3:1 ligation ratio consistently produced the best results (Dardel, 1988; Topcu, 2000). 
High fidelity DNA polymerase with lower error rate was substituted for Taq DNA 
polymerase because sequence results showed single nucleotide mutations and deletions. Of 
five positive clones sequenced, all had mutations or deletion. In comparison, all the positive 
clones from the Phusion polymerase amplification did not have any form of mutation or 
deletion except for the 2.4 kb long NS-P450 amplicon. For this, of two positive clones 
sequenced, one had a single nucleotide synonymous substitution while the other had no 
form of error in the sequence result. 
In conclusion, the target genes were amplified, cloned into the vectors, transformed and 
sequence verified. In-silico translation of the verified sequences showed that all the genes 
were all in-frame. These mutant plasmids would be investigated in the next chapter for the 
expression of the requisite terpene as well as the metabolic effect of the terpene on E. coli. 
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4.1 Introduction 
The universal building blocks of terpenes, present in all organisms have been harnessed for 
several metabolic engineering projects using more efficient secondary hosts with varying 
degrees of success, as discussed in section 2.5.3 In this regard, E. coli and yeast have 
served as the main hosts for metabolic engineering of terpenes. In E. coli, the presence of 
the non-mevalonate pathway or 2-C-methyl-D-erythritol 4-phosphate/1-deoxy-D-xylulose 
5-phosphate pathway (MEP/DXP) synthesizes isopentenyl pyrophosphate (IPP) and 
dimethylallyl pyrophosphate (DMAPP) using glyceraldehyde-3-phosphate and pyruvate as 
source materials (Rohmer et al., 1996). These precursors for terpene biosynthesis which are 
inter-convertible isomers are then condensed by the farnesyl pyrophosphate synthase (ispA) 
to generate the farnesyl pyrophosphate FPP in both mevalonate and DXP pathways (Wilkin 
et al., 1990). This organism could therefore provide a pool of precursors which could be 
tapped for heterologous terpene production by inserting a down-stream terpene gene to take 
advantage of these precursors but yield to date has not been significant. However, the 
precursors are essential for the survival of the organism because they are used in the 
biosynthesis of several important cell wall components such as bactoprenol, glycosyl 
carrier lipids, dolichols and respiratory chain quinones as well as prenylation of tRNA and 
post translational modification (Apfel et al., 1999; Carter et al., 2003; Connolly and 
Winkler, 1989). 
 Engineering the DXP pathway to over-produce the precursors would potentially 
circumvent any ill effect, but as noted by Martin et al. (2003a), this approach suffers from 
limitations due to possible negative regulatory mechanisms in E. coli. Engineering the 
mevalonate pathway with or without the DXP pathway for the purpose of providing a flux 
of precursors in E. coli for terpene production has shown significant success and several 
important terpenes such as bisabolene, 900 mg/L; amorphadiene, 500 mg/L; taxadiene, 
1000 mg/L; lycopene, 8 mg/g dry cell weight  (Ajikumar et al., 2010; Alper et al., 2005; 
Peralta-Yahya et al., 2011a; Redding-Johanson et al., 2011b) have been synthesised. Some 
of these terpene synthetic pathways require additional down-stream processing enzymes 
such as cytochrome P450. Though cytochrome P450 catalyses critical steps in the pathway 
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of many important terpenes such as the anticancer taxol and the antimalarial artemisinin, 
expression of this non-native gene in E. coli  has proved very difficult for diverse reasons 
such as the absence of endogenous electron tranfer protein partners, codon usage as well as 
stability of the expressed protein amongst others(Schuler and Werck-Reichhart, 2003). 
Functional assays of the sesquiterpene gene (alr4685) (NS1) and the adjacent cytochrome 
P450 (alr4686) (P450) products from Nostoc sp.7120 have been carried out by Agger et al. 
(2008). They functionally expressed both the terpene synthase and the adjacent cytochrome 
P450 with a qualitative assay of the terpene and terpenoid but could not elucidate the 
structure of the terpenoid because of low yield nor did they quantify the terpene. Harada et 
al. (2009) used a downstream mevalonate utilising plasmid to increase the titres of the 
target terpenoid and thus succeeded in determining this to be 1,2,3,5,6,7,8,8aoctahydro-6-
isopropenyl-4,8a-dimethylnaphth-1-ol through NMR analysis, but no quantitative assay 
was done for either terpene or terpenoid. Peralta-Yahya et al. (2011a) developed an E. coli 
codon-optimized FPP over-producing plasmid using elements of mevalonate pathway from 
yeast and with the downstream idi (IPP isomerase)and ispA from E. coli and used this to 
increase the titres of the bisabolene to 900 mg/L This is a veritable tool for cross platform 
terpene and terpenoid production and engineering.   
In moving forward, a quantitative assay method is therefore desirable which would serve as 
a template for further refinement. In so doing, a baseline productivity level of this system in 
E. coli is needed on which to measure subsequent perturbations. This chapter aims to 
express the terpene synthetic genes cloned in the previous chapter and quantitatively assay 
the terpene product. Subsequently, the quantitative effects of co-expression of FPP over-
producing pathway and the cytochrome P450 will also be examined.   
 
4.2 Materials and methods 
4.2.1 Plasmids and strains 
Three new strains were made by transforming E. coli BL21 (DE3) with FPP pathway, 
pETNS-P450, and ferrodoxin/ferrodoxin-reductase to produce the strains listed in Table 
4.1. To balance the plasmid metabolic load, each strain had three plasmids with or without 
insert. The pBbA5c plasmid backbone was derived from pBbA5c-RFP by digesting out the 
RFP gene with BamHI and BglII, purifying and re-ligating the compatible sticky ends as 
described in 3.2.8.   
Table 4.1 Plasmids and strains 
Plasmid/strain Description source 
pET-NS1-
P450NS 
NS1 and P450 inserted into NcoI-PstI and NdeI-EcoRV 
sites respectively of pETDuet-1 
(H. Harada 
et al., 
2011) 
pETNS1 NS1 inserted into NotI and NcoI  od pETDuet-1 This study 
pETNS1tag NS1 inserted into NotI  and BamHI site of pETDuet-1 This study 
pBbA5c-RFP RFP cloned into pBb plasmid using standard BglBrick 
cloning strategy.  
(Lee et al., 
2011) 
pBbA5c RFP excised from pBbA5c-RFP and re-ligated This study 
pBbA5c-
MevT(CO)-T1-
MBIS(CO, 
ispA) 
Mevalonate pathway genes from S. cerevisiae, idi and 
ispA from E. coli cloned into the pBb plasmid using 
standard BglBrick cloning strategy 
(Peralta-
Yahya et 
al., 2011b) 
pBBR1-MCS2 Cloning vector, KanR (Kovach et 
al., 1995) 
pBBR-FER-
RED 
Ferredoxin I and Ferredoxin-NADP-reductase from Nostoc 
sp.7120 cloned into the HindIII and BamHI site  of  pBBR 
(Agger et 
al., 2008) 
N pETNS1 + pBbA5c + pBBR1-MCS2 transformed into E. 
coli BL21 (DE3) 
This study 
N+ pETNS1 + pBbA5c-MevT(CO)-T1-MBIS(CO, ispA) + 
pBBR1-MCS2  transformed into E. coli BL21 (DE3) 
This study 
P pETNS1-P450 +  pBBR-FER-RED + pBbA5ctransformed 
into E. coli BL21 (DE3) 
This study 
T pETNS1-P450 + pBbA5c-MevT(CO)-T1-MBIS(CO, ispA) +  
pBBR-FER-RED transformed into E. coli BL21 (DE3) 
This study 
C1 pETDuet-1 + pBBR1MCS2 + pBbA5c transformed into E. 
coli BL21 (DE3) 
This study 
BLK Plasmid free E. coli BL21 (DE3) Novagen 
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4.2.2 Expression of sesquiterpene synthase 
The expression of terpene synthase gene (pETNS1tag) in E. coli was carried out in Terrific 
broth (TB) (12 g of bacto-tryptone, 24 g of yeast extract, and 4 ml of glycerol and 100 ml 
of phosphate buffer in 1 L of DH2O). Overnight cultures of 5 ml of cells containing 
plasmid with and without insert containing ampicillin at 100 µg/ml were set up in 50 ml 
tubes using LB broth and grown at 37
o
C. The OD600 was measured after overnight growth 
and a volume of culture enough to give a starting OD600 of 0.01was used to inoculate 500 
ml of TB containing the same concentration of ampicillin. Culture flasks were then 
incubated in a rotary shaker at 30
o
C and growth was monitored by OD600 measurements. 
Cultures were induced with IPTG at a final concentration of 0.4 mM at an OD600 of 0.6 and 
growth continued at 25
o
C. 1 ml of culture was taken at intervals starting at induction to 
monitor recombinant protein accumulation with time. These were spun at 8500 x g for 10 
min at 4
o
C and pellet stored at -20
o
C. Growth was continued for 40 hours post induction 
and a pellet was obtained as above. Subsequent cultures were harvested at 30 hours post 
induction. 
 
4.2.3 Total protein extraction 
Four different methods of protein extraction were tested in order to optimise the protein 
extraction process. These were bead beating, French press, nitrogen cracking and chemical 
lysis. Each method was done in triplicate using 500 ml cultures. 
 
4.2.3.1 Bead beating 
The crude protein lysate from the harvested cell pellets were obtained as follows: 5 ml of 
0.5M TEAB and 500 mg each of glass beads 106 µm and 425-600 µm diameter (Sigma-
Aldrich, UK) were added to cell pellet. This was then vortexed for 30 seconds and chilled 
on ice for 1 min and repeated through 5 cycles and then sonicated in a water bath 
containing ice for another 5 minutes. 100 µl of protease inhibitor cocktail (Sigma-Aldrich, 
UK) and 0.1% Benzonase (Novagen) was added and incubated on ice for 15 min. To 
remove cell debris, cells were centrifuged at 13,000 rpm for 30 min at 4
o
C. Supernatant 
containing the total protein extract (crude cell lysate) was collected into sterile 
microcentrifuge tubes by pipetting and stored at -20
o
C until used. 
4.2.3.2 French press 
For French press, the cell pellet was resuspended in 5 ml of 0.5M TEAB as previously 
described and subjected to French pressure using standard operating procedure and 
collected in 50 ml tubes. 100 µl of protease inhibitor cocktail (Sigma-Aldrich, UK) and 
0.1% Benzonase (Novagen) was added and incubated on ice for 15 min and clarified by 
centrifuging at 13,000 rpm at 4
o
C for 30 min and aspirating the supernatant into sterile 1.5 
ml microcentrifuge tubes.  
 
4.2.3.3 Mechanical cracking with liquid nitrogen  
For mechanical cracking with liquid nitrogen, cells were thawed on ice, protease inhibitor 
cocktail added and subjected to mechanical grinding and liquid nitrogen according to a 
standard procedure and collected in sterile 1.5 ml microcentrifuge tubes. Protease inhibitor 
cocktail (Sigma) and 0.1% Benzonase (Novagen) was added and incubated on ice for 15 
min and clarified by centrifuging at 13, 000 rpm for 30 min at 4
o
C. Supernatant containing 
total protein was aspirated into fresh sterile 1.5 tubes (Eppendorf) and stored at -20
o
C until 
used. 
 
4.2.3.4 Chemical lysis 
Chemical lysis was done using BugBuster
TM
 Protein extraction reagent (primary amine 
free) (Novagen) according to the manufacturer’s protocol using Benzonase (Novagen) and 
protease inhibitor cocktail (Sigma) and centrifuging at 13,000 rpm at 4
o
C for 30 min and 
supernatant was aspirated into sterile 1.5 ml microcentrifuge tubes.  
Total protein quantification was done by Bradford assay kit (Sigma, UK) and absorbance at 
595 nm was measured using a multi well plate reader (GENiOS-Tecan, UK). 
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4.2.4 SDS-PAGE of total lysate and cell pellet 
A 12% bis/acrylamide gel was prepared and used to separate the proteins in both the crude 
protein extract and the 1 ml cell pellets from section 4.2.2.   
The loading buffer (62.5 mM Tris HCl pH 6.8, 2% SDS, 25% glycerol, 0.01% 
bromophenol blue) was mixed with 10% β-mercaptoethanol and added into the sample in a 
2: 1 ratio, heated for 5 minutes at 95
o
C, and loaded onto the gel. Pre-stained protein 
Proto arkers™ (Fischer Scientific) were used alongside the samples. The gel was 
electrophoresed at 80 volts until the dye front entered the resolving and 200 volts until the 
dye front ran through the resolving gel using the Protean II multicell (Bio-Rad). The gel 
was stained using instant blue stain solution (Expedeon, UK) in an orbital shaker for an 
hour. The gel was washed with de-ionized water and further immersed in de-ionized water 
until de-staining was achieved. 
 
4.2.5 In-gel digestion of over-expressed band 
SDS PAGE gel bands containing the over-expressed protein was cut out and subjected to 
in-gel protein trypsin digestion as described by Gan et al (2005). Briefly, the gel was 
completely de-stained using ammonium bicarbonate, reduced and alkylated using 
dithiothreitol and iodoacetamide respectively. Trypsin (1:40 w/w) was added and digested 
overnight and peptides eluted from gel using ammonium bicarbonate, formic acid and 
acetonitrile washing cycles. Peptide solution was vacuum dried using vacuum concentrator 
(Concentrator 5301, Eppendorf, UK). The dried peptides were stored at -20
o
C until further 
analysis. 
 
4.2.6 Protein purification 
Protein lysate from E. coli strain containing pETDuet-NS1tag from chemical lysis was 
purified using an affinity column.  
Affinity chromatography was performedusing His.Bind purification kit (Novagen) to purify 
terpene synthase protein from protein lysate according to the manufacturer’s instructions. 
Eluted fractions from column affinity chromatography were concentrated using an Amicon 
Ultra-15 (Millipore) centrifugal filters according to the manufacturer’s instructions. 
Purified protein sample were subjected to SDS-PAGE and in-gel tryptic digestion as 
outlined in sections 4.2.4 and 4.2.5. 
4.2.7 LC-MS identification of proteins 
The dried peptide fractions were resuspended in 15 µl of buffer A (3% acetonitrile and 
0.1% formic acid) and analyzed on a HCT Ultra Electrospray ionization (ESI) - Ion trap 
(Bruker Daltonics, UK) coupled to an online  nanoLC capillary liquid chromatography 
system (Famos, Switchos and Ultimate from Dionex/LC Packings, Amsterdam, The 
Netherlands). The peptides were desalted on a µ-PrecolumnTMcartridge of 5 µm particle 
size of 300 µm id x 5 mm od before separation on a PepMap C-18 RP capillary column 
(Dionex/LC Parkings) on a constant flow rate of 0.3 µl/min. A 45 minutes gradient starting 
with 3% buffer B (97% acetonitrile and 0.1% formic acid) and ramped to 35% in 45 
minutes was used. Data acquisition was set in the positive ion mode with a mass range of 
300 – 2000 m/z. Peptides with +2, +3 and +4 charge states were selected for further 
fragmentation. The protein identification search using MASCOT 2.0 (Matrix Science) was 
done on E. coli BL21 (DE3) and Nostoc sp. 7120 database downloaded from Uniprot 
(www.uniprot.org) on 14/02/2012. The search parameters were as follows: MS tolerance of 
1.2 Da, MS/MS tolerance at 0.6, oxidation of methionine as fixed  and cysteine 
modification with iodoacetamide as variable, with no missed cleavage of trypsin. 
 
4.2.8 Growth curve measurement 
Growth measurements were done to test the effect of the organic solvent, dodecane on E. 
coli pETNS1 strain and to assess growth characteristics of other mutants. 
 
4.2.8.1 Effect of dodecane on growth 
To test the effect of dodecane on the growth of E. coli containing pETNS1,starter culture 
was used to inoculate fresh TB supplemented with 100 µg/ml ampicillin at an initial 
concentration of 0.01 OD600 (optical density at 600 nm).  Two hundred microliters of the 
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freshly inoculated media were added to each well in a 96-well plate (Fisher Scientific, UK) 
and half of the samples were layered with 20 µl of dodecane. Uninoculated TB broth was 
used as a control for contamination. The 96-well plate was incubated with aeration (orbital 
shaking) at 30°C in a Genios multiplate reader (Tecan, USA) and the absorbance was 
recorded every 30 minutes for 72 hours. Three replicates of each sample were used.  
 
4.2.8.2 Growth measurement of mutants 
Overnight cultures of each E. coli strain was used to inoculated fresh 5ml TB with 
appropriate antibiotics supplementation and grown to an OD600 of between 0.6 and 0.8 and 
induced with 0.4 mM IPTG after which 200 µl of the culture was added to 96-well plate 
and incubated as described above.   
 
4.2.9 SPME-GCMS analysis of sesquiterpene 
100 ml of culture of E. coli cells(BLK, pETNS1, N, N+, P, T and C1) were grown and 
induced as described in triplicates and assayed for terpene production. Cultures were tightly 
sealed in layers of aluminium foil and head space sampled 30 hours post induction for 30 
min by solid-phase microextraction (SPME) using a 100 µM polydimethylsiloxane fiber 
(Supelco). After absorption, analysis was done on Finnigan Trace GC Ultra gas 
chromatograph coupled to a Finnigan Trace DSQ quadrupole mass spectrometer (Thermo-
Fisher) operating in a split mode. Separation was done on a TR-5MS capillary column 
(length, 30 m; inner diameter, 0.25 mm; film thickness, 0.25 µm) (Thermo-Fisher). 
Polydimethylsiloxane fibre was desorbed for 5 min using an injection port of 250
o
C and 
oven temperature was set at 100
o
C for 7 minutes and ramped at 20
o
C/min to 300
o
C and 
held for 2 min. Mass spectra was scanned in the range of 40 to 250 atomic mass units 
(amu) at 1 second interval. Spectra was searched against NIST 11 database (Scientific 
Instrument Services, Inc NJ, USA). 
 
 
  4.2.10 GCMS calibration curve for β-elemene  
Calibration curve using the sesquiterpene β-elemene (International laboratory, USA) was 
generated for the purpose of quantifying terpene produced from biphasic cultures. β-
elemene standards were made in dodecane solvent at concentrations of 5 µg/ml, 10 µg/ml, 
15 µg/ml, 20 µg/ml 30 µg/ml, 40 µg/ml, 50 µg/ml  and 100 µg/ml in triplicates. Samples 
were run on a Finnigan TraceGC Ultra gas chromatograph coupled to a Finnigan Trace 
DSQ quadrupole mass spectrometer (Thermo-Fisher) using a TR-5MS capillary column 
(length, 30 m; inner diameter, 0.25 mm; film thickness, 0.25 µm) (Thermo). The injection 
port was set at 250
o
C with an injection volume of 0.5 µl and oven program started at 80
o
C 
and held for min then ramped at 10
o
C/min to 120
o
C. It was subsequently ramped at 
3
o
C/min to 160
o
C and then to 270
o
C at 5
o
C/min and held for 5 min. Ionization source was 
set at 230
o
C with a scan rate of 5 scans per second with a full scan range of 40-250 m/z. 
Three injections of each sample were done. A calibration curve was generated by plotting 
the average peak area of each sample against its concentration. 
 
4.2.11 Biphasic culture for sesquiterpene 
Quantification of sesquiterpene produced from E coli mutants was done by growing the 
cells in a biphasic culture with an organic solvent. Three different organic solvents were 
tested. 
 
4.2.11.1 Testing different organic solvents 
100 ml TB were inoculated with overnight cultures of pETNS1 and grown to an OD600 of 
0.6 at 30
o
C and induced with 0.4 mM IPTG. Cultures were layered with 10% (10 ml) of 
octane, decane or dodecane, each in triplicate. Growth was continued at 25
o
C and after 28 
hours of growth, the incubation temperature was increased to 30
o
C for a further 2 hours 
before extracting the organic solvent layer. Aqueous culture was discarded and brine was 
added to the organic solvent layer to further separate any residual media. Complete drying 
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and removal of traces of aqueous media was done by drying over anhydrous magnesium 
sulphate and filtered through filter paper.  
4.2.11.2 Dodecane biphasic culture 
For quantitative analysis of sesquiterpene production, triplicate 100 ml cultures of E. coli 
strains (BLK, N, N+, P and T) were set up as previously described. After induction with 
IPTG, 10 ml (10%) dodecane was layered on the culture and growth continued at 25
o
C and 
processed as described in 4.2.11.1. 
4.2.11.3 GCMS quantitative analysis of sesquiterpene 
Quantization of sesquiterpene from biphasic culture was done by running samples from 
dodecane extract on the GCMS using the same program as in section 4.2.10. Each 
phenotype had three biological replicates and three technical replicates from each of the 
biological replicates. The average peak area was used to generate the concentration using 
the β-elemene standard curve.   
 
4.3 Results 
4.3.1 Protein extraction and quantification 
Soluble protein extract from bead beating, liquid nitrogen cracking, French pressure and 
chemical lysis (using BugBuster
TM
) were performedand quantified using Bradford Ultra 
assay reagent. The quantification results were compared as seen in Figure 4.1. The 
extraction method showed that the French press gave the highest protein concentration per 
ml of culture and therefore the most efficient extraction method with glass bead beating 
giving the lowest yield. However, the French press was less reproducible compared to 
chemical lysis and required larger volume of cultures. Liquid nitrogen cracking was also 
very efficient even though it was time consuming and required some physical energy.  In 
terms of reproducibility of results and ease of procedure, the chemical lysis method was 
superior as evident by the significantly smaller error bars. The lysis buffer of the 
BugBuster
TM  
was also compatible with the affinity chromatography kit and was therefore 
the method of choice for terpene synthase purification. 
 Figure 4.1 Comparison of different methods of protein extraction using plasmid free 
E. coli BL21 (DE3) (BLK1) and E. coli + (plasmid( (NS1). Protein quantitation was 
done from 500 ml of culture for each method. 
 
4.3.2 Over-expression of sesquiterpene synthase   
The total protein lysate of the his-tagged terpene synthase cloned into 
pETDuet(pETNS1tag) and transformed into E. coli(NS1) and plasmid freeE. coli cells  
(BLK) were run on an SDS-PAGE gel to check for over-expression of the terpene synthase 
protein. This was done to confirm that the protein had actually been expressed. As seen in 
Figure 4.2, there was an over-expressed protein band corresponding to the expected 
molecular mass of the protein at 37 kDa, while the wild type control did not show the same 
band. This showed evidence of successful protein expression.  
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Fig 4.2 12% SDS-PAGE of 10 µg of total protein lysate plasmid freeE. coli (BLK1) in 
lane 2 and E. coli with pETNS1tag(NS1) in lane 4. The transformed E. coli lysate 
show over–expressed band corresponding to about 37 kDa band (hollow arrow) 
compared to the marker (M) 
 
4.3.3 Purification of expressed protein 
 The crude protein lysate from pETNS1tag E. coli was purified by nickel affinity 
chromatography. The terminal histidine tag on a protein can bind to the iminodiacetic acid 
(IDA) bound nickel and this  histidine-nickel bond can be broken to elute the histidine 
tagged protein by increasing concentrations of imidazole. SDS-PAGE of the eluted protein 
fraction in Figure 4.3 shows a clear band that correspond to the theoretical size of (37kDa) 
of the putative protein in the mutant cells while the wild type cells did not show any band.   
 
 
 
  
 
 
 
 
 
 
 
 
Fig 4.3 12% SDS PAGE gel of purified putative sesquiterpene synthase protein 
using affinity chromatography. Lane 2 is from anE. coli BL21 (DE3)containing an 
empty pETDUET plasmid as control and lane 3 is the E. coli transformed with 
pETNStag showing the band of interest and M is marker. 
 
4.3.4 Protein expression as a function of time 
Target protein (NS1) expression was surveyed over time to get the best time to harvest 
culture in order to achieve optimal target protein yield. A plasmid free strain without the 
target protein (BLK1) was used as a control. As seen in Figure 4.4, and verified by protein 
densitometry in Figure 4.5, target protein expression was maximal at 30 hours post 
induction and shows reduction from about 40 hours post induction. 
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Fig 4.4 12% SDS-PAGE gel of protein expression time line using protein lysate from 
cells harbouring putative sesquiterpene synthase gene as well as control. Maker 
(M), lane 1(NS1) at induction, 2 negative control at induction, 3, 4, 5 and 6 are for 
expression at 10, 15, 20 and 25 hours post-induction. Lane 7 shows negative control 
at 25 hours post-induction and lanes 8 and 9 are for 30 and 40 hours post induction. 
Each lane had equal volume of culture. 
 
 
 
 
 
 
 
 
 
  
  
Fig 4.5 putative sesquiterpene expression from point of induction with IPTG 
measured by average density (pixels) of over-expressed protein band in 1 ml culture 
volumes during the course of time with a negative control taken at 25 hours post 
induction.  
 
4.3.5 LC-MS identification of expressed protein 
The purified protein from the total protein lysate from the mutant E. coli expressing the 
putative terpene synthase was identified with LC-MS after tryptic digestion. A database 
search on Nostoc sp. 7120 gave a single protein hit as shown in Table 4.2. This protein 
(Alr4685) is a terpene synthase.   
Table 4.2 LC_MS purified protein (NS1tag) identification 
Protein accession Protein description  
Protein 
score 
Protein 
cover 
# of unique 
peptides 
Q8YN85_NOSS1 
Alr4685 protein OS=Nostoc sp. (strain 
PCC 7120 / UTEX 2576) GN=alr4685  
150 22% 6 
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4.3.6 SPME- GCMS in vivo test of terpene synthase activity 
After the identification of the purified protein as a terpene synthase, it was necessary to test 
its activity in vivo as there is always the possibility that the protein may not be functional. 
There are several reasons for inactivity of expressed proteins ranging from mis-folding of 
protein to forming insoluble aggregates. A solid phase micro extraction (SPME) procedure 
combined with GC-MS was done to detect the volatile effluent from E. coli cultures. As 
seen in Figure 4.6, a single chromatographic peak was detected and the fragmentation was 
matched to β-elemene with a 95% confidence in the NIST database.  
 
Fig 4.6GC-MS analysis of volatile organic compounds produced by mutant E. coli 
expressing sesquiterpene synthases from Nostoc sp. A single chromatographic 
peak with a retention time of 9.5 was detected. The NIST database search identified 
this compound as the antiproliferative  β-elemene at 95% match.  
4.3.7 Effect of dodecane on the growth of E. coli 
A biphasic culture using non-miscible dodecane as a solvent to trap the volatile terpene in 
order to do a quantitative assay of the produced terpene.The effect of dodecane on the 
growth of E. coli cells was tested to check if dodecane had any significant impact on the 
growth of the cells. The productivity of the cell is linked to it growth and any factor that 
limits its growth is likely to affect its productivity.  E. coli cells containing the terpene 
synthase were grown with and without dodecane overlay. As seen in Figure 4.7, the growth 
curve of both cells grown with and without dodecane did not show any significant 
difference over a 72 hour period. This confirms that dodecane did not have any significant 
effect on the growth of the cells and hence the productivity.  
 
Fig 4.7 Growth assay of  E. coli containing terpene synthase to check the effect of 
the organic solvent dodecane on growth over a 72 hour period at 30 oC.   
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4.3.8 Effect of plasmid and terpene synthase on the growth of E. coli 
The effect of a pETDuet plasmid and the terpene synthase insert on the growth of E. coli 
cells was also tested using the the plasmid free E. coli BL21 cells as control. The result as 
seen in Figure 4.8 show a consistent growth retardation in the both the plasmid carrying 
and the terpene synthase carrying strains indicating that both imposed a metabolic burden 
on the cells.  
 
Fig 4.8 Post induction growth curve of E. coli cell containing an empty pETDuet 
plasmid, a pETDuet with a terpene synthase insert (NS1) and the plasmid free E. coli 
cells (BL21). 
4.3.9 Calibration curve for terpene quantitation  
To quantitatively assay terpene produced from biphasic cultures using GC-MS, an external 
calibration method using the sesquiterpene β-elemene was done as described in 4.2.10. The 
β-elemene standard was made in dodecane in increasing concentrations this was used to 
generate the calibration curve seen in Figure 4.9. The lower limit of detection for β-
elemene in dodecane solvent was determined experimentally to be 3.5 µg/ml.  
 Fig 4.9 A GC-MS external calibration curve forβ-elemene standard within the 
dynamic range of 3.5-100 µg/ml The area under the curve for each peak intensity 
was plotted against the concentration of the standard producing that peak.  
 
 4.3.10 Testing different organic solvents for in vivo terpene production 
Using SPME-GCMS analysis, the terpene synthase was shown to be active by qualitative 
assay.  For the quantitative assay of the terpene, a biphasic culture using selected organic 
solvents was done to ascertain the toxicity and hence the productivity of the cells in each of 
these solvents. The organic layer of each culture was sampled and the GCMS analysis 
results for octane, decane and dodecane is shown in Figure 4.10. The results show that 
dodecane is the best solvent between these three for biphasic culture with a baseline terpene 
production at 38 µg/ml. These results show a positive correlation with the the logP values 
for the solvents (octane (4.9), decane (6.0) and dodecane (7.0) as previously reported 
(Inoue and Horikoshi, 1991; Sardessai and Bhosle, 2002; T. et al., 2002). The logP value of 
an organic solvent is a measure of a solvent’s hydrophobicity and toxicity and the higher 
the logP value the less toxic it is to the cells.  
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Fig 4.10 GCMS analysis of terpene produced in biphasic cultures using different 
organic solvents at 30 hours post induction showing the effect of the different 
solvents on E. coliterpene production. 
 
4.3.11 Quantitative assay of terpene produced by different phenotypes 
The productivity of the different strains in biphasic flask cultures with dodecane as the 
preferred solvent was assessed. Optimisation of the GC gradient was carried out in order to 
remove dodecane interference to terpene quantification (Figure 4.11). Figure 4.12 shows 
the terpene concentration per millilitre of dodecane solvent at the time of harvest in each 
strain. The N+ (terpene synthase + mevalonate pathway containing pasmid) showed a 
significant increase in terpene yield (more than 34 fold) compared to the mevalonate 
negative strain (N). The P (terpene synthase + cytochrome P450 + ferrodoxin reductase) 
and T (terpene synthase + cytochrome P450 +ferrodoxin reductase + mevalonate pathway 
containing plasmid) strains did not show any improvement over the N strain. Despite the 
fact that all the cultures were harvested at the same time, there were still differences in the 
biomass produced by each strain as a result of differences in growth and metabolism. The 
specific productivity of each strain with respect to terpene production was thus evaluated 
and is as shown in Figure 4.13. The specific productivity of N+ was 40 fold more than that 
of N. There was no significant difference in productivity between N and T while P was 3 
fold less productive than  
 
Figure 4.11 GCMS spectrum of an optimised gradient used to separate the 
ubiquitous dodecane solvent from the terpene. The dodecane shows a wide elution 
time from 6.8 to 8.9 minutes as shown by the double arrows and the terpene elution 
time was at 9.6 minutes.  
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Fig 4.12 Terpene produced by the E. coli strains per ml of dodecane solvent. The E. 
coli strains all contain three plasmids each. N (pETNS1 + pBbA5c + pBBR1- 
MCS2),N+ (pETNS1 + pBbA5c-MevT(CO)-T1-MBIS(CO, ispA) +pBBR1-MCS-2), P 
(pETNS1-P450 +  pBbA5c + pBBR-FER-RED), T (pETNS1-P450 + pBbA5c-MevT(CO)-
T1-MBIS(CO, ispA + pBBR-FER-RED).  
  
Fig 4.13 Specific productivity of E. coli strains per gram of cells. N (pETNS1 + 
pBbA5c + pBBR1- MCS2), N+ (pETNS1 + pBbA5c-MevT(CO)-T1-MBIS(CO, ispA) 
+pBBR1-MCS-2), P (pETNS1-P450 +  pBbA5c + pBBR-FER-RED), T (pETNS1-P450 + 
pBbA5c-MevT(CO)-T1-MBIS(CO, ispA + pBBR-FER-RED).  
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4.4 Discussion 
The success of any metabolic engineering project would inherently require a 
functional expression system upon which further improvement can be done.  The 
functional assay of the terpene synthase and a quantitative assay of the terpene 
product has been carried out in this chapter. A number ofstrategies were employed 
in this chapter for the overall goal of achieving a quantitative assay of the terpene 
yeild. These include sampling time, assay method and choice of trap solvent for the 
terpene. 
In order to quantify and thus determine the productivity of the terpene synthase, the 
in vivo turn-over of the enzyme had to be assessed through the process of expression 
and identification of the protein. A suitable time frame for protein harvest needed to 
be established by measuring the protein accumulation as a function of time because 
recombinant protein degradation by proteolytic enzymes is a common problem that 
could occur during cultivation (Hannig and Makrides, 1998; Murby et al., 1996) and 
this could be subject to the length of cultivation. The BL21 expression host which is 
known to be deficient in both ompT and lon proteases (Sørensen and Mortensen, 
2005) was combined with a culture temperature set at 25
o
C to enhance recombinant 
protein yield. However, the protein time line expression measurements still showed 
recombinant protein reduction beyond 30 hours post-induction. Based on this, both 
the biomass harvest and terpene sampling was done at 30 hours after IPTG 
induction. 
The measurable final product titre of an expression system is not only a function of 
pathway efficiency but also on the efficiency of the assay methods. Thus, in a 
system producing volatile hydrocarbons like terpenes, measurement of product titre 
would have to take into consideration headspace losses during cultivation. To 
minimize the headspace losses, biphasic culture using a non-miscible organic 
solvent was adopted.   Of the three organic solvents tested, dodecane gave the 
highest yield of product and as shown by the growth curve measurement, dodecane 
did not have any negative effect on growth of E. coli. As has been shown 
previously, the logP value of a solvent is a measure of its hydrophobicity and the 
higher the logP value the more hydrophobic and hence the less toxic the solvent. 
Dodecane with a logP value of 7.0 (Inoue and Horikoshi, 1991) and lower volatility 
showed a proportionately more yield of terpene than octane and decane. However, 
dodecane had a very intense solvent peak and significantly broad elution time which 
suppressed the detection of the terpene using GCMS. Optimisation of the GC 
gradient was thus carried out in order to remove dodecane interference for terpene 
quantification. The dodecane biphasic culture gave a yield of 38 µg/ml as quantified 
by GCMS compared to 16 µg/ml for octane and 34 µg/ml for decane as the basal 
expression level of terpene as a single plasmid expression system using the E. coli 
native precursor pool from the DXP pathway. However, using a three plasmid 
system, N (pETNS1 + pBbA5c + pBBR1-MCS2), the terpene yield showed more 
than  a 7 fold decrease. This was done to set a baseline yield for which the 
subsequent strains with multiple plasmids would be compared. The drastic 
reduction in product titre is a direct consequence of metabolic burden of multiple 
plasmids with growth retardation as well as decrease of biomass (Diaz Ricci and 
Hernández, 2000; Redding-Johanson et al., 2011a; Rozkov et al., 2004). This 
multiple plasmid containing terpene synthase strain produced a baseline terpene titre 
of 5.2 µg/ml and a specific productivity of 9 µg/g of dry cell weight. The addition of 
FPP overproducing plasmid to the terpene synthase strain in addition to the 
pBBR1MCS2 plasmid, N+ (pETNS1 + pBbA5c-MevT(CO)-T1-MBIS(CO, ispA) + 
pBBR1-MCS2)  showed a more than 34 fold increase in terpene titres and a specific 
productivity of more than 40 fold when compared to N.  However, when the FPP 
over-producing plasmid was transformed into a strain harbouring the terpene 
synthase and cytochrome P450 on a single pETDuet plasmid with a 
ferrodoxin/ferrodoxin-reductase, T (pETNS1-P450 + pBbA5c-MevT(CO)-T1-
MBIS(CO, ispA) +  pBBR-FER-RED)the terpene product was also significantly 
reduced compared to N+. The titres for this system were comparable to the baseline 
titres for N (the three plasmid system without the FPP overproducing plasmid). This 
was surprising considering that the oxidation product of the terpene was almost 
negligible. Since cytochrome P450s are poorly expressed in E. coli, and was indeed 
observed to be true from SDS-PAGE analysis, this could not be explained by 
assuming that the terpene product had been transformed by the P450. This then 
must be the effect of expressing either the cytochrome P450 with or without the 
ferrodoxin/ferrodoxin-reductase. It is known that the successful expression of 
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multiple, sequential pathway enzymes,  even with optimal level of precursor supply, 
restrictions may be further imposed by cofactor supply, by rapid export of 
intermediates, and by the limited ability of the bacterial host to traffic hydrophobic 
intermediates from the cytosol to membranous hydroxylation sites, and back to the 
cytosolic sites of subsequent redox metabolism (Carter et al., 2003). This would 
expected to be worse when an enzyme with a notorious poor expression in E. coli 
such cytochrome P450 is involved.   
 
4.5 Conclusions 
A robust method for the quantitation of terpenes and terpenoids was developed and 
optimised in this chapter. This method was successfully applied to quantify the 
terpenes produced by recombinant strains of E. coli. A baseline value of 38 mg/L of 
terpenes was produced using the native precursor pool in E. coli. This value 
increased to 178 mg/L of terpenes upon the introduction of the yeast-based FPP 
over-producing pathway in E.coli. This was due to the increased availability of 
precursors for the production of terpenes. This value translates to about 369 mg of 
terpenes per gram of cells. The expression of cytochrome P450 and ferrodoxin 
reductase required to convert the terpenes to terpenoids resulted in an expected, 
significant decrease in terpene production. However a concomitant increase in 
terpenoid production was not detected. 
 
 
 
 
 
 
CHAPTER5 
 
 
Metabolic adaptation of E. coli to 
cyanobacterial sesquiterpene 
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Adaptation to sesquiterpene synthase 
121 
 
 
  
 5.1 Introduction 
The development of metabolic engineering has been spurred not only by the major 
challenges of the 21
st
 century such as climate change, renewable energy, food security, 
pollution and health but also by development of new technologies(Betenbaugh and Bentley, 
2008; Lindberg et al., 2010). With the advent of the post genomic era, availability of new 
tools and technologies and development of system biology/synthetic biology, there has 
been a paradigm shift from seeing the cell as a production line to that of a production 
factory(Cortassa, 2002; Kholodenko and Westerhoff, 2004; Smolke, 2009). The ultimate 
aim of using metabolic engineering from this new perspective is to achieve strain 
improvement and cell engineering using transcriptomics, proteomics, metabolomics, 
computational systems biology, protein engineering and synthetic biology.  
The success of metabolic engineering has been astounding so far with many useful 
compounds already produced through metabolic engineering in the two decades of the 
discipline. In therapeutics, several drugs or drug leads such as the antimalarial compound 
artemesinin and the anticancerous drug taxol which hitherto were produced exclusively by 
plant cultivation have either been wholly heterologously synthesized in microorganisms or 
a biosynthesis of their direct precursor achieved(DeJong et al., 2006b; Dietrich et al., 
2009b; Ro et al., 2006b). In addition several other molecules such as isoprenes, flavinoids, 
dihydroxyacetone and ethanol have been produced in high titres (20.8 mg/l of naringenin, 
700 mg/l dihydroxyacetone, 0.46 g/g of ethanol) through metabolic engineering(Cripps et 
al., 2009; Nguyen and Nevoigt, 2009; Trantas et al., 2009; Watts et al., 2004). There are 
many variables that determine efficiency of a heterologously expressed pathway such as 
consumption of intermediates by native pathways, mRNA abundance and half-life, protein 
abundance and activity. Proteomics and or metabolomics methodologies can help to 
identify pathway bottlenecks which can then be metabolically engineered to increase 
product titres(Pandhal et al., 2013, 2011a).  
E. coli has been employed as an organism of choice for production of many recombinant 
proteins as well as metabolites for reasons ranging from cheap and rapid growth, to 
abundance of genomic, transcriptomic, proteomic and metabolic data (Papagianni, 2012). 
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Targeted proteomics methodologies have recently been applied to metabolically engineer a 
more than three-fold increase of the artemisinin amorpha-4,11-diene titre to greater than 
500 mg/L in E. coli(Redding-Johanson et al., 2011a).  Several other quantitative proteomics 
methodologies are presently widely employed, including the popular iTRAQ(Bantscheff et 
al., 2007).It is the objective of this chapter to use iTRAQ based proteomics to understand 
the metabolic changes that accompany heterologous sesquiterpene expression in E. coli as a 
stepping stone to engineering the terpene production pathway. The expression of the 
sesquiterpene synthase would take advantage of the nativeE. coli DXP precursor pathway 
for the production of terpene as shown in Figure 5.1  
 
 
 
Figure 5.1 Pathway for the biosynthesis of sesquiterpenoids in E. coli showing the 
native DXP pathway for IPP/DMAPP synthesis. IspA, FPP synthase; FPP, farnesyl 
diphosphate; SQT synthase, sesquiterpene synthase 
 
5.2 Materials and Methods 
5.2.1 Culture conditions and cell harvest 
Single colonies of mutant E. coli BL21 (DE3) containing pETDUET (C) and pETDUET-
NS (NS) respectively was inoculated into 5 ml of LB broth containing ampicillin at 100 
µg/ml concentration and grown at 37
o
C in a rotary incubator for 12-16 hours. The overnight 
cultures were used to inoculate 100 ml of terrific broth (TB) (containing ampicillin at100 
µg/ml) in 250 ml culture flasks to make a starting OD600 of 0.01. These were set up as 
biological duplicates of each phenotype. Culture flasks were then incubated in a rotary 
shaker at 30
o
C and growth was monitored by OD600 measurements. Cultures were induced 
with IPTG at a final concentration of 0.4 mM at an OD600 of 0.6 and growth continued at 
25
o
C for further 30 hours. Cultures were harvested by centrifugation at 5400 x g for 10 
minutes at 4
o
C. Pellet was washed twice with 500 mM triethyl ammonium bicarbonate 
(TEAB; pH 8.5), resuspended in 1 ml of 500 mM TEAB containing 0.1% Benzonase 
(Novagen) and flash frozen in liquid nitrogen and stored at -70
o
C until used.  
5.2.2 Protein extraction and quantification 
Thawed cells where lysed using mechanical cracking and liquid nitrogen and protein lysate 
was recovered by centrifugation at 21,000 x g at 4
o
C for 30 minutes. The total protein 
lysate concentration was quantified by a Bradford assay kit (Sigma, UK) following the 
manufacturer’s protocol. 
5.2.3 SDS-PAGE 
SDS-PAGE was set up as detailed in section 4.2.4 using 10 µg of each sample to check the 
accuracy of Bradford assay measurement and for in-gel tryptic digestion. 
5.2.4 In-solution tryptic digestion 
To test for the efficiency of in-solution digestion of proteins, 10 µg of each sample was 
digested. Prior to digestion, the protein samples were reduced with 10 mM final 
concentration of DTT in TEAB for 1 hour at 56
o
C and alkylated with a final concentration 
of 55 mM iodoacetamide in TEAB for 30 minutes in the dark at room temperature. 
Sequencing grade trypsin (Promega, UK) was added to the protein mixture in a 1: 40 (w/w) 
after which acetonitrile was added to a final concentration of 5% and incubated at 37
o
C for 
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14-16 hours. The peptide mixtures were dried in a vacuum concentrator (Concentrator 
5301, Eppendorf, UK) and stored at -20
o
C. 
5.2.5 In-gel tryptic digestion 
Gel pieces from SDS-PAGE were rinsed several times with deionized water and each lane 
corresponding to each condition (wild type or mutant) was cut into 24 equal sized strips and 
processed separately. The gel strips were de-stained and trypsin digested as described in 
4.2.5.  
 
5.2.6 Stacking gel aided purification of proteins and in gel trypsin digestion 
50 µg of protein from each sample was loaded onto widely separated lanes and run at 60V 
until the proteins were concentrated just above the resolving gel and then washed and 
stained with Coomassie brilliant blue. Each concentrated protein blob was then excised, 
diced and then digested as detailed in section 4.2.8 
5.2.7 Pre-labeling SCX peptide fractionation  
Dried peptides were resuspended in 70 µl of buffer A (25% acetonitrile in water, 0.1% 
formic acid) and separation was performed on a PolySULFOETHYL A column (PolyLC, 
USA) 21 cm length, 2.1 mm internal diameter and 5 μm pore size using a BioLC HPLC 
unit (Dionex, UK). The separation programme consisted of 100% buffer A for 5 minutes, 
0-35% buffer B (25% acetonitrile in water, 0.1% formic acid, 500 mM potassium chloride) 
for 30 minute, 35-100% buffer B for 10 minutes, 100% buffer B for 5 minutes, and finally 
100% buffer A for 10minutes. A flow rate of 0.2 ml/min was maintained with an injection 
volume of 70 μl. The gradient was then modified to 0-5% buffer B for 1 minute, 5-30% 
buffer B for 30 minutes, 30-35% buffer B in 5 minutes, 35-100% buffer B in 5 minutes, 
100% buffer B for 5 minutes, and again 100% buffer A for 10minutes.  A UV detector 
UVD170Uset at 214nm and Chromeleon software v6.50 (Dionex/LC packings, The 
Netherlands) was used to monitor the chromatograms and fractions were collected every 
minute using a Foxy Jr. fraction collector (Dionex, UK). The fractions were dried in a 
vacuum centrifuge and stored at -20°C prior to MS analysis. 
 
5.2.8 LC-MS identification of proteins 
The dried peptide fractions were resuspended in 15 μl of buffer A (3% acetonitrile and 
0.1% formic acid) and analyzed on a HCT Ultra Electrospray ionization (ESI) - Ion trap 
(Bruker Daltonics, UK) coupled to an online  nanoLC capillary liquid chromatography 
system (Famos, Switchos and Ultimate from Dionex/LC Packings, Amsterdam, The 
Netherlands). The peptides were desalted on a µ-PrecolumnTMcartridge of 5 µm particle size 
of 300 µm id x 5 mm od before separation on a PepMap C-18 RP capillary column 
(Dionex/LC Parkings) on a constant flow rate of 0.3 µl/min. A 45 minutes gradient starting 
with 3% buffer B (97% acetonitrile and 0.1% formic acid) and ramped to 35% was used. 
Data acquisition was set in the positive ion mode with a mass range of 300 – 2000 m/z. 
Peptides with +2, +3 and +4 charge states were selected for further fragmentation. MS/MS 
data was searched on an in-house Phenyx algorithm server (Genebio, Switzerland) on and 
E. coli BL21 (DE3) and Nostoc sp. 7120 database downloaded from Uniprot 
(www.uniprot.org) on 14/02/2012.The search parameters were as follows: MS tolerance of 
1.2 Da, MS/MS tolerance at 0.6, oxidation of methionine as fixed  and cysteine 
modification with iodoacetamide as variable, with no missed cleavage of trypsin. 
5.2.9 iTRAQ labeling of peptides 
Digested and vacuum dried peptides were resuspended in 50 μl of 500 m  TEAB buffer 
and labelled according to the manufacturer’s (AB-Sciex, CA, USA) instruction briefly as 
follows: The iTRAQ 8-plex labels (113, 114,115 and 116) were resuspended in 125 μl of 
100% isopropanol and mixed with the peptides (Table 5.1). The peptides/label mix were 
left on the bench to incubateat room temperature for two hours, pooled and dried in a 
vacuum centrifuge at room temperature.  
Table 5.1 Phenotypic iTRAQ labeling of samples 
Phenotype             Replicate        Label          Replicate      Label 
Control  (C)                    1                 113              2                114 
Mutant  (NS)                  1                 115              2                116 
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5.2.9 SCX fractionation of labeled peptides 
iTRAQ labeled peptides were fractionated as detailed in section 5.2.7 using a gradient of 0-
5% buffer B for 1 minute, 5-30% buffer B for 30 minutes, 30-35% buffer B in 5 minutes, 
35-100% buffer B in 5 minutes, 100% buffer B for 5 minutes, and again 100% buffer A for 
10minutes. Fractions were then dried in a vacuum centrifuge and stored at -20
o
C prior to 
MS analysis. 
5.2.10 RP-LC-MS/MS analysis 
Each peptide fraction was resuspended in 20 µl of buffer A (3% acetonitrile, 0.1 % formic 
acid) and 8 µl was injected into a nano-LC-ESI-MS/MS system. Mass spectrometric 
analysis was performed using a Q-STAR XL Hybrid ESI Quadrupole Time of Flight (ESI-
qQ-TOF) mass spectrometer (Applied Biosystems, MDS-Sciex) coupled to an online 
capillary nanoLC system (Ultimate 3000, Dionex/LC packings, The Netherlands). 
Separation was done on a PepMap C-18 RP column (LC packings) at a constant flow rate 
of 0.3μl/min using a gradient of 97% buffer A and 3% buffer B (97% acetonitrile in water, 
0.1% FA) for 30 minutes, followed by 3-25% buffer B for 120 minutes, 90% buffer B for 5 
minutes and 100% buffer A for 5 minutes. Data acquisition was set in the positive ion mode 
with a selected mass range of 300 – 2000 m/z. MS/MS was performed on peptides with 2+, 
3+ and 4+ charge states.  A total of two injections were performed. 
 
5.2.11 Data analysis 
Protein identification and quantification was done on a Phenyx algorithm server (binary 
version 2.6;Genebio, Switzerland). Search was performed on an E. coli BL21 (DE3) protein 
database downloaded from Uniprot (www.uniprot.org) on 14/02/2012 using MS tolerance 
of 0.6 Da, MS/MS tolerance of 0.3 Da, and one missed cleavage of trypsin. Peptide 
modification was set as oxidation on methionine as variable, cysteine modification as fixed 
and 8-plex iTRAQ mass shifts (+304 Da, K and N-term). 
5.2.12 Data analysis  
A careful analysis of the relative abundance ratio between phenotypes was carried out using 
the significance testing algorithm, Signifiquant(S. Y. Ow et al., 2009). Quantification was 
obtained at a 95% confidence level from proteins identified by two or more peptides. An 
increased abundance of protein is indicated by fold changes above a factor of 1 and a 
decrease in the abundance of proteins is indicated by fold changes below a factor of 1. 
Multiple test correction was employed on the first search to rule out the possibility of false 
positive results (Pham et al., 2010). The first search was used, therefore, to identify the 
“hotspots” in the bacterial metabolism that undergoes highly differential regulation. In the 
subsequent comparison, the multiple test correction was relaxed to include false negative 
results omitted in the first search. A further reduction of to 90 and 70% confidence level 
was done for pathway enrichment in specific pathways and peptides manually curated. The 
metabolic proteins identified at 95% confidence were mapped onto KEGG Mapper 
metabolic pathways curated by the Kyoto Encyclopedia of Genes and Genomes 
(http://www.genome.jp/kegg/tool/map_pathway2.html; organism code – ebe) 
 
5.3 Results 
5.3.1 Overview of the proteomic analysis workflow and optimisations 
The general proteomic workflow employed in this chapter is presented in Fig 5.2. 
Optimisations were carried out for protein extraction methods (detailed in 4.2.2), trypsin 
digestion as well as SCX-HPLC fractionation of peptides.   
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Fig 5.2 An overview of the iTRAQ proteomics workflow for the iTRAQ 
experiment carried out for this chapter 
  
5.3.1.1 Optimisation of protein extraction method 
Different protein extraction methods were tried as discussed in chapter 4 and 
mechanical cracking with liquid nitrogen was seen to be the optimal method 
for iTRAQ experiments, even though the French press did prove a more 
efficient cell lysis method, but required larger volume (> 5 ml) of cell 
suspension which could be achieved either by growing larger cell culture 
volumes (500 ml and above) or diluting the cell suspension significantly. 
Chemical lysis was also very efficient and much more reproducible compared 
to liquid nitrogen cracking, but the detergents in this buffer are not compatible 
with the iTRAQ workflow.  For these reasons, mechanical cracking with 
liquid nitrogen was used as the preferred protein extraction method.  
 
5.3.1.2 SDS PAGE analysis of extracted proteins 
SDS-PAGE was used to analyze extracted and quantified proteins to further 
validate the quantitative methods. 10 µg of protein of sample was used for this 
purpose and visually inspected for equal loading across replicates as seen Fig 
5.3. This also enabled direct visual comparison of phenotypes to see any 
differences in the protein expression pattern. As a further preliminary check 
on phenotypic differences in the expressed proteins, one lane of representative 
phenotype was digested in 24 equal sized strips. The results, as seen in Table 
5.2 serves as a non-quantitaive crude screening test to show that some proteins 
were relatively over-expressed in between the phenotypes. 
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Table 5.2 Abundant  proteins identified by the mass spectrometerin (NS) but not 
detected in control (with empty vector) E. coli  cells  
AC Score #pept Protein ID 
A1AAG4 114.2 21 CoA-linked acetaldehyde dehydrogenase. 
A1AIF3 92.1 19 Translation elongation factor EF-Tu. 
A2UCU8 73.4 16 Phosphoglycerate kinase  
A7ZMP9 58.6 16 GIyceraldehyde-3-phosphate dehydrogenase (Phosphorylating)  
A2UKH3 40.6 7 Tryptophanase  
A2UGU7 39.7 5 Ribosomal protein L9. 
A2UPI8 35.7 6 Translation elongation factor G. 
A2UKF2 35.4 5 Phosphate ABC transporter, periplasmic phosphate-binding protein 
precursor 
A7ZYQ9 30.9 5 Outer membrane protein A. 
Q6J0R8 30.4 7 Chloramphenicol acetyltransferase  
A2UCU9 29.1 6 Fructose-bisphosphate aldolase, class II  
A1A8N6 28.1 6 Alkyl hydroperoxide reductase, C22 subunit. 
A2UMT9 28.1 5 Ribosomal protein L1. 
A2UKQ4 28.0 4 FAD-dependent pyridine nucleotide-disulphide oxidoreductase. 
A2UL29 20.4 2 Chaperone protein DnaK. 
A2UD96 19.6 4 Porin, Gram-negative type precursor 
A2UKZ7 17.4 4 Purine nucleoside phosphorylase. 
A2UMT8 17.3 5 Ribosomal protein L11. 
A2UNW1 16.6 2 Ribosomal protein L2. 
A2UPE0 16.2 3 50S ribosomal protein L5 (Fragment). 
A1A9I0 15.7 2 PflB.  
A1AIC1 15.5 2 Peroxidase/catalase  
Q1R486 13.3 2 Uridine phosphorylase  
Q68QU6 11.4 3 Malate dehydrogenase (Fragment). 
Q53X36 10.9 2 Elongation factor G (Fragment). 
A2ULA0 9.3 2 Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent  
A1AAT6 9.0 2 Thiol peroxidase. 
A2UPE3 8.3 2 50S ribosomal protein L6. 
Q52JH4 34.0 6 PstS  
Q9ETZ1 27.0 4 Malate dehydrogenase  
A2UL48 23.0 5 Uridine phosphorylase. 
A2UKE5 16.6 2 ATP synthase F1, alpha subunit  
A2UN91 15.5 2 Trigger factor. 
A2UP41 49.3 12 Glyceraldehyde-3-phosphate dehydrogenase (Phosphorylating)  
 
 
 Figure 5.3 SDS-PAGE analysis of 10 μg of each protein sample used in iTRAQ 
experiment, C (E. coli  transformed  with empty pETDuet plasmid) in lanes 2 
and 4 and NS1 (E. coli transformed with pETNS1) lanes 1 and 3. Marker in 
lane M 
 
5.3.1.3 Testing tryptic digestion methods 
Trypsin digestion of protein sample was tested before proceeding to 
fractionation and iTRAQ labeling in the workflow. Initial in-solution 
digestion of protein samples was accompanied by significant protein 
precipitation on reduction with DTT at 56
o
C. Subsequent digestion of these 
samples and RP-LC-MS analysis yielded few protein hits. In order to increase 
the number of identified proteins hits on LC-MS,  the proteins were 
concentrated in an SDS-PAGE stacking gel and subsequently digested  using 
an in-gel digestion method. To check for the efficiency of digestion, a volume 
of the digest equivalent to 5 µg of each protein sample was separated on an 
SDS-PAGE gel. As seen in Fig 5.4, the SDS-PAGE gel of a representative 
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stacking gel and post digestion gel confirm protein concentration and 
purification as well as completion of digestion.  
 
 
Fig 5.4 SDS-PAGE of A) stacking gel showing50 ug of concentrated 
proteins just above the resolving gel in each lane and B) post 
digestion of protein. Notice that in B, there is no visible protein band 
in all lanes. 
 
5.3.1.4 Optimisation of fractionation methods 
To achieve optimal identification and quantification of peptides in RP-LC-MS 
analysis, a two-dimensional chromatographic separation was applied. As a 
result, the number and complexity of peptides presented to the mass 
spectrometer for fragmentation and identification at any given time was 
reduced with significant improvements in protein numbers and especially for 
low abundance proteins. An efficient offline first dimensional HPLC 
separation of peptides significantly enhances the number of peptides 
identified. The efficiency of HPLC separation not only depends on the method 
employed, but significantly on the choice of mobile and stationary phases but 
also on the gradient employed. For any given system with fixed mobile and 
stationary phases, the choice of gradient could make a significant difference to 
the outcome of the iTRAQ experiment. In Fig 5.5, the initial SCX 
chromatogram is seen alongside the fractional distribution of peptides. A 
significant elution of peptides is seen between 22 min and 26 min on the 
gradient. This observation served as a template for subsequent optimisation. 
The resolution of the SCX separation, defined by the frequency of the unique 
occurrence of peptides in a SCX fraction, was calculated by plotting the 
number of peptides seen against the frequency of peptide occurrence. As seen 
in Fig 5.6, the change in peptide resolution efficiency was significantly 
increased from 60% to 79% as a result of the gradient optimisation.  
 
 
Fig 5.5 Distribution of peptides across fractions collected during SCX fractionation. 
The number of peptides per fraction is shown in red squares and the 
chromatographic trace in absorbance (mAU) units is in blue. A significant number of 
the total peptides were seen to be eluted between the short window of 22 to 26 min 
which indicates a poor peptide resolution. 
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Fig 5.6Comparison SCX resolution efficiency of initial run (SCX1) and optimized 
gradient run (SCX2) showing better peptide resolution as a result of gradient 
optimisation. 
 
The optimized SCX gradient parameters were subsequent applied for the 
fractionation of the iTRAQ experiment discussed in the following section. 
 
5.3.2 Investigation ofE. coli cellular adaptation strategies 
The abundance of proteins present in control cells relative to that of sesquiterpene 
expressing cells was compared. A total of 5467 peptides and 410 unique E. coli 
proteins with iTRAQ labels were found at 1 % false discovery rate (FDR) and 218 
of these had regulatory information. The list of proteins with differential 
intracellular abundance as identified from Signifiquant is presented in Tables 5.3 
and 5.4. Figure 5.7 shows the distribution of the regulated proteins into the different 
functional groups with significant up regulation of the protein synthetic machinery 
and metabolic stress response.  
 
Table 5.3 List of proteins differentially regulated between pETDuet (empty) 
carrying and pETNS1 (terpene synthase)E. coli at 95% confidence level with 
multiple test correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EB40 Chaperone protein DnaK (HSP70) 3.50 Stress protein 
C6EGF2 30S ribosomal protein S3 2.65 Translation 
C6EJY6 50S ribosomal protein L19 2.37 Translation 
C6EGF8 50S ribosomal protein L5 2.27 Translation 
C6EE36 50S ribosomal protein L11 2.24 Translation 
C6EGG8 30S ribosomal protein S13 2.22 Translation 
C6EGE5 30S ribosomal protein S10 2.17 Translation 
C6EGG1 50S ribosomal protein L6 2.06 Translation 
C6EGH0 30S ribosomal protein S4 2.05 Translation 
C6EK89 
AhpC component, subunit of alkylhydroperoxide 
reductase 
1.81 Oxidative stress protein 
C6EGG4 50S ribosomal protein L30 1.79 Translation 
C6EG95 Tryptophanase 1.38 Amino acid metabolism 
C6EG74 Glutamine--fructose-6-phosphate aminotransferase 
-1.56 Carbohydrate 
metabolism 
C6EEY2 6-phosphofructokinase -1.67 Energy metabolism 
C6EBG1 Transaldolase 
-1.72 Pentose phosphate 
pathway 
C6EK07 Autonomous glycyl radical cofactor -2.04 Energy metabolism 
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Table 5.4 List of proteins differentially regulated between wild and mutant E. 
coli at 95% confidence level without multiple test correction 
Uniprot 
accession 
Number 
Protein ID 
Fold 
change 
Function 
C6EI53 OmpF, subunit of outer membrane porin F  4.24 Ion transport 
C6EB40 Chaperone protein DnaK (HSP70) 3.50 Stress protein 
C6EGF0 30S ribosomal protein S19 2.94 Translation 
C6EGF2 30S ribosomal protein S3 2.65 Translation 
C6EGE6 50S ribosomal protein L3 2.50 Translation 
C6EGG3 30S ribosomal protein S5 2.39 Translation 
C6EJY6 50S ribosomal protein L19 2.37 Translation 
C6EGF8 50S ribosomal protein L5 2.27 Translation 
C6EE36 50S ribosomal protein L11 2.24 Translation 
C6EGG8 30S ribosomal protein S13 2.22 Translation 
C6EGE5 30S ribosomal protein S10 2.17 Translation 
C6EGE7 50S ribosomal protein L4 2.15 Translation 
C6EGG1 50S ribosomal protein L6 2.06 Translation 
C6EGH0 30S ribosomal protein S4 2.05 Translation 
C6EGE9 50S ribosomal protein L2 1.84 Translation 
C6EK89 AhpC, subunit of alkylhydroperoxide reductase 1.81  stress protein 
C6EGG4 50S ribosomal protein L30 1.79 Translation 
C6EEX9 Triosephosphate isomerase 1.72 Glycolysis/Gluconeogenesis 
C6EGG5 50S ribosomal protein L15 1.68 Translation 
C6EGF5 30S ribosomal protein S17 1.54 Translation 
C6EII4 Fructose bisphosphate aldolase monomer 1.53 Glycolysis/Gluconeogenesis  
C6EG97 tRNA modification GTPase MnmE 1.38 Translation 
C6EG95 Tryptophanase 1.38 Amino acid metabolism 
C6EAU1 Dihydrolipoyl dehydrogenase 1.36 Pyruvate metabolism 
C6EAB5 Elongation factor Ts 1.34 Translation 
C6EE66 Catalase-peroxidase 1.27 Amino acid metabolism 
C6EEX2 Glycerol kinase -1.27 Glycerol metabolism 
C5W3D5 Oligopeptide transporter subunit -1.33 Transporter 
C6EKF6 Serine hydroxymethyltransferase -1.35 Amino acid metabolism 
    
Uniprot 
accession 
Number 
Protein ID 
Fold 
change 
Function 
C6ECY6 Aspartate ammonia-lyase -1.39 Amino acid metabolism 
C6EKI4 Peptidase B -1.43 Proteolysis 
C6ED05 
Alpha-galactosidase monomer, subunit of alpha-
galactosidase 
-1.49 
Carbohydrate metabolism 
C6EI52 Asparagine--tRNA ligase -1.54 Translation 
C6EG74 
Glutamine--fructose-6-phosphate 
aminotransferase 
-1.56 
Carbohydrate metabolism 
C6EEY2 6-phosphofructokinase -1.67 Glycolysis/Gluconeogenesis 
C6EBG1 Transaldolase -1.72 Pentose phosphate pathway 
C6EIG9 S-adenosylmethionine synthase -1.79 Amino acid metabolism 
C6EBX3 Pyruvate kinase -1.82 Glycolysis/Gluconeogenesis 
C6EK07 Autonomous glycyl radical cofactor -2.04 Energy metabolism 
C6EJ92 CTP synthase -2.78 Nucleotide metabolism 
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Figure 5.7 Functional annotation of differentially regulated proteins expressed 
between wild type and mutant E. coli expressing sesquiterpene synthase using 
iTRAQ. Protein annotationwas performed using KAAS (Kegg Automatic Annotation 
Server). 
 
5.3.2.1 Stress response 
Cells are exposed to a variety of environmental stress factors especially during growth. 
These stress factors are usually caused by changes in pH, temperature, nutrient level, 
dissolved oxygen, osmolality, as well as chemicals and production of heterologous 
proteins. Additionally, the metabolic stress level in a recombinant expression system 
depends also on how much recombinant protein is produced, the size and copy number of 
the plasmid (Glick, 1995).  As seen in Table 5.5, there was significant elevation (> 3 fold) of 
the heat shock protein DnaK (HSP70). This protein with other heat shock proteins, are 
involved in proper protein folding especially during heterologous protein over-expression. 
Additionally, there was an increase in alkylhydroperoxide reductase (1.81) and catalase-
peroxidase (1.27). These proteins are responsible for mopping up oxygen free radicals 
produced during increased respiratory stress, which usually accompanies an increased 
metabolic load (Christman et al., 1985; Hassan and Fridovich, 1977; Yamamoto et al., 
1999). The relative metabolic stress here is due mainly to production of the heterologous 
sesquiterpene synthase as other factors were constant in both phenotypes.  
 
Table 5.5 List of differentially regulatedproteins characterised as stress proteins 
Uniprot 
Accession 
Number 
Protein ID 
Fold 
change 
C6EB40 
C6EK89 
C6EE66 
 
Chaperone protein DnaK (HSP70) 
AhpC component, subunit of alkylhydroperoxide reductase 
Catalase-peroxidase 
3.50 
1.81 
1.27 
 
5.3.2.2 Central carbon metabolism 
The central carbon metabolism (CCM) of E. coli plays a dominant role in almost all 
metabolic processes of the organism. Growth and survival are key themes that serve 
as modulators of metabolism. The CCM is a combination of pathways that are 
responsible for utilization of carbon sources and energy generation/conservation and 
these include glycolysis/gluconeogenesis, pentose phosphate pathway and the 
tricarboxylic acid cycle (TCA) with the glyoxylate shunt. The major carbon source 
was primarily supplied by the glycerol in the TB growth media. Figure 5.6 shows 
the regulated enzymes that are involved in the CCM. There is a significant up 
regulation of triosephosphate isomerase (1.72) which is a bidirectional enzyme that 
interconverts dihydroxyacetone phosphate (DHAP) to glyceraldehyde 3-phosphate 
(G3P). Additionally, fructose bisphosphate aldolase, another bidirectional enzyme 
that converts fructose bisphosphate to DHAP and G3P is also up-regulated (1.53). 
This enzyme can increase the flux of DHAP and G3P in glycolysis by hydrolysis of 
fructose bisphosphate or reduce flux of these molecules by forming fructose 
bisphosphate in the gluconeogenetic pathway. Evidence of repression of glycolysis 
is seen in the down regulation of the regulatory points (irreversible) at 6-
phosphofructokinase (-1.67) and pyruvate kinase (-1.82) and up regulation of the 
aldolase and triosephosphate isomerase. The up-regulation of triosephosphate 
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isomerase and aldolase enzymes, point to increase utilization of glycerol (glycerol to 
DHAP) which is subsequently converted to G3P. 
 
Table 5.6 List of differentially regulatedproteins involved in central carbon 
metabolism 
Uniprot 
accession 
Number 
Protein ID 
Fold 
change 
C6EEX9 Triosephosphate isomerase 1.72 
C6EII4 Fructose bisphosphate aldolase monomer 1.53 
C6EAU1 Dihydrolipoyl dehydrogenase 1.36 
C6EEX2 Glycerol kinase -1.27 
C6ED05 Alpha-galactosidase monomer, subunit of alpha-galactosidase -1.49 
C6EG74 Glutamine--fructose-6-phosphate aminotransferase -1.56 
C6EEY2 6-phosphofructokinase -1.67 
C6EBG1 Transaldolase -1.72 
C6EBX3 Pyruvate kinase -1.82 
C6EK07 Autonomous glycyl radical cofactor (PFL) -2.04 
 
Dihydrolipoyl dehydrogenase up regulation (1.36) translates to increase generation of 
acetyl CoA from pyruvate as well as increase in acetoacetate/acetyl CoA from catabolism 
of amino acids-leucine, valine, isoleucine as well as glycine, serine and threonine. These 
feed into the TCA cycle which generatesfurther acetoacetate or directly from acetoacetate 
to gluconeogenesis pathway. 
There is also a significant down regulation of the pentose phosphate pathway enzyme 
transaldolase (-1.72) which is responsible for the reversible conversion of G3P and 
sedoheptulose 7-phosphate (Sh7P) to fructose 6-phosphate and erythrose 4-phosphate 
(E4P) which would also serve to increase flux towards G3P and reduce formation of the 
E4-P needed for downstream synthesis of DNA. There is also a significant down regulation 
of autonomous glycyl cofactor of the pyruvate formate lyase (-2.04). This enzyme catalyzes 
the reversible conversion of pyruvate and coenzyme-A to formate and acetyl -CoA 
 5.3.3.3 Amino acid metabolism 
Protein biosynthesis is a complex process that involves many steps from initiation, 
elongation and termination. Each of these steps requires many factors such as mRNAs, 
tRNAs, ribosomes, elongation factors and numerous enzymes. As seen in Table 5.7 
significant up-regulation of the translation machinery is seen in the subunits of both the 30S 
and 50S. Increased expression of the protein synthetic machinery is not only needed for 
making of recombinant protein but also for synthesis of stress response proteins.  
There is an increase in tryptophan catabolism as seen in the up regulation of both 
tryptophanase and catalase-peroxidase. These generate pyruvate, indole and ammonia.  
There is a down regulation of Serine hydroxymethyltransferase, Aspartate ammonia-lyase 
and S-adenosylmethionine synthase which metabolizes serine, aspartate and methionine 
respectively. Serine hydroxymethyltransferase is also involved in serine and glycine 
metabolism Aspartate ammonia lyase converts aspartate to fumarate so a down regulation 
will probably favour the alternate route to oxaloacetate.  
  
Adaptation to sesquiterpene synthase 
143 
 
Table 5.7 List of differentially regulated proteins involved in protein biosynthesis 
and amino acid metabolism 
Uniprot accession 
Number 
Protein ID Fold change 
C6EGF0 30S ribosomal protein S19 2.94 
C6EGF2 30S ribosomal protein S3 2.65 
C6EGE6 50S ribosomal protein L3 2.50 
C6EGG3 30S ribosomal protein S5 2.39 
C6EJY6 50S ribosomal protein L19 2.37 
C6EGF8 50S ribosomal protein L5 2.27 
C6EE36 50S ribosomal protein L11 2.24 
C6EGG8 30S ribosomal protein S13 2.22 
C6EGE5 30S ribosomal protein S10 2.17 
C6EGE7 50S ribosomal protein L4 2.15 
C6EGG1 50S ribosomal protein L6 2.06 
C6EGH0 30S ribosomal protein S4 2.05 
C6EGE9 50S ribosomal protein L2 1.84 
C6EGG4 50S ribosomal protein L30 1.79 
C6EGG5 50S ribosomal protein L15 1.68 
C6EGF5 30S ribosomal protein S17 1.54 
C6EG97 tRNA modification GTPase MnmE 1.38 
C6EG95 Tryptophanase 1.38 
C6EAB5 Elongation factor Ts 1.34 
C6EE66 Catalase-peroxidase 1.27 
C6EKF6 Serine hydroxymethyltransferase -1.35 
C6EI89 Serine--tRNA ligase -1.37 
C6ECY6 Aspartate ammonia-lyase -1.39 
C6EKI4 Peptidase B -1.43 
C6EI52 Asparagine--tRNA ligase -1.54 
C6EIG9 S-adenosylmethionine synthase -1.79 
 
  
5.3.3.4 Cell envelope 
The cell envelope, which comprises of the cell wall and membrane play significant 
roles in the metabolism of all organisms. The cell envelope is responsible for influx 
and efflux of substances (nutrients, ions, and molecular species such as oxygen), 
structural integrity as well as signaling. There is a significant up-regulation of the 
outer membrane porin OmpF (4.24) which responds to reduction in nutrients and 
growth retardation as well as acting as an osmoregulator (Buckler et al., 2000; 
Kenney, 1997; Liu and Ferenci, 2001). This protein is a two component sensor 
system that helps to maintain intracellular osmolality. However, the oligopeptide 
ABC transporter that transports oligopeptides into the cell was down-regulated. This 
protein does not however transport exogenous peptides or protein sourced peptides 
but, is involved in cycling of cell wall peptidoglycan proteins (Goodell and Higgins, 
1987).  
The down regulation of glutamine metabolism through Glutamine-fructose-6-
phosphate aminotransferase decreases synthesis of amino sugars and peptidoglycan 
of cell wall backbone. Peptidoglycan synthesis is a complex process that is 
catalysed by several enzymes. The first committed step involves the conversion of  
fructose-6 phosphate  into glucosamine-6 phosphate by the dimeric enzyme 
glutamine-fructose-6-phosphate aminotransferase using glutamine as a nitrogen 
source (Badet-Denisot et al., 1995; Barreteau et al., 2008). The down- regulation of 
this enzyme (-1.56) indicates decreased synthesis of peptidoglycan. Down 
regulation of Glutamine-fructose-6-phosphate aminotransferasewould indicate 
reversal of the reaction and towards glycolysis and to G3-P and pyruvate required 
by E. coli for synthesis of IPP/DMAP through the non-mevalonate pathway. 
Table 5.8 List of differentially regulatedproteins involved in cell wall metabolism 
Uniprot accession 
Number 
Protein ID 
Fold 
change 
C6EI53 
OmpF, subunit of outer membrane porin F and The Colicin A Import 
System 
4.24 
C5W3D5 Oligopeptide transporter subunit -1.33 
C6EG74 Glutamine-fructose-6-phosphate aminotransferase -1.56 
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5.4 Discussion 
The aim of this chapter was to examine the metabolic changes that accompany the 
expression of the sesquiterpene from Nostoc sp. PCC 7120 in E. coli.  
Expression of a heterologous proteins such as sesquiterpene synthase, induces a 
metabolic burden on the host cell and causes significant perturbation of the host 
metabolism (Glick, 1995; Hoffmann and Rinas, 2004; Sano, 1990). An iTRAQ-
based proteomic assessment of a recombinant sesquiterpene synthase gene 
containing E. coli BL21 (DE3) has been carried out. The results show that metabolic 
changes in the cell envelope construction, central carbon metabolism as well as 
amino acid and protein metabolism occur as a result of the expression of 
sesquiterpene synthase in E. coli as depicted in Figure 5.8. 
The cell wall of both Gram positive and negative bacteria is made up significantly 
of peptidoglycan which is heteropolymer complex of N-acetylmuramoyl-peptides 
and N-acetylglucosamine (GlcNAc) monomers whose synthesis is complex and 
involves many cytoplasmic and membrane enzymes (Vollmer et al., 2008). The 
cytoplasmic aspect of the synthetic process involves the synthesis of the monomer 
component which is subsequently linked to C55 undecaprenyl pyrophosphate by the 
synthase to form lipid II.  The C55undecaprenyl pyrophosphate chain is made up of 
isopentenyl pyrophosphate and dimethylallyl pyrophosphate monomers whose 
synthetic precursors are generated by the DXP pathway (Bouhss et al., 2008; 
Pandhal et al., 2011b). These monomers are apparently being hijacked from cell 
wall synthesis to make the sesquiterpene. As a result, there was a significant up 
regulation of OmpF signifying nutrient limitation, growth impairment and reduced 
intracellular osmolality (Kenney, 1997). This might also serve as a route of 
exporting the potentially toxic sesquiterpene from the cell. In an attempt to meet the 
increased energy requirements of the cell, other available energy sources are 
mobilized. This is seen in the reduction of cell wallsynthesis as shown by the down 
regulation of Glutamine-fructose-6-phosphate aminotransferase (glmS). This 
assertion is further made evident by the significant down-regulation of 
tetrahydrodipicolinate N-succinyltransferase seen at the 90% confidence level. 
Tetrahydrodipicolinate N-succinyltransferaseis required in the 
lysine/diaminopimelic acid (DAPA) biosynthesis, an important component of the 
peptidoglycan layer of E. coli (Barreteau et al., 2008; Born and Blanchard, 1999). 
This indicates a redirection of synthetic flux from cell wall synthesis to terpene 
synthesis.  
 
Figure 5.8 Metabolic changes in E. coli pETNS relative to pETDUET using iTRAQ based 
quantitation at 30 h post induction. Red and blue arrows show increased and decreased 
protein abundance respectively. Red and blue outlined boxes show increased and reduce 
flux of metabolites and purple boxes show precursors for terpene production.  F6P, 
fructose-6-phosphate; FBP, fructose1,6 bisphosphate; G3P, glyceraldehyde-3-phosphate; 
DHAP, dihydroxy acetone phosphate; PEP, phosphoenol pyruvate; E4P, Erythrose-4-
phosphate; DMAPP, dimethylallyl pyrophosphate; IPP, isopentenyl pyrophosphate.  
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At the 90% confidence level, Glycerol-3-phosphate transporter is also seen to be 
significantly up regulated. This protein is responsible for the transport of glycerol-3 
phosphate but not glycerol. The glycerol-3 phosphate in this case is sourced from 
the cell wall and a high concentration of glycerol-3 phosphate reduces the need for 
the glycerol kinase enzyme (Lemieux et al., 2004; Maurel et al., 1994; Voegele et 
al., 1993). This is in agreement with the down regulation of glycerol kinase which is 
responsible for converting intracellular glycerol to glycerol-3 phosphate for 
subsequent conversion to DHAP. This is in accordance with the postulation of Noor 
et al (2010) that if a given precursor becomes redundant (with alternative 
environmental source(s)), a shortcut would evolve to bypasses that precursor and 
hence its enzyme.This route is likely due to exhaustion of glycerol in the media at 
30 hours post induction cultivation time and also leading to the significant up-
regulation of OmpF protein.. There is therefore not only a reduction in cell wall 
synthesis but an active degradation of cell components and mobilization of 
metabolites from the cell wall.UDP-N-acetylglucosamine pyrophosphorylase 
(glmU) which catalyzes the last two steps in the synthesis of UDP-N-acetyl-alpha-
D-glucosamine is in the same operon as glmS. 
Tryptophanase up regulation leads to increase in pyruvate as well as indole which 
has an inhibitory role not only in cell growth but in terpenoid biosynthesis as well. 
Indole has been implicated  as an inhibitor of both the isoprenoid pathway as well as 
growth by Ajikumar et al (2010). The up regulation of tryptophanase which converts 
tryptophan to pyruvate and indole is seen. The pyruvate from the activity of 
tryptophanase contributes to the flux of pyruvate. 
There is a likely increase flow of metabolites through the CCM towards synthesis of the 
foreign protein and in so doing; there is consequential reduction in normal metabolic 
processes of the cell including cell wall synthesis. This affects the growth and viability of 
the cell. The biosynthesis of the foreign protein is not only energy consuming (in form of 
ATP and GTP), but also uses up pools of synthetic and metabolic precursors such as amino 
acids and aminoacyl-tRNAs  
There was a relative depression of biosynthetic activity at the time of sampling (30 hours 
post induction) as shown by the growth curve data. This may be as a result of many factors 
including the decrease in the synthesis of aromatic amino acid through the shikimate 
pathway. The down regulation of the oxidative phase of the pentose phosphate pathway 
which supplies biosynthetic precursors for nucleotide synthesis will affect replication and 
growth.  
The increase abundase of the unidirectional aspartate oxidase which converts asparttate to 
oxaloacetate, down regulation of aspartate ammonia-lyase which converts aspartate to 
fumarate would favour a flux towards oxaloacetate. An increase in the generation of 
oxaloacetate should favour the gluconeogenetic pathway. If this were true, then, there 
should be an up regulation of phosphoenolpyruvate carboxykinase enzyme which converts 
oxaloacetate to PEP. This enzyme was not among regulated proteins at the 95% confidence 
level. However, on further reduction of the confidence level to 70%, it was seen to be up-
regulated (1.34). Since there is no evidence of up-regulation of gluconeogenesis enzymes 
beyond fructose bisphosphate aldolase, the significance of this would be to increase the flux 
of G3P for making terpene precursors needed in the DXP pathway for ultimate synthesis of 
the recombinant sesquiterpene. The down regulation of the both 6-phosphofructokinase and 
pyruvate kinase which are the major controlling enzymes in the glycolytic pathway 
indicates a repression of glycolysis.  
 
5.5 Conclusions 
In this chapter, iTRAQ-based proteomic method was used to study the effect of a 
heterologous expression of sesquiterpene synthase form Nostoc sp. PCC 7120in E. 
coli compared to pETDuet plasmid control. The findings and conclusions are 
limited by the poor iTRAQ data and also the lack of metabolomics data. 
In order to increase proteome coverage and reduce protein under-estimation, the 
first dimentional offline SCX-HPLC fractionation was first optimised. 
The proteomic data showed evidence of possible growth retardation in the mutant 
which is in aggrement with the growth curve data in Figure 4.8. This is likely the 
result of reduced availability of precursors (IPP and DMAPP) which are essential 
for the biosynthesis of cell wall components. These precursors which are 
synthesized from pyruvate and G-3-P through the DXP pathway are channelled to 
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the synthsis of terpene.The utilisation of the energy and metabolic resources of the 
cell for the synthesis of a foreing protein and metabolite and the subsequent 
metabolic adaption is responsible for growth retardation that was observed 
compared to the control.This growth retardation and mobilization of cell resources 
towards recombinant protein synthesis at the expense of the cell is likely to be 
ameliorated if an external source of precursors (IPP/DMAPP) could be supplied to 
the cell. Alternatively, the synthesis of these precursors could be done by supplying 
the alternate mevalonate pathway to the cells which should relief the burden on the 
native E. coli DXP pathway.In the next chapter, this hypothesis would be tested 
using an adaptation of the iTRAQ-based proteomics methods used in this chapter. 
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6.1 Introduction 
The heterologous expression of several classes of terpenes has been achieved in E. coli and 
S. cerevisiae with subsequent optimisation or metabolic engineering for improved yield. As 
previously noted, in chapter 5, the expression of terpene synthase in E. coli induces a 
significant burden on the cell with deleterious consequences (Barkovich and Liao, 2001b). 
In order to circumvent the excess burden and drain that the terpene production imposes on 
the host cell DXP pathway, several groups have engineered exogenous mevalonate pathway 
genes from S. cerevisiae into hostswith or withoutadditional DXP pathway genes(Atsumi 
and Liao, 2008; Enfissi et al., 2005; Martin et al., 2003b; Peralta-Yahya et al., 2011a) and 
with modifying cytochrome P450 (Hisashi Harada et al., 2011). These efforts have been 
rewarded with improved yield of products, but further refinement and metabolic 
engineering is still needed in order to achieve a truly commercially viable strain for many 
of these products. This would indeed require a better understanding of the metabolic 
perturbations of the exogenous mevalonate pathway genes and indeed other modifying 
enzymes such as cytochrome P450 and its ferrodoxin-reductase partner. Indeed, pathway 
performance is a complex interplay of transcription regulation, mRNA abundance, protein 
abundance, and native pathway consumptions of intermediates/precursors to which final 
product titres may not be truly representative of (Redding-Johanson et al., 2011a). To this 
end, a new paradigm of a systemic approach to rational metabolic engineering of 
terpene/terpenoid is required. This is even more imperative considering the known 
difficulties of heterologous expression of the downstream processing cytochrome P450 
enzymes (Agger et al., 2008). A SRM based proteomic approach to metabolic engineering 
of a mevalonate overproducing terpene synthetic system was reported by Redding-
Johanson et al (2011a) with a  more than three-fold increase inamorpha-4,11-dienetiters. 
Even though a significant improvement was recorded, the objective was centered on 
optimizing the expression of both mevalonatekinaseandphosphomevalonatekinase which 
were found to be potential bottlenecks in the expression of the mevalonate pathway. This 
approach therefore ignored the potentially more important central carbon metabolism, the 
regulatory mechanisms of E. coli and other important global metabolic changes that may 
affect the final product.  It is therefore the objective of this chapter to examine the systemic 
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changes that are activated in this system which can then serve as tools for further rational 
engineering. Using an 8-plex iTRAQ, the proteome of four phenotypes are compared using 
the mutant (N) from chapter 5 as control to check for the effect of the exogenous 
mevalonate pathway (N+), cytochrome P450 and the ferrodoxin-reductase (P) and also the 
combined effect of expressing the mevalonate pathway and the P450-ferrodoxin-reductase 
(T). The pathway for the biosynthesis of sesquiterpenoids with an exogenous mevalonate 
from yeast is shown in Figure 6.1. 
 
Figure 6.1 Pathway for the biosynthesis of sesquiterpenoids in E. coli showing the 
exogenous mevalonate pathway from yeast and the native DXP pathway for 
IPP/DMAPP synthesis. IspA, FPP synthase; FPP, farnesyl diphosphate; SQT 
synthase, sesquiterpene synthase 
 
 
 
6.2 Materials and Methods 
Several of the methods used in this chapter are identical to those used in chapter 5. 
However, a few modifications were made for the purpose of further optimization of the 
entire system.  
 
6.2.1 Culture conditions and cell harvest 
Culture was set up and grown as described in section 5.2.1 using phenotypes N 
(pETDUETNS1 + pBbA5c + pBBRIMCS-2), N
+
(pETDUETNS1 + pBbA5c-MevT-MBIS 
+ pBBRIMCS-2), P (pETDUETNS-P450NS + pBbA5c + pBBR-FER-RED) and T 
(pETDUETNS-P450NS + pBbA5c-MevT-MBIS + pBBR-FER-RED) as described in 
section 4.2.1. Two biological replicates of each phenotype were set up.  
 
6.2.2 Protein extraction and quantification 
Proteins from the cultures were extracted and quantified as previously described in section 
5.2.2. 
 
6.2.3 SDS-PAGE 
SDS-PAGE gel electrophoresis for the purpose of checking for accuracy of protein 
quantification and post-trypsin digestion assessment was performed as described in section 
5.2.3. 
 
6.2.4 In-gel tryptic digestion 
In-gel tryptic digestion was performed as described in section 5.2.5. 
 
6.2.5 Solution-phase tryptic digestion 
Solution phase tryptic digestion was performed as described in section 5.2.4.  
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6.2.5.1 RapiGest aided solution-phase tryptic digestion 
Biological replicates of each phenotype were digested using 100 µg of each protein sample 
as detailed in 5.2.4. The digestion was carried out using a final concentration of 0.1% 
RapiGest surfactant solution (Waters, UK) in 500 mM TEAB according to the 
manufacturer’s instructions. Reduction and alkylation was performed using a final 
concentration of 10 Mm methyl methanethiolsulfonate (MMTS) and 2.5 mMTris (2-
carboxyethyl)phosphine (TCEP) respectively. A protein to trypsin ratio of 1:40 (w/w) was 
used and incubated at 37
o
C for 16 hrs after adding a 5% (v/v) of acetonitrile. Each one of 
the 8 peptide digest solutionswere centrifuged and then divided into two equal parts; one 
for fractionation optimization and the other was used for iTRAQ labeling. 
 
6.2.6 SCX peptide fractionation  
The pH of each peptide solution was reduced to <2 to precipitate the surfactant by adding 
an appropriate volume of formic acid and centrifuged at 13, 000 rpm for 10 minutes and the 
supernatant further divided into two equal parts of 25 µg each. These were separately 
pooled to make two lots of 200µg and vacuum centrifuged. One set of the vacuum dried lot 
was fractionated using the optimized SCX gradient as detailed in section 5.2.7 while the 
other was reserved for HILIC fractionation.  
 
6.2.7 Pre-labeling HILIC peptide fractionation 
The second set of 200µg of dried peptides were dissolved in buffer A ( 80% acetonitrile, 10 
mM ammonium  formate, pH 3) and separated on an Agilent 1100-series HPLC (Agilent, 
Berkshire UK), coupled to a 200mm PolyHYDROXYETHYL-A (5 μm, 4.6mm ID, 200Å, 
PolyLC) analytical HILIC column. Using a constant flow rate of 0.5 ml/min, peptides were 
isocratically eluted on buffer A for 45 min and gradient was started with 0-20% buffer B 
(5% acetonitrile, 10 mM ammonium formate, pH 5) for 5 minutes, 20-60% B for 50 
minutes and 60-100% for 10 minutes and maintained at 100% B for another 10 minutes. 
The chromatography was monitored at 280 nm and fractions were collected at 1 minute 
interval using a Foxy Jr. fraction collector. The fractions were dried in a vacuum 
concentrator and subjected to LC-MS analysis as detailed in 5.2.8 
 
6.2.8 iTRAQ labeling of peptides 
Peptide samples (50 µg each) from section 6.2.5.1 were each labeled with iTRAQ 8-plex 
labels as described in section 5.2.8. After labeling, the surfactant was removed as described 
in section 6.2.6. The label for each of the 8 samples is shown in Table 6.1.  
 
Table 6.1 Phenotypic iTRAQ labeling of samples 
 
6.2.9 
HILIC 
fraction
ation of 
labeled 
peptides 
Peptides were then pooled and vacuum dried and subjected to HILIC separation as 
described in section 6.2.7 and the fractions vacuum dried. Each vacuum dried fraction was 
dissolved in 25 µl of buffer A (3% (v/v) acetonitrile, 0.1% (v/v) formic acid) centrifuged at 
13,000 rpm for 5 minutes and supernatant aspirated for RP-LC-MS/MS analysis. 
 
6.2.10 RP-LC-MS/MS and protein identification 
Tandem mass spectrometry was performed on a Quadrupole time-of-flight (Q-ToF) 
QSTAR XL (Applied Biosystems, MDS-Sciex) equipped with and electrospray ion source 
fitted with a 15 μm fused-silica emitter tip, PicoTip FS360-75-15-N-5-C15 (New 
Objective, Woburn, MA). This was coupled to an Ultimate 3000 HPLC system (Dionex, 
Surrey, UK). Fractions were desalted online using a300 µm i.d x 5 cm trap column packed 
with C18, 5 µm, 100 Å particles (LC Packings, CA, USA) under 0.1% (v/v) TFA and 3% 
Phenotype Replicate Label Replicate Label 
N 
  N
+
 
P 
T 
1 
1 
1 
1 
113 
114 
115 
116 
2 
2 
2 
2 
117 
118 
119 
121 
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(v/v) acetonitrile for 15 minutes, and eluted to a75 μmx15 cm analytical column packed 
with C18, 5 µm, 100 Å particles (LC Packings, CA, USA)  in 0.1%(v/v) formic acid with 
an acetonitrile gradient extending from 3% to 90%. A 150 min LC program was run at a 
constant flow rate of 0.3 µl/min starting with 3% buffer B (97% (v/v) acetonitrile in water, 
0.1% (v/v) FA) for 20minutes followed by 3- 35% B in 95 minutes then ramped to 90% B 
in 0.5 minute and held at 90% B for 7 minutes and 3% B for another 28 minutes. A total of 
two injections of 8 µl each were done to increase coverage and confidence of results. Data 
acquisition was set in the positive ion mode with a selected mass range of 300 – 2000 m/z. 
MS/MS was performed on peptides with 2+, 3+ and 4+ charge states and all other 
parameters as described by Ow et al. (2008b). 
 
6.2.11 Data and quantitative analysis  
 
Tandem MS data generated was converted to MGF using Analyst QS version 1.1 
(ABSciex, Foster City, CA) and protein identification and quantification was performed on 
a Phenyx algorithm server (binary version 2.6;Genebio, Switzerland). Search was 
performed on an E. coli BL21 (DE3) protein database downloaded from Uniprot 
(www.uniprot.org) on 14/02/2012 using MS tolerance of 0.6 Da, MS/MS tolerance of 0.3 
Da, and one missed cleavage of trypsin. Peptide modification was set to include 8-plex 
iTRAQ mass shifts (+304 Da, K and N-term), methylthiol (+146 Da, C) as fixed 
modifications, and oxidation of methionine (+116 Da, M) as a variable 
modification.Peptide level filters were set to a z-score of 5.0 and a p-value significance of 
1×10
-5
. Analysis of the relative abundance ratio between phenotypes was carried out using 
the significance testing algorithm, Signifiquant (S. Y. Ow et al., 2009) and only proteins 
identified by two or more peptides at 95% confidence were considered with or without 
Bonferonni correction. Relative increase or decrease in abundance of protein is measured 
by fold changes above and below a factor of 1. The identified proteins were mapped onto 
colour coded pathways using the search and colour pathway of KEGG mapper 
(http://www.genome.jp/kegg/tool/map_pathway2.htmlorganism code – ebe). All identified 
proteins were organised into functional groups using annotation based on cluster of 
orthologous groups (COG). 
 
 6.3 Results 
6.3.1 Overview of the proteomic analysis workflow and optimisations 
The general proteomic workflow for the 8-plex iTRAQ is presented in Fig 6.2. An 
optimized protein extraction method as described in 4.2.2 was used and further 
optimisations were carried out for trypsin digestion and peptide fractionation. 
 
Fig 6.2 An overview of 8-plex iTRAQ proteomics workflow for the with points of 
optimization at B and E. A, protein extraction and quantitation; B, trypsin digestion; 
C, peptide labelling of individual samples; D, pooling of samples and vacuum 
drying; E, offline HILIC fractionation; F, Q-ToF MS scan; G and H,  low mass zone 
showing 8-plex reporter ions   
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6.3.1.1 SDS PAGE analysis of extracted proteins 
Extracted protein samples for 8-plex iTRAQ were subjected to SDS-PAGE analysis 
as described in 5.3.1.2 using 10 µg aliquots. As seen in Fig 6.3, there is uniformity 
in the intensity of the lanes showing the accuracy of the concentration 
measurements. There is also evidence of phenotypic differences in the banding 
pattern of the samples.   
 
Fig 6.3 SDS-PAGE Analysis of 10 µg of each protein sample from transformed E. coli 
cells showing equal loading. N (1 & 3), N+ (2 & 5), P (4 & 6), T (7 & 8)  
 
6.3.1.2 Testing tryptic digestion methods 
Further optimization of tryptic digestion was carried out by comparing in-gel, 
solution-phase and surfactant aided in-solution digestion protocols. As seen in Table 
6.2, the surfactant aided in-solution digestion method yielded significantly more 
protein hits of the representative phenotype as compared both to in-gel digestion 
and solution-phase tryptic digestion without surfactant. To ensure that the surfactant 
aided solution-phase tryptic digestion was complete, aliquots equivalent to 5 µg of 
each representative phenotype was run on an SDS-PAGEwith evidence of complete 
digestion of each sampleas seen in Fig 6.4. The stacking gel aided tryptic digestion 
showed significantly good protein hits on LC-MS analysis. In the subsequent 
experiment, the in-gel digestion was again compared to in-solution digestion with 
the aid of surfactant. The use of surfactant in in-solution digestion gave a 
remarkable improvement over the stacking gel aided digestion. This method was 
used subsequently. 
 
 
Fig 6.4 SDS-PAGE analysis of a volume of digestion solution equivalent to 5 µg. 
lanes 1-8 (protein digest),  M (marker). 
 
6.3.1.3 Optimization of fractionation methods 
SCX was used in the first experiment as detailed in 5.3.1.4 and subsequently 
compared with HILIC in this experiment. A significant improvement was observed 
as measured by the separation and resolution efficiency, peptide distribution profile 
as well as the proteome coverage. Fig 6.5 shows the peptide distribution of HILIC 
fractionation and Fig 6.6 shows a direct comparison of peptide distribution profile 
from the same sample between HILIC and SCX. The HILIC fractionation shows 
significantly better distribution of unique peptides across the spectrum as well as 
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greater number of unique peptides in each fraction. In terms of resolution efficiency, 
HILIC was seen to have a significantly better resolution compared to SCX. As seen 
in Fig 6.7, more peptides where resolved into a single fraction (81%) using HILIC 
fractionation as opposed to SCX (71%). This is significant enough to affect under-
estimation as a result of compression ratios (S. Y. Ow et al., 2009). Even though the 
SCX gradient has been so optimized to increase the resolution efficiency 
significantly as seen in Fig 5.6, the difference in resolution efficiencies between 
HILIC and SCX (10%) in this experiment gave a significant difference in the total 
peptide and protein numbers as seen in Table 6.2 
 
 
Fig 6.5 Distribution of unique peptides from HILIC separation showing number of 
unique peptides per fraction collected. Fractions were collected every 1 minute 
interval. Fraction 42 was lost during processing. 
 
 
 
 Fig 6.6 comparison of SCX and HILIC peptide distribution showing better peptide 
distribution profile and increased number of peptides per fraction in HILIC.  
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Fig 6.7 comparison between HILIC and SCX resolution efficiencies showing that 
most peptides were resolved into one fraction in HILIC (81%) compared to SCX 
fractionation (71%) 
 
Table 6.2 comparison of performance parameters between HILIC and SCX 
fractionation methods 
 
  
Parameter HILIC SCX Difference in 
performance  
Resolution 
efficiency 
81% 71% 10% 
Number 
of peptides 
2097 575 3.6 fold 
Total proteins 646 244 2.6 fold 
6.3.2 Overview of iTRAQ results and presentation outline 
Four phenotypes in duplicates were examined and compared in order to understand 
the adaptation strategies and metabolic changes induced by the heterologous protein 
expression. A total of 16613 peptides and 714 unique E. coli proteins with iTRAQ 
labels were found at 1% false discovery rate (FDR) with FDR Slice (version 4.0). 
From this, 582 proteins were found to have regulatory information  as seen in the 
global metabolic map in Figure 6.8, using KEGG mapper to show pathways that are 
covered by these proteins. 
In order to understand the metabolic changes and the dynamics of these changes 
between phenotypes, comparisons were done between the phenotypes to answer 
specific questions. To understand the metabolic effects of the mevalonate pathway 
and the P450/ferrodoxin-reductase on the terpene producing mutant (N), each one 
was independently compared to N. To further our understanding of the metabolic 
spectrum, N+ was compared to T and finally a comparison was done between P and 
T. Since the objective is to get a better understanding of the metabolic and 
regulatory mechanisms responsible for the expression or otherwise of the desired 
products as seen in chapter 3; the comparison between N and N+ was used as a 
reference point for reporting the other comparisons and as template for optimization.  
The cluster analysis dendogram seen in Figure 6.9 shows a clear aggregation of all 
biological replicates as well as wide phenotypic differences between the control (N) 
and the test samples. The phenotypic divergence is greatest between N and N+ 
followed by N and T which further validates the rationale for using N vs N+ as a 
reference point. 
 
 
 
 
 
Fig 6.8 Global map of pathwaysenzymes in E. coli with all differentially regulated proteins identified in the study shown in 
red. Mapping was done  using KEGG colour mapper. 
 
 
 
 
 
Fig 6.9 cluster analysis data of 8-plex iTRAQ labeled biological phenotypes 
showing biological replicates (113/117, 115/119, 116/121 and 114/118) 
clustered together as well as phenotypic segregation. 
 
6.3.3 Investigating E. coli adaptation strategies to mevalonate expression 
In order to investigate the adaptation strategies of a terpene expressing E. coli 
mutant to the addition of a heterologous eukaryotic mevalonate pathway, both 
phenotypes were compared. The comparison between N and N+ would show the 
metabolic and regulatory changes needed for increased production of the 
sesquiterpene as well as possible optimization steps or points to explore for further 
strain improvement. A list of differentially regulated proteins between N and N+ is 
seen in Table 6.3. A total of 104 proteins were differentially regulated between the 
control terpene mutant (N) and the mevalonate pathway mutant.  
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6.3.3 Investigation of E. coli cellular adaptation strategies to mevalonate 
expression 
Cellular adaptation strategies of E coli mutant (N+) expressing terpene synthase and 
the eukaryotic mevalonate pathway from S. cerevisiae against a mevalonate 
negative strain (N) was investigated using an 8-plex iTRAQ. The comparison 
between N and N+ would show the metabolic and regulatory changes for increased 
production of the sesquiterpene as well possible optimization steps or points to 
explore for further strain improvement. A total of 104 proteins as seen in Table 6.4 
either showed increased or reduced abundance at the 95% confidence level with 
multiple test correction applied. These proteins are further classified into major 
functional groups and metabolic pathways as seen in Figure 6.10. A further 147 
unique differentially regulated proteins were discovered at the 95% confidence 
when the Bonferroni correction was turned off, as seen in Table 6.5.  
 
Table 6.3 List of proteins differentially regulated between N and N+ at 95% 
confidence level with multiple test correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EIL9 Isopentenyl-diphosphate Delta-isomerase (IPP isomerase) 29.01 
Terpenoid 
biosynthesis 
C6EL48 Farnesyl diphosphate synthase/geranyl diphosphate synthase 21.24 
Terpenoid 
biosynthesis 
C6EL58 Predicted protein (Putative uncharacterized protein yfeK) 10.35 Uncharacterised  
C6EHL8 Cold shock protein CspG 5.29 Stress  
C6E9W2 Glycerophosphoryl diester phosphodiesterase  5.23 
Glycerol 
metabolism 
C6ECC2 Inorganic pyrophosphatase 4.98 
Oxidative 
phosphorylation 
C6EGB7 Peptidyl-prolyl cis-trans isomerase 4.94 Protein folding 
C6EK14 RNA polymerase sigma factor 4.65 
Transcription 
regulation 
C6EDY9 
Extracellular solute-binding protein family 1 (MalE, subunit of 
maltose ABC transporter)  
4.46 Transporter  
C6ED05 Alpha-galactosidase monomer, subunit of alpha-galactosidase 4.36 
Galactose 
metabolism 
C6EEN8 NAD-dependent malic enzyme (NAD-ME)  4.12 TCA 
C5W9Z4 Phosphorylase 4.11 
Starch and 
sucrose 
metabolism 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6ECU7 Superoxide dismutase 3.08 Stress 
C6EHL0 
Molybdopterin guanine dinucleotide-containing S/N-oxide 
reductase  
3.05 
Two-
component/mem
brane 
C6EIK5 Glycine dehydrogenase [decarboxylating]  2.86 
Amino acid 
metabolism 
C6EAU3 Pyruvate dehydrogenase E1 component  2.67 
Pyruvate 
metabolism 
C6EKP9 Malate dehydrogenase (NADP(+))  2.51 
Pyruvate 
metabolism 
C6EJL8 Citrate synthase 2.47 TCA 
C6EJJ0 
Phospho-2-dehydro-3-deoxyheptonate aldolase  (3-deoxy-D-
arabino-heptulosonate 7-phosphate synthase)  
2.47 
Amino acid 
biosynthesis/shik
imate pathway 
C6EGM8 Acetaldehyde dehydrogenase/PFL-deactivase 2.35 
Pyruvate 
metabolism 
C6EGZ6 Malate dehydrogenase 2.30 TCA 
C5W1L3 Lac repressor (LacI transcriptional repressor) 2.28 
Lactose 
metabolism 
C6ECZ5 Lysine--tRNA ligase 2.23 Translation 
C6EHG4 Glucans biosynthesis protein G 2.12 stress 
C6EKC3 6,7-dihydropteridine reductase  2.12 
Nitrotoluene 
degradation 
C6ELD0 3-oxoacyl-(Acyl carrier protein) synthase    2.11 
Fatty acid 
biosynthesis 
C6ECP3 Phenylalanine--tRNA ligase alpha subunit 2.07 Translation 
C6EAU2 Dihydrolipoamide acetyltransferase    2.04 
Pyruvate 
metabolism 
C6ELF7 Acetate kinase (Acetokinase) 1.98 
Pyruvate/acetate 
metabolism 
C6EAL5 D-tagatose-1,6-bisphosphate aldolase subunit GatZ 1.97 
Galactose 
metabolism 
C6EGF8 50S ribosomal protein L5 1.97 Translation 
C6EIH4 Transketolase (Transketolase 1, thiamin-binding)  1.96 
Pentose 
phosphate 
pathway 
C6EB00 Chaperone SurA (Peptidyl-prolyl cis-trans isomerase  1.93 stress 
C6EEC4 
Cold-shock DNA-binding domain protein (CspA transcriptional 
activator)  
1.91 Stress 
C6EAH8 D-lactate dehydrogenase NADH independent) 1.84 
Pyruvate 
metabolism 
C6ECA9 Alpha,alpha-phosphotrehalase (Trehalose-6-P hydrolase) 1.82 
Starch  
metabolism 
C6ED16 Alkylphosphonate utilization operon protein PhnA 1.81 
Phosphonate/pho
sphinate 
metabolism 
C6EAL9 
Alcohol dehydrogenase GroES domain protein (Galactitol-1-
phosphate dehydrogenase)  
1.81 
Galactose 
metabolism 
C6EAU1 Dihydrolipoyl dehydrogenase  1.81 
Pyruvate 
metabolism 
C6ECY6 Aspartate ammonia-lyase 1.79 
Amino acid 
metabolism 
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Uniprot 
Accession 
Number 
Protein ID 
 
Fold 
change 
Function 
C6EGE6 50S ribosomal protein L3 1.77 Translation 
C6EBG1 Transaldolase  1.76 
Pentose 
phosphate 
pathway 
C5W9B3 Polyribonucleotide nucleotidyltransferase  1.73 
RNA 
degradation/DN
A metabolism 
C6ELF6 Phosphate acetyltransferase 1.70 
Pyruvate 
metabolism 
C6EDN5 Mannose-6-phosphate isomerase  1.69 
Fructose 
metabolism 
C6EI89 Serine--tRNA ligase 1.67 Translation 
C6ECS9 Pyruvate kinase  1.65 
Glycolysis/gluco
neogenesis 
C5W0U2 AhpF component, subunit of alkylhydroperoxide reductase  1.59 Stress 
C6EJT4 Alanine--tRNA ligase  1.55 Translation 
C6EGV5 Isocitrate dehydrogenase [NADP]  1.55 TCA 
C6EII3 Phosphoglycerate kinase 1.54 
Glycolysis/gluco
neogenesis 
C6ECP1 50S ribosomal protein L20 1.53 Translation 
C6EKJ5 Histidine--tRNA ligase  1.52 Translation 
C6EGG2 50S ribosomal protein L18 1.45 Translation 
C6EKI4 Peptidase B  1.44 Proteolysis  
C6EIK4 Glycine cleavage system H protein 1.41 
Amino acid 
metabolism 
C6EAB9 
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase  
1.40 
Amino 
acid/peptidoglyc
an biosynthesis 
C6EAA0 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit 
alpha  
1.37 
Pyruvate 
metabolism 
C6EK89 AhpC component, subunit of alkylhydroperoxide reductase  1.36 Stress 
C6EBI7 Purine nucleoside phosphorylase DeoD-type (PNP) 1.31 
Nucleotide 
metabolism 
C6EIL8 Lysine--tRNA ligase  1.29 Translation 
C6EE39 Elongation factor Tu (EF-Tu) 1.14 Translation 
C6EE33 50S ribosomal protein L7/L12 -1.18 Translation  
C6EH56 NusA antitermination factor  -1.23 
Transcription 
regulation 
C6EH57 Translation initiation factor IF-2 -1.27 Translation 
C6EGF5 30S ribosomal protein S17 -1.28 Translation 
C6EE32 DNA-directed RNA polymerase subunit beta  -1.32 
Transcription 
regulation 
C6EG71 
ATP synthase subunit beta (ATP synthase F1 sector subunit 
beta) (F-ATPase subunit beta) 
-1.33 
Oxidative 
phosphorylation 
C6EGF3 50S ribosomal protein L16 -1.37 Translation 
C6EB56 6-phosphogluconate dehydrogenase, decarboxylating  -1.39 
Pentose 
phosphate 
pathway 
C6EG69 
ATP synthase subunit alpha  (ATP synthase F1 sector subunit 
alpha) (F-ATPase subunit alpha) 
-1.41 
Oxidative 
phosphorylation 
C6EL60 Crr, subunit of enzyme II [glc], trehalose PTS permease, -1.41 Glycolysis/gluco
EIIBCMalX and N-acetylmuramic acid PTS permease  neogenesis 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EGG4 50S ribosomal protein L30 -1.43 Translation 
C6EGE8 50S ribosomal protein L23 -1.45 Translation 
C6EGG5 50S ribosomal protein L15 -1.45 Translation 
C6EGE7 50S ribosomal protein L4 -1.47 Translation 
C6EGC3 30S ribosomal protein S7 -1.47 Translation 
C6EB28 Bifunctional riboflavin kinase / FMN adenylyltransferase  -1.50 
Riboflavin 
metabolism 
C6EG32 Thioredoxin -1.50 Stress  
C6EDF4 50S ribosomal protein L28 -1.52 Translation 
C6EGG3 30S ribosomal protein S5 -1.52 Translation 
C6EGH2 50S ribosomal protein L17 -1.54 Translation 
C6EJY3 30S ribosomal protein S16 -1.56 Translation 
C6EI70 Integration host factor subunit beta (IHF-beta) -1.59 
Transcription 
regulation 
C6EI25 OmpA domain protein transmembrane region-containing protein  -1.61 Transporter  
C5WBA2 Thiol:disulfide interchange protein DsbA 
-1.67 Stress/protein 
folding 
C6EJT9 
S-ribosylhomocysteine lyase  (AI-2 synthesis protein) 
(Autoinducer-2 production protein LuxS) 
-1.67 Amino acid 
metabolism/quor
um sensing 
C6EBI8 Phosphopentomutase  -1.67 
Pentose 
phosphate 
pathway 
C6EHT0 30S ribosomal protein S21 -1.75 Translation 
C6ED65 Single-stranded DNA-binding protein -1.75 DNA replication 
C6EC07 
Cold-shock DNA-binding domain protein (Stress protein, 
member of the CspA family  
-1.75 Stress 
C6ECE9 30S ribosomal protein S6 -1.79 Translation 
C6EE18 HU, DNA-binding transcriptional regulator, alpha subunit  -1.89 
Transcription 
regulation 
C6EJ93 
Enolase (2-phospho-D-glycerate hydro-lyase) (2-
phosphoglycerate dehydratase) 
-2.00 
Glycolysis/gluco
neogenesis 
C6EGH0 30S ribosomal protein S4 -2.00 Translation 
C6EFW4 Predicted protein (Putative uncharacterized protein yciN) -2.17 Uncharacterised  
C6ECP5 Integration host factor subunit alpha (IHF-alpha) -2.33 
Transcription 
regulation  
C6EKZ0 Adenylate kinase  (ATP-AMP transphosphorylase) -2.38 
Energy 
metabolism/Nucl
eotide synthesis 
C6EJ54 CSD sulfur transfer protein  -2.5 
Amino acid 
metabolism 
C6EC51 Peptide methionine sulfoxide reductase MsrB -2.5 Protein repair 
C6EIX0 DNA protection during starvation protein  -3.03 DNA damage 
C6EG51 D-ribose transporter subunit  -5.00 Transporter 
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Table 6.4 List of additional proteins that are differentially regulated between N and 
N+ at 95% confidence level without multiple test correction  
Uniprot 
Accession  
Number 
 
Protein ID 
Fold 
change 
C6EAC3 Protease Do (Serine protease Do) 5.29 
C6EJZ3 Chorismate mutase 4.35 
C6EAL7 
Galactitol-specific enzyme IIB component of PTS  (GatB, subunit of 
galactitol PTS permease) 
4.33 
C6EBZ9 Carboxy-terminal protease for penicillin-binding protein 3 2.96 
C6EGF9 30S ribosomal protein S14 2.88 
C6EAL6 
Galactitol-specific enzyme IIA component of PTS  (GatA, subunit of 
galactitol PTS permease) 
2.68 
C6EJ77 Conserved protein (Putative uncharacterized protein ygdH) 2.57 
C6EAJ8 Antiporter inner membrane protein (Mrp protein) 2.24 
C6EK45 Pyrimidine-specific ribonucleoside hydrolase RihA 2.18 
C6EJV6 DNA binding protein, nucleoid-associated (H-NS-like DNA-binding protein  2.12 
C6EEX0 Cell division protein ZapB 2.11 
C6EKJ1 Nucleoside diphosphate kinase (NDK) (NDP kinase) 2.09 
C6EDI0 Protein-export protein SecB 2.02 
C6EGY5 Beta-hexosaminidase (N-acetyl-beta-glucosaminidase) 2.02 
C6EHB9 3-oxoacyl-[acyl-carrier-protein] synthase 2 2.00 
C6EB72 Exodeoxyribonuclease I 2.00 
C6EHZ8 Cytochrome-c3 hydrogenase 1.93 
C6EIJ6 D-3-phosphoglycerate dehydrogenase 1.91 
C6EH47 Predicted RNA-binding protein 1.88 
C6EAS3 3-methyl-2-oxobutanoate hydroxymethyltransferase 1.86 
C6EHW4 Antibiotic biosynthesis monooxygenase (Quinol monooxygenase)) 1.84 
C6EKK2 GMP synthase [glutamine-hydrolyzing] (Glutamine amidotransferase) 1.80 
C6EGG7 50S ribosomal protein L36 1.80 
C6EGR9 Dihydroxyacetone kinase subunit M, subunit of dihydroxyacetone kinase  1.79 
C6EHC1 3-oxo-acyl-[acyl-carrier-protein] reductase 1.77 
C6EGA1 50S ribosomal protein L34 1.76 
C6EAB7 Methionine aminopeptidase (EC 3.4.11.18) 1.75 
C6EK18 Elongation factor 4 (EF-4) (Ribosomal back-translocase LepA) 1.74 
C6ELH6 Protein translocase subunit SecD 1.64 
C6ECP4 Phenylalanine--tRNA ligase beta subunit 1.62 
C6EIL5 DsbC[reduced], subunit of protein disulfide oxidoreductase  1.61 
C6EKN1 Peroxiredoxin 1.59 
C6EL61 
Phosphoenolpyruvate-protein phosphotransferase (Phosphotransferase 
system, enzyme I) 
1.54 
C6EK23 Pyridoxine 5'-phosphate synthase (PNP synthase) 1.53 
C6EFU4 Enoyl-[acyl-carrier-protein] reductase [NADH] 1.52 
C6ELL5 Delta-aminolevulinic acid dehydratase 1.49 
C6EEI7 Oligopeptidase A 1.47 
C6EJL1 
2-oxoglutarate dehydrogenase, E2 subunit, dihydrolipoamide 
succinyltransferase 
1.47 
C6EBZ8 ProP effector 1.45 
C6EIK3 Aminomethyltransferase  (Glycine cleavage system T protein) 1.45 
C6EH42 50S ribosomal protein L27 1.44 
Uniprot 
Accession  
number 
Protein ID 
Fold 
change 
C6VCK1 ATP-dependent helicase 1.42 
C6EE53 Phosphoenolpyruvate carboxylase (PEPC) 1.40 
C6EGL0 Cell shape determining protein, MreB/Mrl family 1.38 
C6EI53 OmpF, subunit of outer membrane porin F and The Colicin A Import System 1.36 
C6EIG9 S-adenosylmethionine synthase (AdoMet synthase) 1.36 
C6EBF4 Ferritin iron storage protein (Cytoplasmic) 1.35 
C6EKJ4 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase 1.34 
C6EKZ1 Chaperone protein HtpG (Heat shock protein HtpG) 1.33 
C6EDZ9 Glucose-6-phosphate isomerase (GPI) 1.32 
C6ECJ2 Nitroreductase (Predicted oxidoreductase) 1.30 
C6ED67 Conserved protein (Putative uncharacterized protein yjbR) 1.30 
C6EI75 Phosphoserine aminotransferase 1.28 
C6EG30 Transcription termination factor Rho (ATP-dependent helicase Rho) 1.27 
C6EII4 Fructose bisphosphate aldolase monome 1.27 
C6EBI0 
ABC transporter related (Fused predicted transporter subunits of ABC 
superfamily: ATP-binding components) (YjjK) 
1.24 
C6EJT2 Protein RecA (Recombinase A) 1.24 
C6EGA6 CRP transcriptional dual regulator (DNA-binding transcriptional dual  1.23 
C6EJL0 Succinyl-CoA ligase [ADP-forming] subunit beta 1.22 
C6EGF7 50S ribosomal protein L24 1.21 
C6ELG9 6,7-dimethyl-8-ribityllumazine synthase 1.20 
C6EAA7 Chaperone protein skp 1.15 
C6EEX9 Triosephosphate isomerase 1.14 
C6EJP6 Phosphoglucomutase 1.14 
C6EAB5 Elongation factor Ts (EF-Ts) 1.11 
C6EL63 Cysteine synthase -1.09 
C6EA12 50S ribosomal protein L25 -1.14 
C6EGH1 DNA-directed RNA polymerase subunit alpha -1.15 
C6E9U5 Bifunctional polymyxin resistance protein ArnA -1.16 
C6EDH1 ADP-L-glycero-D-manno-heptose-6-epimerase -1.18 
C6EFL3 Peptidyl-prolyl cis-trans isomerase -1.18 
C6EF45 Conserved protein (Putative uncharacterized protein yihD) -1.18 
C6EAJ7 Methionine--tRNA ligase (Methionyl-tRNA synthetase) -1.19 
C6EJL4 Succinate dehydrogenase flavoprotein subunit -1.19 
C6EJY6 50S ribosomal protein L19 -1.19 
C6EE31 DNA-directed RNA polymerase -1.20 
C6ED11 BasR transcriptional regulator  -1.22 
C6EC17 L-serine deaminase I -1.23 
C6EI80 Pyruvate formate lyase activating enzyme 1 -1.23 
C6EGE5 30S ribosomal protein S10 -1.23 
C6EB40 Chaperone protein DnaK (HSP70) -1.23 
C6EGK4 AccC, subunit of biotin carboxylase and acetyl-CoA carboxylase -1.25 
C6EC50 Glyceraldehyde 3-phosphate dehydrogenase-A monomer -1.25 
C6EDU7 3-hydroxy acid dehydrogenase monomer -1.25 
C6ECH2 Adenylosuccinate synthetase -1.25 
C6EEY2 6-phosphofructokinase -1.27 
C6EAB3 Ribosome-recycling factor (RRF) (Ribosome-releasing factor) -1.27 
C6EH41 50S ribosomal protein L21 -1.28 
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Uniprot 
Accession 
Number 
 
Protein ID 
Fold 
change 
C5W6A7 UPF0265 protein YeeX (UPF0265 protein B21_01896/ECBD_1650) -1.28 
C6EGF2 30S ribosomal protein S3 -1.30 
C6EGT6 5-carboxymethyl-2-hydroxymuconate Delta-isomerase -1.30 
C5W723 NADH-quinone oxidoreductase subunit C/D -1.30 
C6EBW1 Aspartate--tRNA ligase -1.30 
C6ECX8 Elongation factor P (EF-P) -1.32 
C6EL62 
Phosphohistidinoprotein-hexose phosphotransferase component of PTS 
system (Hpr) 
-1.32 
C6ECH0 Ribonuclease R (RNase R) -1.35 
C6EHF4 N-methyl-L-tryptophan oxidase -1.35 
C6EGG8 30S ribosomal protein S13 -1.35 
C6EDH9 Glutaredoxin 3 (Reduced glutaredoxin 3) -1.35 
C6EH58 Ribosome-binding factor A -1.35 
C6EH03 Glutathione S-transferase domain protein (Stringent starvation protein A) -1.37 
C6EI52 Asparagine--tRNA ligase -1.37 
C6EF71 Uridine phosphorylase -1.37 
C6ELD4 Aspartate-semialdehyde dehydrogenase -1.39 
C6EF35 Coproporphyrinogen III dehydrogenase -1.39 
C6EIH1 Biosynthetic arginine decarboxylase -1.39 
C6EIX1 
Cationic amino acid ABC transporter, periplasmic binding protein (GlnH, 
subunit of glutamine ABC transporter) 
-1.41 
C6EAC1 UPF0325 protein YaeH -1.41 
C6EH02 30S ribosomal protein S9 -1.41 
C6ELG8 N utilization substance protein B homolog (Protein NusB) -1.43 
C6EAI8 Conserved protein (Putative uncharacterized protein yehS) -1.43 
C6EGF4 50S ribosomal protein L29 -1.43 
C6EAT1 Carbonic anhydrase -1.43 
C6EH35 
MlaC, subunit of phospholipid ABC transporter (Toluene tolerance family 
protein) 
-1.45 
C6EGC2 30S ribosomal protein S12 -1.45 
C6EHM5 Phosphotyrosine-protein phosphatase -1.47 
C6EDU2 Uncharacterized protein YdfK -1.52 
C6EDR4 Diamine N-acetyltransferase (Spermidine N1-acetyltransferase) -1.56 
C6EAR5 
Predicted subunit with GalU (Predicted subunit with GalU, subunit of 
glucose-1-phosphate uridylyltransferase) 
-1.59 
C6EI79 Formate acetyltransferase (Pyruvate formate lyase I) -1.61 
C6EK50 Conserved protein (Putative uncharacterized protein ybeL) -1.64 
C6EAV7 Protein translocase subunit SecA -1.67 
C6EG68 ATP synthase subunit delta -1.67 
C6EI98 Translation initiation factor IF-1 -1.67 
C6EGK5 Acetyl-CoA carboxylase (Biotin carboxyl carrier protein) -1.69 
C6EFG0 Fe/S biogenesis protein NfuA -1.69 
C6EH24 Predicted ribosome-associated, sigma 54 modulation protein -1.75 
C6EAD0 Glutamate-1-semialdehyde 2,1-aminomutase -1.82 
C6EK62 UPF0250 protein YbeD -1.82 
C5WA02 Glycerol 3-phosphate dehydrogenase, aerobic  -1.82 
C6ECW3 Oligoribonuclease -1.89 
C6EIE8 Probable Fe(2+)-trafficking protein -1.92 
Uniprot 
Accession 
Number 
Protein ID 
Fold 
change 
C6EEY9 Superoxide dismutase -1.92 
C6EA47 Sigma factor-binding protein Crl -1.96 
C6ECD1 2',3'-cyclic-nucleotide 2'-phosphodiesterase -1.96 
C6EGD0 Bacterioferritin -2.08 
C6EG70 ATP synthase gamma chain -2.08 
C6EEW7 Pyruvate-flavodoxin oxidoreductase -2.17 
C6EBP2 Conserved inner membrane protein (Putative uncharacterized protein yjiN) -2.17 
C6EJL3 Succinate dehydrogenase and fumarate reductase iron-sulfur protein -2.27 
C6EG59 Aspartate--ammonia ligase -2.44 
C6EIU5 Glutathione S-transferase domain protein -2.44 
C6EHD7 Flagellar basal body FlaE domain protein -3.13 
C6EG50 Ribokinase -3.57 
C6EF32 
NtrB (Sensory histidine kinase in two-component regulatory system with 
GlnG) 
-3.70 
 
 
 
 
 
Figure 6.10 Functional annotation of regulated proteins between N and N+ was performed using KAAS. For annotation, the 
bi-directional best hit (BBH) method was used 
 
 
 
 
 
6.3.3.1General stress response 
The expression of the heterologous mevalonate pathway genes in E. coli induces 
and exacerbates different stressful conditions on the cell as seen in Table 6.5. There 
is an increase in the cold shock response as a result of growing cells at a 
temperature of 30
o
C even though the cold shock protein response is not expected at 
this temperature (Goldstein et al., 1990). The major cold shock proteins, cold shock 
protein CspG (5.29), cold shock protein CspA (1.91) are up regulated though cold 
shock protein CspC (-1.75) is down regulated. These proteins especially CspA, 
CspB and CspG are responsible for acting as chaperones to RNA polymerase  and 
ensure efficient translation of proteins (Jiang et al., 1997; Jones et al., 1996; 
Nakashima et al., 1996). And in order to ensure proper folding of the proteins, there 
is an up-regulation of the peptidyl-prolyl cis-trans isomerase (4.94) and Chaperone 
SurA (Peptidyl-prolyl cis-trans isomerase SurA) (1.93) 
Oxidative stress is induced by the normal metabolic processes of the cell that 
produce reactive oxygen species (ROS). The metabolic burden imposed by the 
heterologous proteins production further increases the oxidative stress as evidenced 
by the increase in abundance of superoxide dismutase (3.08),AhpF component, 
subunit of alkylhydroperoxide reductase (1.59) and AhpC component, subunit of 
alkylhydroperoxide reductase (1.36). These proteins which serve to protect DNA, 
lipids and other proteins from damage are under the regulation of the OxyR regulon 
(Bauer et al., 1999; Kim et al., 2002; Lynch, 1996). There is a down regulation of 
thioredoxin (-1.50),Integration host factor subunit alpha (IHF-alpha) (-2.33), 
Integration host factor subunit beta (IHF-beta) (-1.59), Thiol:disulfide interchange 
protein (DsbA) (-1.67) as well as the DNA protection during starvation protein 
(Dps) (-3.03).  Dps is regulated by rpoS and IHF in the stationary phase and the 
OxyR and IHF in the exponential phase and serve to protect DNA from ROS (Bauer 
et al., 1999). The up-regulation of both RNA polymerase sigma factor (rpoE) (4.65) 
and Alpha,alpha-phosphotrehalase (1.82) would suggest that the is significant 
periplasmic stress as well as osmotic stress. Accumulation of trehalose which is an  
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osmo-protectant  is an indication of high osmotic stress (Boos et al., 1987; Strom 
and Kaasen, 1993a). It has been noted that the osmo-protectiveness of trehalose is 
not due to externally supplied trehalose (Strom and Kaasen, 1993b). There is also an 
increase in abundance of proteins involved in xenobiotic metabolism as seen by the 
up regulation of 6,7-dihydropteridine reductase subunit of dihydropteridine 
reductase (2.12) and acetaldehyde dehydrogenase/alcohol dehydrogenase/PFL-
deactivase (2.35). These proteins are responsible for degrading nitrotoluene, 
chloroalkanes/alkenes, xylene and benzoates which are toxic to the cell (Choi et al., 
2008).  
There is a down regulation of both NusA antitermination factor (Transcription 
elongation factor NusA) (-1.23) and DNA-directed RNA polymerase subunit beta 
(RNAP subunit beta) (-1.32) which are responsible for transcription of DNA and an 
up-regulation of the RNA degrading Polyribonucleotide nucleotidyltransferase 
(1.73), indicating a repression of protein synthesis. However, Purine nucleoside 
phosphorylase DeoD-type (PNP) (1.31) is up-regulated, showing likely active 
synthesis of nucleotide. HU, DNA-binding transcriptional regulator (-1.89) binds to 
curved DNA and represses transcription by reducing  RNA polymerase access to the 
condensed DNA(Atlung and Ingmer, 2003; Dame, 2005a; Dame et al., 2006; 
Luijsterburg et al., 2006). 
 There is up-regulation of the Lac repressor (LacI transcriptional repressor) (2.28) 
which represses the lactose operon in the phase of glucose abundance appears 
anomalous. There is concurrent up regulation the cAMP-receptor protein (CRP) 
(1.23), which would indicate catabolite activation and activation of the cAMP-CRP 
regulon. 
 
 
 
 
 
 Table 6.5 List of differentially regulated proteins involved in transcriptional 
control and stress response at 95% confidence level with multiple test 
correction 
 
  
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold change 
C6EHL8 Cold shock protein CspG  5.29 
C6EGB7 Peptidyl-prolyl cis-trans isomerase 4.94 
C6EK14 RNA polymerase sigma factor 4.65 
C6EDY9 
Extracellular solute-binding protein family 1 (MalE, subunit of maltose ABC 
transporter) 
4.46 
C6ECU7 Superoxide dismutase 3.08 
C5W1L3 Lac repressor (LacI transcriptional repressor) (Lactose operon repressor) 2.28 
C6EKC3 
6,7-dihydropteridine reductase (Dihydropteridine reductase monomer, 
subunit of dihydropteridine reductase) 
2.12 
C6EB00 Chaperone SurA (Peptidyl-prolyl cis-trans isomerase SurA) 1.93 
C6EEC4 Cold-shock DNA-binding domain protein (CspA transcriptional activator) 1.91 
 Alpha,alpha-phosphotrehalase (Trehalose-6-P hydrolase) 1.82 
C5W9B3 Polyribonucleotide nucleotidyltransferase 1.73 
C5W0U2 AhpF component, subunit of alkylhydroperoxide reductase 1.59 
C6EKI4 Peptidase B 1.44 
C6EK89 AhpC component, subunit of alkylhydroperoxide reductase 1.36 
C6EBI7 Purine nucleoside phosphorylase DeoD-type (PNP) 1.31 
C6EH56 NusA antitermination factor (Transcription elongation factor NusA) -1.23 
C6EE32 DNA-directed RNA polymerase subunit beta (RNAP subunit beta) -1.32 
C6EL60 
Crr, subunit of enzyme II (Glucose-specific PTS system enzyme IIA 
component)  
-1.41 
C6EG32 Thioredoxin -1.50 
C6EI70 Integration host factor subunit beta (IHF-beta) -1.59 
C5WBA2 Thiol:disulfide interchange protein DsbA -1.67 
C6EJT9 S-ribosylhomocysteine lyase  (AI-2 synthesis protein)  -1.67 
C6ED65 Single-stranded DNA-binding protein -1.75 
C6EC07 
Cold-shock DNA-binding domain protein (Stress protein, member of the 
CspA family; predicted DNA-binding transcriptional regulator) 
-1.75 
C6EE18 HU, DNA-binding transcriptional regulator, alpha subunit  -1.89 
C6ECP5 Integration host factor subunit alpha (IHF-alpha) -2.33 
C6EKZ0 Adenylate kinase  (ATP-AMP transphosphorylase) -2.38 
C6EC51 Peptide methionine sulfoxide reductase MsrB -2.5 
C6EIX0 DNA protection during starvation protein -3.03 
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6.3.2.2 Central carbon metabolism (CCM) 
There is evidence of an increase in glycolytic activity, as seen in Table 6.6and 6.7 as a 
result of the mevalonate pathway.  There is up regulation of pyruvate kinase (1.65), 
phosphoglycerate kinase (1.54) and phosphoglycerate mutase (1.92). Pyruvate kinase is 
responsible for the final irreversible step in the glycolytic pathway by converting PEP to 
pyruvate. Enolase (-2.00) is, however, down-regulated. The significance of this may be 
related to its participation in RNA degradosome complex. Also up regulated are fructose 
bisphosphate aldolase monomer (1.27) and triosephosphate isomerase (1.14). The down 
regulation of 6-posphofructokinase (1.27) is in keeping with repression of gluconeogenesis 
and up regulation of glycolysis.  
Other carbon sources are seen to have been mobilized in the mevalonate mutant.  Both 
MalE (subunit of maltose ABC transporter), which actively transports maltose and 
maltodextrin into the cell and malP (the maltodextrin phosphorylase) which releases 
glucose-1-phosphate from maltodextrin are up-regulated by more than 4 fold. Glucose-1-
phosphate is converted to glucose-6-phosphate by phosphoglucomutase (1.14) before 
entering the glycolytic pathway.  Other sources of hexose sugars for the glycolytic pathway 
that are up-regulated include gat A (2.68), gatB (4.33), gatD (1.81) and gatZ (1.97) the gat 
operon for galactitol utilization which generates G-3-P and DHAP from galactitol.  manA 
(mannose -6-phosphate isomerase) (1.69) which converts mannose-6-phosphate to 
fructose-6-phosphate as well as treC (trehalose-6-phosphate) (1.82) which hydrolyses 
trehalose-6-phosphate to glucose-6-phosphate. Crr, (Glucose-specific PTS system enzyme 
IIA component) (-1.41) is, however, seen to be down regulated. This enzyme functions in 
the PEP: PTS system for import and phosphorylation of extracellular glucose and is known 
to negatively regulate rpoS a down regulation of this enzyme is therefore in keeping with 
the up regulation of the maltose transporter, as an up regulation will directly inhibit the 
maltose transporter. This would indicate exhaustion of available extracellular glucose and 
therefor activation of alternative carbon source utilization (Higgins, 1992). 
There is also a general up-regulation of pyruvate metabolic enzymes as well as the TCA 
cycle enzymes.There is up-regulation of the three components of the pyruvate 
dehydrogenase enzyme complex (E1p component) (2.67), dihydrolipoamide 
acetyltransferase (2.04) and dihydrolipoyl dehydrogenase (1.81)] which in co-operation 
converts pyruvate to acetyl CoA. A further source of pyruvate is provided by the up 
regulation of the malic enzymes [NAD-dependent malic enzyme (4.12) and malate 
dehydrogenase (Oxaloacetate-decarboxylating) (NADP(+)) (2.51)] which decarboxylates 
malate and oxaloacetate to pyruvate. Both these enzymes are positively regulated by acetyl-
CoA and acetyl-P respectively(Bologna et al., 2007). The up-regulation of both acetate 
kinase (1.98) and  phosphate acetyl transferase (1.70), as well as acetaldehyde 
dehydrogenase (2.35) suggests conversion of acetyl-CoA to acetate through acetyl-P and 
acetaldehyde respectively, which would  indicate a flux of pyruvate and acetyl CoA (El-
Mansi and Holms, 1989). Also, there is up-regulation of lactate dehydrogenase (1.84) 
forming lactate. A further evidence of increase in acetyl-CoA is seen in the up regulation of 
the irreversible acetyl-CoA carboxytransferase (1.37) which converts acetyl-CoA to 
malonyl-CoA for synthesis of fatty acids. In the TCA cycle, four enzymes are up-regulated 
including citrate synthase (2.47), Isocitrate dehydrogenase (1.55), and the 
dihydrolipoamide acetyltransferase subunit of the 2-oxoglutarate dehydrogenase complex 
(2.04) as well as malate dehydrogenase (2.30). The up regulation of these TCA cycle 
enzymes are in keeping with the increase of acetyl-CoA and pyruvate as previously noted. 
 In the pentose phosphate pathway, four enzymes are regulated. While the Transketolase 
(1.96) and Transaldolase (1.76) are up regulated, the 6-phosphogluconate dehydrogenase (-
1.39) and phosphopentomutase (-1.67) are down regulated. The down regulation of 6-
phosphogluconate dehydrogenase suggests a diminution of the oxidative phase of the 
pentose phosphate pathway but an up regulation of the non-oxidative phase as seen by the 
up regulation of both the transketolase and transaldolase enzymes. These would further add 
to the pool of fructose-6-phosphate and glyceraldehyde-3-phosphate for glycolysis. The 
down regulation of phosphopentomutase would also suggest that the products of the 
pentose phosphate pathway are not channeled to other biosynthetic activities but to increase 
the flux of the glycolytic pathway towards pyruvate and acetyl-CoA. The increase in 
acetyl-CoA would not favor the oxidative phase of the pentose phosphate pathway, as 
acetyl-CoA is a known inhibitor of glucose-6-phosphate dehydrogenase. 
There is up regulation of the inorganic pyrophosphatase (4.98), which is needed for 
biosynthetic activity. Inorganic pyrophosphatase hydrolyses pyrophosphate to phosphate 
with release of energy that can be utilized to drive forward many biosynthetic reactions. 
Also, there is up regulation of the alkylphosphonate utilization operon protein (1.81). 
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However, the up regulation of both the inorganic pyrophosphatase and the 
alkylphosphonate utilization operon protein  may be due to the increased terpene synthetic 
activity, which generates increased load of inorganic pyrophosphate (Urbina et al., 1999). 
 
Table 6.6 List of differentially regulated proteins involved in central carbon 
metabolism between N and N+ at 95% confidence level without multiple test 
correction 
Uniprot 
accessio
n # 
ID 
fold 
change 
C6ED05 Alpha-galactosidase monomer, subunit of alpha-galactosidase 4.36 
C6EAL7 
Galactitol-specific enzyme IIB component of PTS (GatB, subunit of galactitol PTS 
permease) 
4.33 
C6EAL6 
Galactitol-specific enzyme IIA component of PTS (GatA, subunit of galactitol PTS 
permease) 
2.68 
C6EIJ6 D-3-phosphoglycerate dehydrogenase 1.91 
C6EAS3 3-methyl-2-oxobutanoate hydroxymethyltransferase 1.86 
C6EHC1 3-oxo-acyl-[acyl-carrier-protein] reductase 1.77 
C6EL61 
Phosphoenolpyruvate-protein phosphotransferase (Phosphotransferase system, enzyme 
I) 
1.54 
C6EFU4 Enoyl-[acyl-carrier-protein] reductase [NADH] 1.52 
C6EJL1 2-oxoglutarate dehydrogenase, E2 subunit, dihydrolipoamide succinyltransferase 1.47 
C6EE53 Phosphoenolpyruvate carboxylase 1.40 
C6EDZ9 Glucose-6-phosphate isomerase 1.32 
C6EII4 
Fructose bisphosphate aldolase monomer, subunit of fructose bisphosphate aldolase 
class II 
1.27 
C6EEX9 Triosephosphate isomerase 1.14 
C6EJP6 Phosphoglucomutase 1.14 
C6EJL4 Succinate dehydrogenase flavoprotein subunit -1.19 
C6EC50 Glyceraldehyde 3-phosphate dehydrogenase-A monomer, -1.25 
C6EEY2 6-phosphofructokinase -1.27 
C6EL62 Phosphohistidinoprotein-hexose phosphotransferase component of PTS system (Hpr) -1.32 
C6EAR5 
Predicted subunit with GalU (Predicted subunit with GalU, subunit of glucose-1-
phosphate uridylyltransferase) 
-1.59 
C6EI79 Formate acetyltransferase (Pyruvate formate-lyase (Inactive)) -1.61 
C6EGK
5 
Acetyl-CoA carboxylase (Acetyl-CoA carboxylase, biotin carboxyl carrier protein) -1.69 
C5WA0
2 
Glycerol 3-phosphate dehydrogenase, aerobic (sn-glycerol-3-phosphate 
dehydrogenase, aerobic, FAD/NAD(P)-binding) 
-1.82 
C6EJL3 
Succinate dehydrogenase and fumarate reductase iron-sulfur protein  (Succinate 
dehydrogenase iron-sulfur protein, subunit of succinate dehydrogenase) 
-2.27 
C6EG51 
D-ribose transporter subunit (Periplasmic binding protein/LacI transcriptional 
regulator) (RbsB, subunit of ribose ABC transporter) 
-5.00 
  
Table 6.7 List of differentially regulated proteins involved in central carbon 
metabolism at 95% confidence level with multiple test correction 
Uniprot 
Accession 
Number 
Protein ID 
Fold 
change 
C6E9W2 
Glycerophosphoryl diester phosphodiesterase (Glycerophosphoryl diester 
phosphodiesterase, periplasmic) 
5.23 
C6ECC2 Inorganic pyrophosphatase 4.98 
C6EDY9 
Extracellular solute-binding protein family 1 (MalE, subunit of maltose ABC 
transporter) 
4.46 
C6EEN8 NAD-dependent malic enzyme (NAD-ME) 4.12 
C5W9Z4 Phosphorylase 4.11 
C6EAU3 Pyruvate dehydrogenase E1 component 2.67 
C6EKP9 
Malate dehydrogenase (Oxaloacetate-decarboxylating) (NADP(+)), Phosphate 
acetyltransferase 
2.51 
C6EJL8 Citrate synthase 2.47 
C6EGM8 Acetaldehyde dehydrogenase/alcohol dehydrogenase/PFL-deactivase 2.35 
C6EGZ6 Malate dehydrogenase 2.30 
C5W1L3 Lac repressor (LacI transcriptional repressor) (Lactose operon repressor) 2.28 
C6ELD0 3-oxoacyl-(Acyl carrier protein) synthase  (Beta-ketoacyl synthase) 2.11 
C6EAU2 Dihydrolipoamide acetyltransferase   2.04 
C6ELF7 Acetate kinase (Acetokinase) 1.98 
C6EAL5 D-tagatose-1,6-bisphosphate aldolase subunit GatZ 1.97 
C6EIH4 Transketolase (Transketolase 1, thiamin-binding) 1.96 
C6EJI9 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase 1.92 
C6EAH8 
D-lactate dehydrogenase (D-lactate dehydrogenase, FAD-binding, NADH 
independent) 
1.84 
C6ECA9 Alpha,alpha-phosphotrehalase (Trehalose-6-P hydrolase) 1.82 
C6EAL9 
Alcohol dehydrogenase GroES domain protein (Galactitol-1-phosphate 
dehydrogenase) 
1.81 
C6EAU1 Dihydrolipoyl dehydrogenase 1.81 
C6EBG1 Transaldolase 1.76 
C6ELF6 Phosphate acetyltransferase 1.70 
C6EDN5 Mannose-6-phosphate isomerase 1.69 
C6ECS9 Pyruvate kinase 1.65 
C6EGV5 Isocitrate dehydrogenase [NADP] 1.55 
C6EII3 Phosphoglycerate kinase 1.54 
C6EAA0 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha 1.37 
C6EG71 ATP synthase subunit beta (ATP synthase F1 sector subunit beta)  -1.33 
C6EB56 6-phosphogluconate dehydrogenase, decarboxylating -1.39 
C6EG69 ATP synthase subunit alpha  (ATP synthase F1 sector subunit alpha)  -1.41 
C6EL60 Crr, subunit of enzyme II [glc], trehalose PTS permease -1.41 
C6EBI8 Phosphopentomutase -1.67 
C6EJ93 Enolase (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase) -2.00 
C6EKZ0 Adenylate kinase  (ATP-AMP transphosphorylase) -2.38 
 
6.3.3.3 Amino acid metabolism 
The amino acid biosynthetic activity in N+ compared to N is seen in Table 6.8. 
There is up regulation of both 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase (1.40) and phospho-2-dehydro-3-deoxyheptonate aldolase 
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(2.47). 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase is 
involved in the biosynthesis of lysine and diaminopimelate which is a precursor for 
the synthesis of the cell wall peptidoglycan. Phospho-2-dehydro-3-deoxyheptonate 
aldolase is used in the shikimate pathway for the synthesis of the aromatic amino 
acids tryptophan, tyrosine and phenylalanine from PEP and Erythrose-4-phosphate.  
The up-regulation of glycine dehydrogenase [decarboxylating] (2.86)suggests 
increase in the metabolism of glycine, threonine and serine. This enzyme is also 
involved in the lipoylprotein component of the dihydrolipoamide acetyltransferase 
of the pyruvate dehydrogenase complex. This is in keeping with the increase 
demand on this enzyme. Additionally, the glycine cleavage system H protein which 
functions in the glyoxylate metabolism is also up-regulated (1.41). There is also up-
regulation of the aspartate ammonia-lyase (1.79), which catabolizes aspartate to 
Fumarate. Cysteine and methionine metabolism is down regulated as seen by the 
down regulation of S-ribosylhomocysteine lyase (AI-2 synthesis protein) (-1.67). 
  
Table 6.8 List of differentially regulated proteins involved in amino acid metabolism 
at 95% confidence level with multiple test correction 
Uniprot 
Accession 
Number 
Protein ID Fold change 
C6EIK5 Glycine dehydrogenase [decarboxylating] 2.86 
C6EJJ0 
Phospho-2-dehydro-3-deoxyheptonate aldolase  (3-deoxy-D-arabino-
heptulosonate 7-phosphate synthase) 
2.47 
C6ECY6 Aspartate ammonia-lyase 1.79 
C6EIK4 Glycine cleavage system H protein 1.41 
C6EAB9 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase 1.40 
C6EJT9 
S-ribosylhomocysteine lyase  (AI-2 synthesis protein) (Autoinducer-2 
production protein LuxS) 
-1.67 
C6EJ54 
CSD sulfur transfer protein (Putative uncharacterized protein ygdL) 
(UBA/THIF-type NAD/FAD binding protein) 
-2.5 
 
6.3.3.4 Protein biosynthesis 
The complex process of protein biosynthesis shows a mixed picture, with the up- 
regulation of phenylalanine (2.07), serine (1.67) and Histidine (1.52) --tRNA ligases 
and down regulation of the translation initiation factor (-1.27) as well as several 
ribosomal proteins. In terms of protein synthesis, there is no significant increase in 
synthesis in N+ compared to N, as seen in Table 6.9.  
Table 6.9 List of differentially regulated proteins involved in protein biosynthesis at 
95% confidence level with multiple test correction 
Uniprot 
Accession 
Number 
Protein ID Fold change 
C6ECP3 Phenylalanine--tRNA ligase alpha subunit 2.07 
C6EGF8 50S ribosomal protein L5 1.97 
C6EGE6 50S ribosomal protein L3 1.77 
C6EI89 Serine--tRNA ligase 1.67 
C6ECP1 50S ribosomal protein L20 1.53 
C6EKJ5 Histidine--tRNA ligase 1.52 
C6EGG2 50S ribosomal protein L18 1.45 
C6EIL8 Lysine--tRNA ligase 1.29 
C6EE39 Elongation factor Tu (EF-Tu) 1.14 
C6EE33 50S ribosomal protein L7/L12 -1.18 
C6EH57 Translation initiation factor IF-2 -1.27 
C6EGF5 30S ribosomal protein S17 -1.28 
C6EGF3 50S ribosomal protein L16 -1.37 
C6EGG4 50S ribosomal protein L30 -1.43 
C6EGE8 50S ribosomal protein L23 -1.45 
C6EGG5 50S ribosomal protein L15 -1.45 
C6EGE7 50S ribosomal protein L4 -1.47 
C6EGC3 30S ribosomal protein S7 -1.47 
C6EDF4 50S ribosomal protein L28 -1.52 
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Uniprot 
Accession 
Number 
Protein ID Fold change 
C6EGG3 30S ribosomal protein S5 -1.52 
C6EGH2 50S ribosomal protein L17 -1.54 
C6EJY3 30S ribosomal protein S16 -1.56 
C6EHT0 30S ribosomal protein S21 -1.75 
C6EGH0 30S ribosomal protein S4 -2.00 
 
6.3.3.4 Cell envelope 
There is evidence of active metabolism at the cell envelope as seen by the up- 
regulation of lipopolysaccharide core heptose(II)-phosphate phosphatase (2.07), 
which is an important enzyme in the synthesis of the outer membrane of E. coli 
(Table 6.10) This is complemented by the up-regulation of 2,3,4,5-
tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (1.40) which, as stated 
in 6.3.3.3,is involved in the biosynthesis of cell wall peptidoglycan as well as the 
glucan biosynthesis G (2.12) which is an enzyme in the pathway for synthesis of 
osmoregulated periplasmic glucan (OPG). Synthesis of OPGs is stimulated in 
response to osmotic stress.  
Molybdopterin guanine dinucleotide-containing S/N-oxide reductase is up regulated 
more than three fold. This protein in association with two other members of the 
torCAD operon is responsible for reducing trimethylamine N-oxide (TMAO) to 
trimethylamine which is used in anaerobic growth conditions as a component of the 
respiratory chain to generate energy especially on non-fermemntable carbon sources 
as glycerol (Méjean et al., 1994; Santini, 1998). 
  
Table 6.10 List of differentially regulated proteins involved in cell wall metabolism at 
95% confidence level with multiple test correction 
Uniprot 
Accession 
Number 
Protein ID Fold change 
C6EDY9 
Extracellular solute-binding protein family 1 (MalE, subunit of maltose 
ABC transporter) 
4.46 
C6EHL0 Molybdopterin guanine dinucleotide-containing S/N-oxide reductase 3.05 
C6EHG4 Glucans biosynthesis protein G 2.12 
C6E9U8 Lipopolysaccharide core heptose(II)-phosphate phosphatase 2.07 
C6EAB9 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase 1.40 
C6EI25 
OmpA domain protein transmembrane region-containing protein (Outer 
membrane protein 3a (II*;G;d)) 
-1.61 
C6EG51 
D-ribose transporter subunit (Periplasmic binding protein/LacI 
transcriptional regulator) 
-5.00 
 
Table 6.11 List of differentially regulated proteins involved in terpenoid biosynthesis 
at 95% confidence level with multiple test correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold change Function 
C6EIL9 
Isopentenyl-diphosphate Delta-isomerase 
(IPP isomerase) 
29.01 Terpenoid biosynthesis 
C6EL48 
Farnesyl diphosphate synthase/geranyl 
diphosphate synthase 
21.24 Terpenoid biosynthesis 
 
6.3.4 Investigation of E. coli cellular adaptation strategies to mevalonate, P450 
and ferrodoxin-reductase expression 
The enhanced terpenoid biosynthetic pathway comprising of terpene synthase, the 
cytochrome P450 and the ferrodoxin-reductase with mevalonate pathway was 
compared to the terpene synthase mutant using the 8-plex iTRAQ.  A total of 69 
proteins were differentially regulated, as seen in Table 6.12 and an additional 151 
proteins without Bonferroni correction. There are fewer enzymes that are 
differentially regulated here, which is in keeping with the phenotypic clustering but 
unexpected in the light of the metabolic load. The terpene pathway enzymes 
isopentenyl-diphosphate Delta-isomerase (16.08) and farnesyl diphosphate 
synthase/geranyl diphosphate synthase (8.26) are both up regulated but are 1.8 fold 
and 2.6 fold less than N+ respectively. The lac repressor (LacI) (-1.27) and MalE, 
subunit of maltose ABC transporter (-1.22) are both down regulated at the 95% 
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confidence level without Bonferroni correction, but contrary to what was seen 
earlier. There is also an increase in translation activity, as seen with the up 
regulation of ribosomes and elongation factors. 
 
Table 6.12 List of proteins differentially regulated between N and T at 95% 
confidence level with multiple test correction  
 Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6ECQ0 UPF0061 protein YdiU 18.57 Uncharacterised 
C6V8W6 Putative uncharacterized protein 16.84 Uncharacterised 
C6EIL9 Isopentenyl-diphosphate Delta-isomerase (IPP isomerase) 16.08 
Terpenoid 
backbone 
biosynthesis 
C6EHX3 Extracellular solute-binding protein family 5  14.98 Transporter 
C6EL48 Farnesyl diphosphate synthase/geranyl diphosphate synthase 8.26 
Terpenoid 
backbone 
biosynthesis 
C6EHL8 Cold shock protein CspG 6.38 Stress 
C6EKZ1 Chaperone protein HtpG (Heat shock protein HtpG)  4.59 Stress 
C6ECC2 Inorganic pyrophosphatase 4.40 
Oxidative 
phosphorylation 
C6ED05 
Alpha-galactosidase monomer, subunit of alpha-
galactosidase(Alpha-galactosidase, NAD(P)-binding) 
4.20 
Galactose 
metabolism 
C6EK14 RNA polymerase sigma factor 3.53 
Transcription 
regulation 
C6EGF8 50S ribosomal protein L5 3.04 Translation 
C6EB40 Chaperone protein DnaK (HSP70) 2.85 stress 
C6EGG2 50S ribosomal protein L18 2.62 Translation 
C6EGA1 50S ribosomal protein L34 2.53 Translation 
C6EGE6 50S ribosomal protein L3 2.45 Translation 
C6ECU7 Superoxide dismutase 2.45 Stress 
C6EE78 ATP-dependent protease ATPase subunit HslU 2.42 Stress 
C6ECP1 50S ribosomal protein L20 2.34 Translation 
C6EEC4 
Cold-shock DNA-binding domain protein (CspA 
transcriptional activator) (Major cold shock protein) 
2.27 Stress 
C6E9U8 Lipopolysaccharide core heptose(II)-phosphate phosphatase 2.25 
Outer membrane 
biosynthesis 
C6ECY2 60 kDa chaperonin (GroEL protein) 2.23 Stress 
C6ECY6 Aspartate ammonia-lyase 2.22 
Amino acid 
metabolism 
C6ED16 Alkylphosphonate utilization operon protein PhnA 2.17 
Phosphonate/phosp
hinate metabolism 
C6EEI7 Oligopeptidase A 2.17 Proteolysis/stress 
C6EJX9 Protein GrpE (HSP-70 cofactor) 2.15 Stress 
C6EH42 50S ribosomal protein L27 1.93 Translation 
C6EJZ8 ATP-dependent chaperone ClpB (ClpB chaperone) 1.82 Stress 
C6EBZ8 ProP effector 1.73 Transporter 
C6EH63 
ATP-dependent RNA helicase (DEAD/DEAH box helicase 
domain protein) 
1.71 
Stress/ RNA 
degradation 
 Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EIL8 Lysine--tRNA ligase 1.70 Translation 
C6EGG0 30S ribosomal protein S8 1.68 Translation 
C6EFU4 Enoyl-[acyl-carrier-protein] reductase [NADH] 1.66 
Fatty acid 
metabolism 
C6EGF1 50S ribosomal protein L22 1.65 Translation 
C6EAB6 30S ribosomal protein S2 1.63 Translation 
C6ECB7 Fructose-1,6-bisphosphatase class 1 (FBPase class 1) 1.62 
Glycolysis/glucone
ogenesis 
C6ECE6 50S ribosomal protein L9 1.59 Translation 
C6EJT2 Protein RecA (Recombinase A) 1.59 
Homologous 
recombination/DN
A repair 
C6EBG1 Transaldolase 1.53 
Pentose phosphate 
pathway 
C6EGF7 50S ribosomal protein L24 1.46 Translation 
C6EC50 Glyceraldehyde 3-phosphate dehydrogenase-A monomer 1.44 
Glycolysis/glucone
ogenesis 
C6EG30 
Transcription termination factor Rho (ATP-dependent helicase 
Rho) 
1.41 
Transcription 
regulation 
C6EGC4 Elongation factor G (EF-G) 1.41 Translation 
C5W9B3 Polyribonucleotide nucleotidyltransferase 1.34 RNA degradation 
C6EGG8 30S ribosomal protein S13 1.32 Translation 
C6EJY6 50S ribosomal protein L19 1.29 Translation 
C6EKX2 Chaperone and weak protein oxidoreductase 1.29 Stress 
C6EGN0 Global DNA-binding transcriptional dual regulator H-NS  1.28 
Transcription 
regulation 
C6EGB7 Peptidyl-prolyl cis-trans isomerase 1.27 
Stress/protein 
folding 
C6EAB5 Elongation factor Ts (EF-Ts) 1.27 Translation 
C6EGF5 30S ribosomal protein S17 1.26 Translation 
C6EE39 Elongation factor Tu (EF-Tu) 1.18 Translation 
C6EI70 Integration host factor subunit beta (IHF-beta) 0.84 
Transcription 
regulation 
C6EKZ0 Adenylate kinase (ATP-AMP transphosphorylase) 0.76 
Cell growth/ 
nucleotide 
biosynthesis 
C6EL60 Crr, subunit of enzyme II [glc], trehalose PTS permease 0.76 PTS 
C6EB56 6-phosphogluconate dehydrogenase, decarboxylating 0.76 
Pentose phosphate 
pathway 
C6EJ93 Enolase (2-phospho-D-glycerate hydro-lyase) 0.74 
Glycolysis/glucone
ogenesis 
C6ED65 Single-stranded DNA-binding protein 0.73 
Homologous 
recombination/DN
A repair 
C6EAA7 Chaperone protein skp 0.70 Stress 
C6EBX6 Glucose-6-phosphate 1-dehydrogenase 0.70 
Pentose phosphate 
pathway 
C6EG71 ATP synthase subunit beta 0.69 
Oxidative 
phoshorylation 
C6EF45 Conserved protein (Putative uncharacterized protein yihD) 0.68 Uncharacterised 
C5WBA2 Thiol:disulfide interchange protein DsbA 0.66 
Stress/protein 
folding 
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Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EG32 Thioredoxin 0.61 Stress 
C6EG69 
ATP synthase subunit alpha (ATP synthase F1 sector subunit 
alpha) 
0.57 
Oxidative 
phoshorylation 
C6EBI8 Phosphopentomutase 0.52 
Pentose phosphate 
pathway 
C6EIX1 
Cationic amino acid ABC transporter, periplasmic binding 
protein (GlnH, subunit of glutamine ABC transporter) 
0.52 
Transporter 
(glutamine) 
C6EIX0 DNA protection during starvation protein 0.45 stress 
C6EG68 
ATP synthase subunit delta (ATP synthase F(1) sector subunit 
delta) 
0.43 
Oxidative 
phoshorylation 
C6EG70 
ATP synthase gamma chain (ATP synthase F1 sector gamma 
subunit) 
0.32 
Oxidative 
phoshorylation 
 
6.3.4.1 Central carbon metabolism (CCM) 
Inthe central carbon metabolism of N compared to T, the direction of 
glycolysis/gluconeogenesis was favorable towards gluconeogenesis. As seen in 
Table 6.13, fructose-1,6-bisphosphatase (1.62) and glyceraldehyde 3-phosphate 
(1.44) are up regulated  and enolase (-1.35)  is down regulated. In addition to these, 
Crr, subunit of enzyme II [glc], PTS permease (-1.32) is down regulated. There is 
no evidence of any change in activity in the TCA cycle or pyruvate metabolism. In 
the pentose phosphate pathway, glucose-6-phosphate dehydrogenase (-1.43), 6-
phosphogluconate dehydrogenase (-1.32) and phosphopentomutase (-1.92) are all 
down regulated,while transaldolase (1.53) is up regulated. This does not suggest any 
significant increase in activity of the pathway. There is, however, an up regulation 
of alpha-galactosidase, NAD(P)-binding (4.20) which hydrolyses glycerolipids and 
glycolipids. Enoyl-[acyl-carrier-protein] reductase (1.66) fatty acid biosynthesis is 
up regulated.  
 
 
 
 
 Table 6.13 List of differentially regulated proteins involved central carbon 
metabolism between N and T at 95% confidence level with multiple test correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
C6ED05 Alpha-galactosidase monomer, subunit of alpha-galactosidase 4.20 
C6EFU4 Enoyl-[acyl-carrier-protein] reductase [NADH] 1.66 
C6ECB7 Fructose-1,6-bisphosphatase class 1 1.62 
C6EBG1 Transaldolase 1.53 
C6EC50 Glyceraldehyde 3-phosphate dehydrogenase-A monomer 1.44 
C6EL60 Crr, subunit of enzyme II [glc], trehalose PTS permease -1.32 
C6EB56 6-phosphogluconate dehydrogenase, decarboxylating -1.32 
C6EJ93 Enolase (2-phospho-D-glycerate hydro-lyase) -1.35 
C6EBX6 Glucose-6-phosphate 1-dehydrogenase -1.43 
C6EG71 ATP synthase subunit beta -1.45 
C6EG69 ATP synthase subunit alpha (ATP synthase F1 sector subunit alpha) -1.75 
C6EBI8 Phosphopentomutase -1.92 
C6EG68 ATP synthase subunit delta (ATP synthase F(1) sector subunit delta) -2.33 
C6EG70 ATP synthase gamma chain (ATP synthase F1 sector gamma subunit) -3.12 
 
6.3.4.2 Stress response 
The stress response of T relative to N is expected to be significant considering the 
additional burden of the mevalonate pathway, cytochrome P450 and the electron 
transport protein ferrodoxin- reductase.As shown in Table 6.14, there is up 
regulation of both the heat shock and the cold shock proteins, in keeping with the 
relative increase in metabolic burden. The components of the shock proteins up 
regulated included Cold shock protein CspG (6.38), Cold-shock DNA-binding 
domain protein (CspA transcriptional activator) (Major cold shock protein) (2.27), 
Chaperone protein HtpG (Heat shock protein HtpG) (4.59), Protein GrpE (HSP-70 
cofactor) (2.15) and Chaperone protein DnaK (HSP70) (2.85). Otherstress response 
proteins that are up regulated include 60 kDa chaperonin (GroEL protein) (2.23), 
ATP-dependent protease ATPase subunit HslU (2.42), ATP-dependent chaperone 
ClpB (ClpB chaperone) (1.82) and the chaperone and weak protein oxidoreductase 
(1.29). These heat shock proteins may not be responding to heat shock but to other 
denaturing stimuli (Gross, 1996). Oxidative stress is evidenced by the up regulation 
of Superoxide dismutase (2.45) even though there is no evidence of up regulation of 
the alkylhydroperoxide reductases, but there is down regulation of Thioredoxin (-
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1.64). In addition to osmotic stress, there is an indication of perisplamic osmotic 
stress as seen by the up regulation of Extracellular solute-binding protein family 5 
(Predicted transporter subunit) (14.98),ProP effector (1.73)  and the RNA 
polymerase sigma factor E (rpoE) (3.53)(Kunte et al., 1999). There is also evidence 
of stress induced transcriptional regulation, as seen with the up regulation of ATP-
dependent RNA helicase (DEAD/DEAH box helicase domain protein) (1.71), 
Transcription termination factor Rho (ATP-dependent helicase Rho) (1.41) and 
Global DNA-binding transcriptional dual regulator H-NS (H-NS transcriptional 
dual regulator) (1.28). H-NS is a global transcriptional repressor that causes 
condensation and supercoiling of DNA (Atlung and Ingmer, 2003; Dame, 2005; 
Dame et al., 2006; Luijsterburg et al., 2006) 
  
Table 6.14 List of differentially regulated proteins involved stress response and 
transcription regulation between N and T at 95% confidence level with multiple test 
correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
C6EHX3 Extracellular solute-binding protein family 5 (Predicted transporter subunit) 14.98 
C6EHL8 Cold shock protein CspG 6.38 
C6EKZ1 Chaperone protein HtpG (Heat shock protein HtpG)  4.59 
C6EK14 RNA polymerase sigma factor 3.53 
C6EB40 Chaperone protein DnaK (HSP70) 2.85 
C6ECU7 Superoxide dismutase 2.45 
C6EE78 ATP-dependent protease ATPase subunit HslU 2.42 
C6EEC4 Cold-shock DNA-binding domain protein (CspA transcriptional activator)  2.27 
C6E9U8 Lipopolysaccharide core heptose(II)-phosphate phosphatase 2.25 
C6ECY2 60 kDa chaperonin (GroEL protein) 2.23 
C6EEI7 Oligopeptidase A 2.17 
C6EJX9 Protein GrpE (HSP-70 cofactor) 2.15 
C6EJZ8 ATP-dependent chaperone ClpB (ClpB chaperone) 1.82 
C6EBZ8 ProP effector 1.73 
C6EH63 ATP-dependent RNA helicase (DEAD/DEAH box helicase domain protein) 1.71 
C6EJT2 Protein RecA (Recombinase A) 1.59 
C6EG30 Transcription termination factor Rho (ATP-dependent helicase Rho) 1.41 
C5W9B3 Polyribonucleotide nucleotidyltransferase 1.34 
C6EKX2 Chaperone and weak protein oxidoreductase 1.29 
C6EGN0 Global DNA-binding transcriptional dual regulator H-NS  1.28 
C6EGB7 Peptidyl-prolyl cis-trans isomerase 1.27 
C6EI70 Integration host factor subunit beta (IHF-beta) -1.19 
C6EKZ0 Adenylate kinase (ATP-AMP transphosphorylase) -1.32 
C6ED65 Single-stranded DNA-binding protein -1.37 
C6EAA7 Chaperone protein skp -1.43 
C5WBA2 Thiol:disulfide interchange protein DsbA -1.52 
C6EG32 Thioredoxin -1.64 
C6EIX1 
Cationic amino acid ABC transporter, periplasmic binding protein (GlnH, 
subunit of glutamine ABC transporter) 
-1.92 
C6EIX0 DNA protection during starvation protein -2.22 
 
6.3.5 Investigation of E. coli cellular adaptation strategies to cytochrome P450 
and ferrodoxin-reductase 
To investigate the effect of cytochrome P450 on the expression of terpene synthase 
in E. coli, phenotypes N and P were compared. As seen in Table 6.15, a total of 69 
proteins from the iTRAQ experiment showed differences in abundance, with 44 
proteins showing increased abundance and 25 with reduced abundance. These 
proteins were then grouped into functional groups and are discussed according to 
the major metabolic pathways that they represent. 
Systemic profile 
193 
 
 
Table 6.15 List of proteins differentially regulated between N and P at 95% 
confidence level with multiple test correction 
 
 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EHX3 Extracellular solute-binding protein family 5  25.43 Transporter 
C6ECQ0 UPF0061 protein YdiU 22.42 Uncharacterised 
C6V8W6 Putative uncharacterized protein 14.44 Uncharacterised 
C6EHL8 Cold shock protein CspG  5.63 Stress 
C6ED05 Alpha-galactosidase monomer,  4.55 Galactose metabolism 
C6EKZ1 Chaperone protein HtpG (Heat shock protein HtpG)  4.25 Stress 
C6ECC2 Inorganic pyrophosphatase 4.11 
Oxidative 
phosphorylation 
C6EGF8 50S ribosomal protein L5 3.10 Translation 
C6EGA1 50S ribosomal protein L34 2.92 Translation 
C6ECY6 Aspartate ammonia-lyase 2.70 Amino acid metabolism 
C6ECU7 Superoxide dismutase 2.64 Stress 
C6EK14 RNA polymerase sigma factor 2.57 Transcription regulation 
C6EGG2 50S ribosomal protein L18 2.47 Translation 
C6EB40 Chaperone protein DnaK (HSP70) 2.41 Stress 
C6EE78 
ATP-dependent protease ATPase subunit HslU (Heat 
shock protein HslU) 
2.41 stress 
C6EGE6 50S ribosomal protein L3 2.34 Translation 
C6E9U8 
Lipopolysaccharide core heptose (II)-phosphate 
phosphatase 
2.31 
Outer membrane 
biosynthesis 
C6EH42 50S ribosomal protein L27 2.24 Translation 
C6EJX9 Protein GrpE (HSP-70 cofactor) 2.19 stress 
C6ECP1 50S ribosomal protein L20 2.13 Translation 
C6ED16 Alkylphosphonate utilization operon protein PhnA  2.10 
Phosphonate/phosphinate 
metabolism 
C6ECY2 60 kDa chaperonin (GroEL protein) (Protein Cpn60) 2.08 Stress 
C6EJZ8 ATP-dependent chaperone ClpB (ClpB chaperone) 2.07 Stress 
C6EKC3 6,7-dihydropteridine reductase  2.06 
Nitroaromatic  
degradation 
C6EEI7 Oligopeptidase A 1.97 Proteolysis/stress 
C6EHB1 
Endoribonuclease L-PSP (Predicted L-PSP (MRNA) 
endoribonuclease) 
1.95 
Inhibitor of protein 
synthesis 
C6ECB7 Fructose-1,6-bisphosphatase class 1 (FBPase class 1) 1.93 
Glycolysis/gluconeogene
sis 
C6EFU4 Enoyl-[acyl-carrier-protein] reductase [NADH] 1.90 Fatty acid metabolism 
C6EBG1 Transaldolase 1.88 
Pentose phosphate 
pathway 
C6EEC4 
Cold-shock DNA-binding domain protein (CspA 
transcriptional activator) (Major cold shock protein) 
1.81 stress 
C6EC50 Glyceraldehyde 3-phosphate dehydrogenase-A monomer 1.81 
Glycolysis/gluconeogene
sis 
C6EIL8 Lysine--tRNA ligase 1.71 Translation 
C6ECE6 50S ribosomal protein L9 1.61 Translation 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EAL5 D-tagatose-1,6-bisphosphate aldolase subunit GatZ 1.59 
Glycerol metabolism 
 
C6EGF1 50S ribosomal protein L22 1.58 Translation 
C6ECA5 
Conserved protein, subunit of YjgF homotrimer 
(Endoribonuclease L-PSP) (Ketoacid-binding protein) 
1.57 
Inhibitor of protein 
synthesis 
C6EH63 
ATP-dependent RNA helicase (DEAD/DEAH box 
helicase domain protein)  
1.56 Stress/ RNA degradation 
C6EJT2 Protein RecA (Recombinase A) 1.52 
Homologous 
recombination/DNA 
repair 
C6ECZ5 Lysine--tRNA ligase 1.51 Translation 
C6EAB6 30S ribosomal protein S2 1.50 Translation 
C6EGC4 Elongation factor G (EF-G) 1.33 Translation 
C6EAB5 Elongation factor Ts (EF-Ts) 1.32 Translation 
C6EAU3 Pyruvate dehydrogenase E1 component 1.19 Pyruvate metabolism 
C6EE39 Elongation factor Tu (EF-Tu) 1.15 Translation 
C6EE18 
HU, DNA-binding transcriptional regulator, alpha 
subunit (Histone family protein DNA-binding protein)  
0.87 Transcription regulator 
C6EJ93 
Enolase (2-phospho-D-glycerate hydro-lyase) (2-
phosphoglycerate dehydratase) 
0.84 
Glycolysis/gluconeogene
sis 
C6EE33 50S ribosomal protein L7/L12 0.83 Translation 
C6EKZ0 Adenylate kinase (ATP-AMP transphosphorylase) 0.83 
Cell growth/ nucleotide 
biosynthesis 
C6EDF4 50S ribosomal protein L28 0.80 Translation 
C6EC07 Cold-shock DNA-binding domain protein  0.79 
Stress /transcription 
regulation 
 
C6EB56 6-phosphogluconate dehydrogenase, decarboxylating 0.79 
Pentose phosphate 
pathway 
C6EGG4 50S ribosomal protein L30 0.79 Translation 
C6ED65 Single-stranded DNA-binding protein 0.73 
Homologous 
recombination/DNA 
repair 
C6EAA7 Chaperone protein skp 0.72 stress 
C6EG71 ATP synthase subunit beta  0.72 Oxidative phoshorylation 
C6E9U5 Bifunctional polymyxin resistance protein ArnA 0.71 
Outer membrane 
biosynthesis 
C6EHM5 
Phosphotyrosine-protein phosphatase (Protein tyrosine 
phosphatase) 
0.70 Signal transduction/PTM 
C6EG32 Thioredoxin 0.65 Stress 
C6EBX6 Glucose-6-phosphate 1-dehydrogenase 0.64 
Pentose phosphate 
pathway 
C6EBI8 Phosphopentomutase 0.63 
Pentose phosphate 
pathway 
C6EG68 ATP synthase subunit delta  0.59 Oxidative phoshorylation 
C6EG69 ATP synthase subunit alpha  0.58 Oxidative phoshorylation 
C6EC51 Peptide methionine sulfoxide reductase MsrB 0.57 
Protein repair/oxidative 
stress 
C6EIX0 DNA protection during starvation protein 0.57 stress 
C5WBA2 Thiol:disulfide interchange protein DsbA 0.57 Stress/protein folding 
C5W1L3 
Lac repressor (LacI transcriptional repressor) (Lactose 
operon repressor) 
0.55 Transcription regulation 
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Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
Function 
C6EIX1 Cationic amino acid ABC transporter 0.50 Transporter (glutamine) 
C6EJL4 Succinate dehydrogenase flavoprotein subunit  -2.04 TCA cycle 
C6EG70 ATP synthase gamma chain subunit 0.37 Oxidative phoshorylation 
 
6.3.4.1Central carbon metabolism 
A total of twelve proteins involved in the central carbon metabolism were regulated 
as seen in Table 6.16; four of these belong to the pentose phosphate pathway, with 3 
in the glycolysis/gluconeogenesis pathway. In the glycolytic/gluconeogenetic 
pathway, the up regulation of irreversible gluconeogenetic fructose-1,6-
bisphosphatase (1.93) would strongly suggest that there is gluconeogenesis in P 
compared to N. The up regulation of the bidirectional glyceraldehyde 3-phosphate 
(1.81) and down regulation of enolase (-1.19) which is another bidirectional enzyme 
may tend to support this. Also, tagatose-1,6-bisphosphate aldolase (1.59) which 
converts tagatose-1,6-bisphosphateb to DHAP and G-3-P could be acting in concert 
with the gluconeogenesis. Also of significant note is the down regulation of the only 
TCA cycle (succinate dehydrogenase flavoprotein subunit (-2.04)) enzyme. The up 
regulation of pyruvate dehydrogenase (1.19) in the light of the above may not be 
significant.  In the pentose phosphate pathway there is a down regulation of three 
out of the four regulated enzymes. Only transaldolase (1.88) was observed to be up-
regulated, while glucose-6-phosphate dehydrogenase (-1.56) and 6-
phosphogluconate dehydrogenase (-1.27) in the oxidative phase of the pathway 
were down regulated. This does not suggest any increase in activity in the pathway. 
Phosphopentomutase (-1.59) which functions in the biosynthetic pathway for purine 
synthesis was down regulated. There is however an up regulation of Alpha-
galactosidase, NAD(P)-binding (4.55). 
  
 Table 6.16 List of differentially regulated proteins between N and P involved 
in central carbon metabolism at the 95% confidence level with multiple test 
correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
C6ED05 
Alpha-galactosidase monomer, subunit of alpha-galactosidase (Alpha-
galactosidase, NAD(P)-binding) 
4.55 
C6ECB7 Fructose-1,6-bisphosphatase class 1 (FBPase class 1) 1.93 
C6EFU4 Enoyl-[acyl-carrier-protein] reductase [NADH] 1.90 
C6EBG1 Transaldolase 1.88 
C6EC50 
Glyceraldehyde 3-phosphate dehydrogenase-A monomer, subunit of 
glyceraldehyde 3-phosphate dehydrogenase-A complex 
1.81 
C6EAL5 D-tagatose-1,6-bisphosphate aldolase subunit GatZ 1.59 
C6EAU3 Pyruvate dehydrogenase E1 component 1.19 
C6EJ93 Enolase (2-phospho-D-glycerate hydro-lyase) -1.19 
C6EB56 6-phosphogluconate dehydrogenase, decarboxylating -1.27 
C6EBX6 Glucose-6-phosphate 1-dehydrogenase -1.56 
C6EBI8 Phosphopentomutase -1.59 
C6EJL4 Succinate dehydrogenase flavoprotein subunit -2.04 
 
6.3.4.2 Stress response 
The stress response (Table 6.17) in this case is due to the expression of the 
cytochrome P450 and the ferrodoxin-reductase (in plasmids) which is the only 
difference between N and P.  Compared to the stress response between N and N+, 
the cold shock response here is similar with cold shock protein CspG (5.63) and 
cold shock protein CspA (1.91) observed to be up regulated and cold shock protein 
CspC (-1.27) was down regulated. In addition, there are heat shock proteins that are 
up regulated here but not observed in N vs N+. These include Chaperone protein 
HtpG (Heat shock protein HtpG) (4.25), chaperone protein DnaK (HSP70) (2.41), 
ATP-dependent protease ATPase subunit HslU (2.41), Protein GrpE (HSP-70 
cofactor) (2.19). Other chaperone proteins include 60 kDa chaperonin (GroEL 
protein) (2.08) and ATP-dependent chaperone ClpB (ClpB chaperone) (2.07). These 
additional stress response proteins are also seen in T and would therefore be due to 
the presence of P450 and the ferrodoxin –reductase. In terms of oxidative stress, 
superoxide dismutase (2.64) and thioredoxin (-1.54) are regulated in the same 
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direction while the alkylhydroperoxide reductases are not diferentially regulated. 
Thiol:disulfide interchange protein (DsbA) (-1.75) as well as the DNA protection 
during starvation protein (Dps) (-1.75) were down regulated. The periplasmic stress 
regulator RNA polymerase sigma factor (rpoE) (2.57)was up regulated. One major 
significant difference is seen in the down regulation of Lac repressor (LacI 
transcriptional repressor) (-1.82) which is similar to the trend seen in T. 
 
Table 6.17 List of differentially regulated proteins involved in transcriptional 
control and stress response between N and P at 95% confidence level with 
multiple test correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
C6EHL8 
Cold shock protein CspG (Cold-shock DNA-binding domain protein) 
(DNA-binding transcriptional regulator) 
5.63 
C6EKZ1 
Chaperone protein HtpG (Heat shock protein HtpG) (High temperature 
protein G) 
4.25 
C6ECU7 Superoxide dismutase 2.64 
C6EK14 RNA polymerase sigma factor 2.57 
C6EB40 Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) 2.41 
C6EE78 ATP-dependent protease ATPase subunit HslU (Heat shock protein HslU) 2.41 
C6EJX9 Protein GrpE (HSP-70 cofactor) 2.19 
C6ECY2 60 kDa chaperonin (GroEL protein) (Protein Cpn60) 2.08 
C6EJZ8 ATP-dependent chaperone ClpB (ClpB chaperone) 2.07 
C6EEI7 Oligopeptidase A 1.97 
C6EHB1 Endoribonuclease L-PSP (Predicted L-PSP (MRNA) endoribonuclease) 1.95 
C6EEC4 
Cold-shock DNA-binding domain protein (CspA transcriptional activator) 
(Major cold shock protein) 
1.81 
C6EH63 
ATP-dependent RNA helicase (DEAD/DEAH box helicase domain 
protein) (DeaD, DEAD-box RNA helicase) 
1.56 
C6EJT2 Protein RecA (Recombinase A) 1.52 
C6EE18 
HU, DNA-binding transcriptional regulator, alpha subunit (Histone family 
protein DNA-binding protein) (Transcriptional dual regulator HU-alpha 
(HU-2), subunit of HU transcriptional dual regulator) 
0.87 
C6EC07 
Cold-shock DNA-binding domain protein (Stress protein, member of the 
CspA family; predicted DNA-binding transcriptional regulator) (Stress 
protein, member of the CspA-family) 
0.79 
C6ED65 Single-stranded DNA-binding protein 0.73 
C6EAA7 Chaperone protein skp 0.72 
C6EG32 Thioredoxin -1.54 
C6EIX0 DNA protection during starvation protein -1.75 
C5WBA2 Thiol:disulfide interchange protein DsbA -1.75 
C5W1L3 Lac repressor (LacI transcriptional repressor) (Lactose operon repressor) -1.82 
 
 6.3.3.4 Protein biosynthesis 
There is general up regulation of protein biosynthetic machinery as observed by the 
up regulation of the ribosomal proteins and the translation elongation factors (Table 
6.18). At the same time, there is an up regulation of Endoribonuclease L-PSP 
(Predicted L-PSP (MRNA) endoribonuclease) (1.95) Endoribonuclease L-PSP   
((Ketoacid-binding protein (1.57) and ATP-dependent RNA helicase (DeaD, 
DEAD-box RNA helicase) (1.56) which are known to inhibit protein synthesis and 
to degrade RNA (Lüking et al., 1998; Toone et al., 1991). 
 
Table 6.18 List of differentially regulated proteins involved in protein 
biosynthesis between N and P at 95% confidence level with multiple test 
correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold change 
C6EGF8 50S ribosomal protein L5 3.10 
C6EGA1 50S ribosomal protein L34 2.92 
C6ECY6 Aspartate ammonia-lyase 2.70 
C6EGG2 50S ribosomal protein L18 2.47 
C6EGE6 50S ribosomal protein L3 2.34 
C6EH42 50S ribosomal protein L27 2.24 
C6ECP1 50S ribosomal protein L20 2.13 
C6EHB1 Endoribonuclease L-PSP (Predicted L-PSP (MRNA) endoribonuclease) 1.95 
C6EIL8 Lysine--tRNA ligase 1.71 
C6ECE6 50S ribosomal protein L9 1.61 
C6EGF1 50S ribosomal protein L22 1.58 
C6ECA5 
Conserved protein, subunit of YjgF homotrimer (Endoribonuclease L-PSP) 
(Ketoacid-binding protein) 
1.57 
C6EH63 
ATP-dependent RNA helicase (DEAD/DEAH box helicase domain protein) 
(DeaD, DEAD-box RNA helicase) 
1.56 
C6ECZ5 Lysine--tRNA ligase 1.51 
C6EAB6 30S ribosomal protein S2 1.50 
C6EGC4 Elongation factor G (EF-G) 1.33 
C6EAB5 Elongation factor Ts (EF-Ts) 1.32 
C6EE39 Elongation factor Tu (EF-Tu) 1.15 
C6EE33 50S ribosomal protein L7/L12 0.83 
C6EDF4 50S ribosomal protein L28 0.80 
C6EGG4 50S ribosomal protein L30 0.79 
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6.3.3.4 Cell envelope 
There is some evidence of active metabolism at the cell envelope in terms of cell wall 
biosynthetic activities and membrane transport as seen in Table 6.19. The 
lipopolysaccharide core heptose(II)-phosphate phosphatase (2.31) was up regulated while 
the bifunctional polymyxin resistance protein (-1.41) which is responsible producing lipid 
A of the cell wall lipopolysaccharide backbone was down regulated. The extracellular 
solute-binding protein family 5 (25.43) was up regulated. The extracellular solute-binding 
protein family 5 is perisplasmic dipeptide binding and import protein that responds to 
osmotic shock (Olson et al., 1991; Tam and Saier, 1993). Also down regulated was the 
phosphotyrosine-protein phosphatase (-1.43) which is responsible for regulation of many 
cell processes such as growth and differentiation, cell cycle and transcription  control 
amongst others through post-translational modification (Zhang et al., 1995). 
 
Table 6.19 List of differentially regulated proteins involved in cell envelope 
metabolism between N and P at 95% confidence level with multiple test 
correction 
Uniprot 
Accession 
Number 
 
Protein ID 
 
Fold 
change 
C6EHX3 
Extracellular solute-binding protein family 5 (Predicted transporter subunit) 
(Predicted transporter subunit: periplasmic-binding component of ABC 
superfamily) 
25.43 
C6E9U8 Lipopolysaccharide core heptose (II)-phosphate phosphatase 2.31 
C6E9U5 Bifunctional polymyxin resistance protein ArnA -1.41 
C6EHM5 Phosphotyrosine-protein phosphatase (Protein tyrosine phosphatase) -1.43 
C6EIX1 
Cationic amino acid ABC transporter, periplasmic binding protein (GlnH, 
subunit of glutamine ABC transporter)(Glutamine ABC transporter 
periplasmic protein) 
-2.00 
 
6.3.4 Investigation of E. coli cellular adaptation strategies between N+ and T 
To study the effect of cytochrome P450 and ferrodoxin-reductase on a mevalonate 
and terpene synthase expressing E. coli mutant, N+ was compared to T. a direct 
comparison between these two mutants would indicate metabolic effect of the P450 
and the ferrodoxin-reductase on the system. It would also give more insight on the 
reason for the difference in terpene yield between the two.  As seen in Table 6.20 a 
total of 127 proteins were differentially regulated at the 95% confidence with 
Bonferroni correction. Figure 6.10 shows the pathways that the differentially 
regulated proteins have been mapped into, which shows at a glance, that pathways 
involved in the central carbon metabolism (glycolysis/gluconeogenesis, pyruvate 
metabolism, the TCA cycle, and the pentose phosphate pathway) are mostly down 
regulated. Also down regulated are the enzymes involved in terpene synthesis. 
There was general up regulation of the ribosomes alongside the other translational 
enzymes such as elongation factor G (1.32), translation initiation factor IF-2 (1.53) 
and translation initiation factor IF-1 (1.72). There was also up regulation of both 
RNA polymerase and of RNA degradation enzymes. However, there was down 
regulation of aminoacyl-tRNA biosynthesis and enzymes of cell division.  
 
6.3.4.1 Central carbon metabolism (CCM) 
There is an overall down regulation of the central carbon metabolism. In the 
glycolysis/gluconeogenesis pathway,phosphoglycerate kinase (-1.41), 
phosphoglycerate mutase (-1.89) and phosphoglucomutase (-1.36) were down 
regulated while fructose-1,6-bisphosphatase (1.60), glyceraldehyde 3-phosphate 
dehydrogenase (1.80) and  enolase (1.46) were up regulated. The up regulation of 
the unidirectional fructose-1,6-bisphosphatase shows evidence of gluconeogenesis 
in T compared to N+. In pyruvate metabolism, 7 enzymes were down regulated 
namely, pyruvate dehydrogenase E1 component (-2.46), dihydrolipoamide 
acetyltransferase (-2.24), dihydrolipoyl dehydrogenase (-1.95), acetaldehyde 
dehydrogenase/alcohol dehydrogenase/PFL-deactivase (-2.13), D-lactate 
dehydrogenase (-2.05), malate dehydrogenase (Oxaloacetate-decarboxylating) (-
2.36) and phosphate acetyltransferase (-1.71) and one up regulated protein pyruvate 
formate-lyase (Inactive) (1.67). The TCA cycle is seen to be repressed as all the 
regulated enzymes were down regulated. The 6 TCA cycle enzymes down regulated 
include 2-oxoglutarate dehydrogenase, E2 subunit, dihydrolipoamide 
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succinyltransferase (-1.36), (succinyl-CoA ligase [ADP-forming] subunit alpha (-
1.39), (succinyl-CoA ligase [ADP-forming] subunit beta (-1.41), Isocitrate 
dehydrogenase (-1.62), Citrate synthase (-2.28) and Malate dehydrogenase (-3.03). 
The general trend of metabolic repression of the central carbon metabolism is also 
seen in the pentose phosphate pathway with phosphoglucomutase (-1.36) and 
Glucose-6-phosphate 1-dehydrogenase (-1.48) down regulated. In addition, other 
sources of carbon utilisation also follow the same trend. D-tagatose-1,6-
bisphosphate aldolase subunit GatZ (-1.63) and Galactitol-specific enzyme IIA 
component of PTS(GatA, subunit of galactitol PTS permease) (-2.24)involved in 
galactitol metabolism,  MalE, subunit of maltose ABC transporter (-5.49) and 
maltose/maltodextrin phosphorylase, malP (-3.68) involved in import and 
metabolism of maltose/maltodextrin were also down regulated. Other down 
regulated carbon metabolic enzymes include trehalose-6-P hydrolase (-2.01) and 
Glycerophosphoryl diester phosphodiesterase (-4.21). 
 
6.3.4.2 Stress response and transcription regulation  
There is a mixed picture of stress response by T with up regulation of heat shock 
and cold shock proteins and chaperones while the oxidative and osmotic stress 
proteins are down regulated as seen by the down regulation of AhpF component, 
subunit of alkylhydroperoxide reductase (-1.40), superoxide dismutase (-1.26), 
RNA polymerase sigma factor (rpoE) (-1.32) and glucans biosynthesis protein G (-
1.66). There was general up regulation of transcription regulators with HU, DNA-
binding transcriptional regulator, alpha subunit (1.68), Global DNA-binding 
transcriptional dual regulator H-NS (1.43) and NusA antitermination factor (1.21) 
all up regulated.DNA-directed RNA polymerase (1.23) and DNA-directed RNA 
polymerase subunit beta (1.16)were also up regulated while Lac repressor (LacI 
transcriptional repressor) (-3.00) was down regulated.  
 
  
Table 6.20 List of proteins differentially regulated between N+ and T at 95% 
confidence level with multiple test correction  
 
Uniprot 
Accession 
Number 
 
Protein ID Fold change Function 
C6ECQ0 UPF0061 protein YdiU 20.50 Uncharacterised 
C6V8W6 Putative uncharacterized protein 19.73 Uncharacterised 
C6EHX3 
Extracellular solute-binding protein 
family 5 (Predicted transporter 
subunit) 
12.69 Transporter 
C6EG51 
D-ribose transporter subunit 
(Periplasmic binding protein/LacI 
transcriptional regulator 
4.27 Transporter 
C6EB40 Chaperone protein DnaK (HSP70) 3.52 Stress 
C6EKZ1 
Chaperone protein HtpG (Heat shock 
protein HtpG) 
3.45 Stress 
C6EE78 
ATP-dependent protease ATPase 
subunit HslU 
2.79 Stress 
C6EFG0 Fe/S biogenesis protein NfuA 2.66 Stress/protein folding 
C6EGH0 30S ribosomal protein S4 2.63 Translation 
C6ECE7 30S ribosomal protein S18 2.62 Translation 
C6EK62 UPF0250 protein YbeD 2.49 Uncharacterised 
C6ECY2 60 kDa chaperonin (GroEL protein) 2.26 Stress 
C6EJX9 Protein GrpE (HSP-70 cofactor) 2.21 Stress 
C6EGF0 30S ribosomal protein S19) 2.13 Translation 
C6ECE9 30S ribosomal protein S6 2.10 Translation 
C6EAV7 Protein translocase subunit SecA 2.09 transporter 
C6EH02 30S ribosomal protein S9 2.09 Translation 
C6EGG0 30S ribosomal protein S8 1.99 Translation 
C6EJZ8 ATP-dependent chaperone ClpB 1.96 Stress 
C6EB30 30S ribosomal protein S20 1.95 Translation 
C6EHT0 30S ribosomal protein S21 1.88 Translation 
C6EGG9 30S ribosomal protein S11 1.86 Translation 
C6EKZ0 Adenylate kinase 1.83 
Cell growth/ nucleotide 
biosynthesis 
C6EGG2 50S ribosomal protein L18 1.80 Translation 
C6EH63 
ATP-dependent RNA helicase 
(DEAD/DEAH box helicase domain 
protein) 
1.80 Stress/ RNA degradation 
C6EC50 
Glyceraldehyde 3-phosphate 
dehydrogenase-A monomer 
1.80 Glycolysis/gluconeogenesis 
C6EGG8 30S ribosomal protein S13 1.79 Translation 
C6EGK5 
Acetyl-CoA carboxylase (Biotin 
carboxyl carrier protein) 
1.74 Fatty acid biosynthesis 
C6EJY3 30S ribosomal protein S16 1.73 Translation 
C6EI98 Translation initiation factor IF-1 1.72 Translation 
C6EI52 Asparagine--tRNA ligase 1.72 Translation 
C6EGF2 30S ribosomal protein S3 1.71 Translation 
C6EAB6 30S ribosomal protein S2 1.71 Translation 
C6EE18 
HU, DNA-binding transcriptional 
regulator, alpha subunit 
1.68 Transcription regulation 
C6EGH2 50S ribosomal protein L17 1.67 Translation 
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Uniprot 
Accession 
Number 
Protein ID Fold change Function 
C6EI79 
Formate acetyltransferase(Pyruvate 
formate-lyase (Inactive)) 
1.67 Pyruvate metabolism 
C6EH58 Ribosome-binding factor A 1.66 Translation 
C6EGF5 30S ribosomal protein S17 1.61 Translation 
C6ECB7 Fructose-1,6-bisphosphatase class 1 1.60 Glycolysis/gluconeogenesis 
C6EGC3 30S ribosomal protein S7 1.59 Translation 
C6EC07 
Cold-shock DNA-binding domain 
protein (Stress protein, member of 
the CspA family; predicted DNA-
binding transcriptional regulator) 
1.58 
Stress /transcription regulation 
 
C6EGE7 50S ribosomal protein L4 1.58 Translation 
C6EGF8 50S ribosomal protein L5 1.54 Translation 
C6EJY6 50S ribosomal protein L19 1.54 Translation 
C6EGF1 50S ribosomal protein L22 1.53 Translation 
C6EH57 Translation initiation factor IF-2 1.53 Translation 
C6EFW4 
Predicted protein (Putative 
uncharacterized protein yciN) 
1.53 Uncharacterised 
C6ECP1 50S ribosomal protein L20 1.52 Translation 
C6ELG8 
N utilization substance protein B 
homolog (Protein NusB) 
1.48 Transcription regulation 
C6EEI7 Oligopeptidase A (EC 3.4.24.70) 1.47 Proteolysis/stress 
C6EGG5 50S ribosomal protein L15 1.47 Translation 
C6ECA5 
Conserved protein, subunit of 
YjgFhomotrimer 
1.47 Inhibitor of protein synthesis 
C6EJ93 Enolase  
1.46 
Glycolysis/gluconeogenesis 
C6EGG3 30S ribosomal protein S5 1.45 Translation 
C6EGE8 50S ribosomal protein L23 1.44 Translation 
C6EH01 50S ribosomal protein L13 1.44 Translation 
C6EGE9 50S ribosomal protein L2 1.44 Translation 
C6EGN0 
Global DNA-binding transcriptional 
dual regulator H-NS 
1.43 Transcription regulation 
C6ECE6 50S ribosomal protein L9 1.43 Translation 
C6EKX2 
Chaperone and weak protein 
oxidoreductase  
1.42 stress 
C6EGK4 
AccC, subunit of biotin carboxylase 
and acetyl-CoA carboxylase 
1.41 Fatty acid biosynthesis 
C6EDF4 50S ribosomal protein L28 1.40 Translation 
C6EGE6 50S ribosomal protein L3 1.38 Translation 
C6EGE5 30S ribosomal protein S10 1.36 Translation 
C6EA12 50S ribosomal protein L25 1.33 Translation 
C6EGC4 Elongation factor G (EF-G) 1.32 Translation 
C6EGG4 50S ribosomal protein L30 1.30 Translation 
C6EI71 30S ribosomal protein S1 1.30 Translation 
C6EGG1 50S ribosomal protein L6 1.29 Translation 
C6ECY6 Aspartate ammonia-lyase 1.24 Amino acid metabolism 
C6EE31 DNA-directed RNA polymerase 1.23 Transcription regulation 
C6EH56 NusA antitermination factor  1.21 Transcription regulation 
C6EE33 50S ribosomal protein L7/L12 1.20 Translation 
 Uniprot 
Accession 
Number 
 
Protein ID Fold change Function 
C6EEC4 
Cold-shock DNA-binding domain 
protein (CspA transcriptional 
activator) 
1.19 Stress 
C6EE32 
DNA-directed RNA polymerase 
subunit beta  
1.16 Transcription regulation 
C6EL29 Trigger factor (TF) 1.11 stress 
C6EAW0 Cell division protein FtsZ 
-1.19 
Cell division 
C6ECU7 Superoxide dismutase 
-1.26 
stress 
C6EBI7 
Purine nucleoside phosphorylase 
DeoD-type 
-1.26 
Nucleotide metabolism 
C6EA50 
Aminoacyl-histidine dipeptidase 
(Peptidase D) 
-1.27 
proteolysis 
C6EAA0 
Acetyl-coenzyme A carboxylase 
carboxyl transferase subunit alpha 
-1.27 
Pyruvate metabolism 
C5W9B3 
Polyribonucleotide 
nucleotidyltransferase 
-1.29 
RNA degradation 
C6EJP6 Phosphoglucomutase 
-1.36 
Pentose phosphate pathway 
C6EJK9 
Succinyl-CoA ligase [ADP-forming] 
subunit alpha 
-1.39 
TCA 
C5W0U2 
AhpF component, subunit of 
alkylhydroperoxide reductase 
-1.40 
Stress 
C6EII3 Phosphoglycerate kinase 
-1.41 
Glycolysis/gluconeogenesis 
C6EJL0 
Succinyl-CoA ligase [ADP-forming] 
subunit beta 
-1.41 
TCA 
C6ECJ2 Nitroreductase  
-1.46 
Nitroaromatic  degradation 
C6EBX6 
Glucose-6-phosphate 1-
dehydrogenase 
-1.48 
Pentose phosphate pathway 
C6EJT4 Alanine--tRNA ligase 
-1.50 
Translation 
C6EI75 Phosphoserine aminotransferase 
-1.57 
Amino acid biosynthesis 
C6EAB9 
2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N-succinyltransferase 
(Tetrahydrodipicolinate N-
succinyltransferase) 
-1.57 Amino acid/peptidoglycan 
biosynthesis 
C6EGV5 Isocitrate dehydrogenase [NADP] 
-1.62 
TCA 
C6EAL5 
D-tagatose-1,6-bisphosphate aldolase 
subunit GatZ 
-1.63 Glycerol metabolism 
 
C6EAA7 Chaperone protein skp 
-1.65 
Stress 
C6EHG4 Glucans biosynthesis protein G 
-1.66 OsmoregulatedPerisplasmicgluc
an biosynthesis 
C6EGL0 
Cell shape determining protein, 
MreB/Mrl family 
-1.69 Peptidoglycan synthesis/cell 
wall 
C6ELF6 Phosphate acetyltransferase 
-1.71 
Pyruvate metabolism 
Systemic profile 
205 
 
 
Uniprot 
Accession 
Number 
 
Protein ID Fold change Function 
C6EIK5 
Glycine dehydrogenase 
[decarboxylating] 
-1.71 
Amino acid metabolism 
C6EKJ5 Histidine--tRNA ligase 
-1.74 
Translation 
C6EIK4 Glycine cleavage system H protein 
-1.78 
Amino acid metabolism 
C6EIL9 
Isopentenyl-diphosphate Delta-
isomerase (IPP isomerase) 
-1.80 
C6EIL9 
C6EJI9 
2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase  
-1.89 
Glycolysis/gluconeogenesis 
C6EAL9 
Alcohol dehydrogenase GroES 
domain protein (Galactitol-1-
phosphate dehydrogenase) 
-1.93 
Galactose metabolism 
C6EAU1 Dihydrolipoyl dehydrogenase 
-1.95 
Pyruvate metabolism 
C6ECP3 
Phenylalanine--tRNA ligase alpha 
subunit 
-1.99 
Translation 
C6ECA9 
Alpha,alpha-phosphotrehalase 
(Trehalose-6-P hydrolase) 
-2.01 
Stress protection 
C6ELD0 
3-oxoacyl-(Acyl carrier protein) 
synthase 
-2.01 
Fatty acid biosynthesis 
C6EAH8 
D-lactate dehydrogenase (D-lactate 
dehydrogenase, FAD-binding, 
NADH independent) 
-2.05 
Pyruvate metabolism 
C6EGM8 
Acetaldehyde dehydrogenase / 
alcohol dehydrogenase / PFL-
deactivase 
-2.13 
Pyruvate metabolism 
C6EB00 
Chaperone SurA (Peptidyl-prolyl cis-
trans isomerase SurA) 
-2.18 
Stress 
C6EAL6 
Galactitol-specific enzyme IIA 
component of PTS  
-2.24 
PTS/ Galactose metabolism 
C6EAU2 Dihydrolipoamide acetyltransferase 
-2.24 
Pyruvate metabolism 
C6EJL8 Citrate synthase 
-2.28 
TCA 
C6EJJ0 
Phospho-2-dehydro-3-
deoxyheptonate aldolase 
-2.29 Amino acid 
biosynthesis/shikimate pathway 
C6EKP9 
Malate dehydrogenase (Oxaloacetate-
decarboxylating) (NADP(+) 
-2.36 
Pyruvate metabolism 
C6EAU3 
Pyruvate dehydrogenase E1 
component 
-2.46 
Pyruvate metabolism 
C6EL48 
Farnesyl diphosphate synthase / 
geranyl diphosphate synthase 
-2.57 
C6EL48 
C5W1L3 
Lac repressor (LacI transcriptional 
repressor) (Lactose operon repressor) 
-3.00 
Transcription regulation 
C6EGZ6 Malate dehydrogenase 
-3.03 
TCA 
C5W9Z4 Phosphorylase 
-3.68 Starch and glycogen 
metabolism 
C6EGB7 Peptidyl-prolyl cis-trans isomerase 
-3.88 
Stress/protein folding 
C6E9W2 
Glycerophosphoryl diester 
phosphodiesterase 
-4.21 
Glycerol metabolism 
Uniprot 
Accession 
Number 
 
Protein ID Fold change Function 
C6EDY9 
Extracellular solute-binding protein 
family 1 (MalE, subunit of maltose 
ABC transporter) 
-5.49 
Transporter 
C6EL58 
Predicted protein (Putative 
uncharacterized protein yfeK) 
-8.75 
Uncharacterised 
 
 
 
 
Figure 6.11 Functional annotation of regulated proteins between N+ and 
Twas performed using KAAS. For annotation, the bi-directional best hit (BBH) 
method was used 
 
6.4 Discussion 
As a follow up to chapter 5, attempts were made to increase the number of  
identifiedproteinsby instituting more optimization steps such as digestion and 
fractionation methodology. Two-dimensional chromatographic separation reduces 
the complexity of peptides presented to the mass spectrometer for fragmentation 
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and identification at any given time with significant improvements in protein 
numbers and especially for low abundance proteins. An efficient offline first 
dimensional HPLC separation of peptides significantly enriches the peptide 
yield.Furthermore, as reported by Ow et al (2011b), up to 20% improvement in 
accuracy of iTRAQ results can be achieved by using high resolution fractionation 
methodologies. As tested in this chapter, the use of high resolution HILIC 
fractionation significantly increased the separation and resolution efficiencies and 
subsequent increased the number of identified and quantified proteins as seen in this 
chapter. 
There was increase in the glycolysis, pyruvate metabolism and TCA cycle enzymes 
(Figure 6.12 and Figure 6.13) to yield acetyl-CoA for the synthesis of DMAPP and 
IPP. The increase in the glycolysis potentially leads to anincrease of pyruvate, 
which is partly converted to lactate by lactate dehydrogenase as well as to acetate by 
a combination of acetate kinase and phosphate acetyl transferase. The increase in 
the glycolytic pathway was from several sources: maltodextrin phosphorylase 
(malP) hydrolyzes maltodextrin to glucose-1-phosphate and enters the glycolytic 
pathway. The up-regulation of the maltodextrin active transport system (malE) 
ensures supply of maltohexose for the glycolytic pathway. Additionally, mannose-
6-phosphate isomerase (manA) converts mannose-6-phosphate to F6P and tagatose-
1,6-bisphosphate aldolase (gatZ) converts tagatose-1,6-bisphosphate to DHAP and 
G3P. Trehalose hydrolase up-regulation ensures the conversion of extracellular 
trehalose-6-phosphate to glucose-6-phosphate. Crr, the Glucose-specific PTS 
system enzyme IIA component was down regulated possibly by CRP mediated 
catabolite repression of glucose transport. 
To get a global picture of the metabolic changes and to deduce the possible 
metabolic rational for the observed phenotypic differences, specific elements were 
examined.  
To examine the elements responsible for the increased abundance of both IPP 
isomerase and FPP synthase which are necessary for terpene synthesis in the 
mutants, it was necessary to re-examine the iTRAQ conditions in which these 
proteins were observed to have increased in abundance (N+ and T).  
 Figure 6.12 Metabolic changes seen in glycolytic/gluconeogenetic pathway E. 
coli mevalonate mutant as compared to control (N) using iTRAQ based 
quantitation at 30 h post induction. Red and blue arrows show increased and 
decreased protein abundance respectively 
 
In so doing, it was important to examine these (T vs N+) in the light of (N vs N+) 
and (N vs T) comparison Table 6.21 shows a list of regulated proteins that are 
commonly regulated in both N+ and T. 
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There was a comparative over expression of FPP synthase (2.57 fold) and IPP 
isomerase (1.8 fold) in N+ compared to that of T.Increased abundance of these 
proteins would require an up regulation of the terpene synthase immediately 
downstream to increase the turnover of the terpene  Since both strains contain the 
FPP overproducing plasmid, but there was a significant difference in expression of 
FPP pathway enzymes, it is reasoned that the greater expression of these enzymes in 
N+ compared to T, would probably be due to over expression or under expression 
of protein that are unique to N+ or proteins that act to reduce expression in T. Since 
IPP isomerase and FPP synthase were up regulated in both conditions, the shared or 
common proteins between them would potentially represent the minimum set of 
proteins required for the successful expression of terpene synthase in an FPP 
expressing mutant under the same growth conditions. The proteins unique to each 
condition would hypothetically represent the reason for the differences in the level 
of expression of the terpene synthase (represented by the level of expression of both 
IPP isomerase and FPP synthase. It is important to bear in mind that the only 
genetic differences in this two strains is in the P450 and the ferrodoxin reductase in 
T but lacking in N+. 
These proteins were almost all differentially regulated in the same direction except 
for the lac repressor protein LacI which was up regulated (2.28) in N+ and down 
regulated (-1.27) in T. The major metabolic functional group of these proteins 
includes stress response proteins, protein synthesis, transcriptional regulators and 
central carbon metabolism. 
 
 
 Figure 6.13 Metabolic changes seen in pyruvate metabolism and TCA cycle of  
E. coli mevalonate mutant as compared to control (N) using iTRAQ based 
quantitation at 30 h post induction. Red and blue arrows show increased and 
decreased protein abundance respectively 
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Table 6.21List of proteins that seen to be regulated in T and N+ compared to the 
control (N) at 95% confidence level with Bonferroni correction 
 
Uniprot 
Accession 
Number Protein ID N vs N+ N vs T 
      
      
 
C6EDY9 Extracellular solute-binding protein family 1 (MalE) 4.46 0.82 5.44 
C6EGB7 Peptidyl-prolyl cis-trans isomerase 4.94 1.27 3.89 
C6EGZ6 Malate dehydrogenase 2.3 0.79 2.91 
C5W1L3 Lac repressor (LacI transcriptional repressor) 2.28 0.79 2.89 
C6EL48 Farnesyl diphosphate synthase / geranyl diphosphate synthase 21.24 8.26 2.57 
C6EAU3 Pyruvate dehydrogenase E1 component 2.67 1.08 2.47 
C6EEN8 NAD-dependent malic enzyme (NAD-ME) 4.12 1.73 2.38 
C6EJL1 2-oxoglutarate dehydrogenase, E2 subunit 1.47 0.78 1.88 
C6EIL9 Isopentenyl-diphosphate Delta-isomerase (IPP isomerase) 29.01 16.08 1.80 
C6EGL0 Cell shape determining protein, MreB/Mrl family 1.38 0.88 1.57 
C6EIH4 Transketolase (Transketolase 1, thiamin-binding) 1.96 1.25 1.57 
C6EEX9 Triosephosphate isomerase 1.14 0.75 1.52 
C6EAJ8 Antiporter inner membrane protein (Mrp protein) 2.24 1.51 1.48 
C6EKC3 6,7-dihydropteridine reductase 2.12 1.44 1.47 
C6EF32 
NtrB (Sensory histidine kinase in two-component regulatory 
system with GlnG) 0.27 0.2 1.35 
C6EIX1 Cationic amino acid ABC transporter 0.71 0.53 1.34 
C6ECS9 Pyruvate kinase 1.65 1.24 1.33 
C6EK14 RNA polymerase sigma factor 4.65 3.53 1.32 
C6EEW7 Pyruvate-flavodoxin oxidoreductase 0.46 0.35 1.31 
C6EJP6 Phosphoglucomutase 1.14 0.88 1.30 
C5W9B3 Polyribonucleotide nucleotidyltransferase 1.73 1.34 1.29 
Uniprot 
Accession 
Number Protein ID N vs N+ N vs T 
      
     
 
C6ELF7 Acetate kinase 1.98 1.58 1.25 
C6EBG1 
Transaldolase 
1.76 1.42 1.24 
C6EJL4 Succinate dehydrogenase flavoprotein subunit 0.84 0.68 1.24 
C6EI80 
Pyruvate formate lyase activating enzyme 1 0.81 0.7 1.16 
C6EBI8 Phosphopentomutase (Phosphodeoxyribomutase) 0.6 0.52 1.15 
C6ECC2 Inorganic pyrophosphatase 4.98 4.4 1.13 
C6EEY2 6-phosphofructokinase 0.79 0.73 1.08 
C6EL62 
Phosphohistidinoprotein-hexose phosphotransferase 
component of PTS system (Hpr) 0.76 0.74 1.03 
C6ED05 Alpha-galactosidase monomer 4.36 4.34 1.00 
C6EE39 Elongation factor Tu (EF-Tu) 1.14 1.18 -1.04 
C6EL60 Crr, subunit of enzyme II [glc] (Glucose-specific PTS) 0.71 0.75 -1.06 
C6EB56 6-phosphogluconate dehydrogenase, decarboxylating 0.72 0.77 -1.07 
C6E9U8 Lipopolysaccharide core heptose (II)-phosphate phosphatase 2.07 2.25 -1.09 
C6EG30 Transcription termination factor Rho 1.27 1.42 -1.12 
C6EE32 DNA-directed RNA polymerase subunit beta 0.76 0.88 -1.16 
C6EEC4 
Cold-shock DNA-binding domain protein (CspA 
transcriptional activator) 1.91 2.27 -1.19 
C6EBZ8 ProP effector 1.45 1.73 -1.19 
C6ED16 Alkylphosphonate utilization operon protein PhnA 1.81 2.17 -1.20 
C6EA47 Sigma factor-binding protein Crl 0.51 0.63 -1.24 
C6ECY6 Aspartate ammonia-lyase 1.79 2.22 -1.24 
C6ED65 Single-stranded DNA-binding protein 0.57 0.73 -1.28 
C6EJT2 
Protein RecA (Recombinase A) 
1.24 1.59 -1.28 
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Uniprot 
Accession 
Number Protein ID N vs N+ N vs T 
      
      
 
C6EI70 Integration host factor subunit beta (IHF-beta) 0.63 0.84 -1.33 
C6EIX0 DNA protection during starvation protein 0.33 0.45 -1.36 
C6EJL3 Succinate dehydrogenase and fumarate reductase  0.44 0.6 -1.36 
C6EJ93 Enolase 0.5 0.74 -1.48 
C6EJV6 DNA binding protein, nucleoid-associated (H-NS-like ) 2.12 3.14 -1.48 
C6EH57 Translation initiation factor IF-2 0.79 1.22 -1.54 
C6EE18 HU, DNA-binding transcriptional regulator, alpha subunit 0.53 0.92 -1.74 
C6EC50 Glyceraldehyde 3-phosphate dehydrogenase-A monomer 0.8 1.39 -1.74 
C6EKZ0 Adenylate kinase (AK) 0.42 0.76 -1.81 
C6ECP5 Integration host factor subunit alpha (IHF-alpha) 0.43 0.78 -1.81 
 
The peptidyl-prolyl cis/trans isomerase (FkpA) chaperone was significantly more 
(3.89 fold) up regulated in N+ than in T. Two other peptidyl-prolyl cis/trans 
isomerases (SurA and Skp) were observed to show similar trend. These proteins act 
as chaperones to ensure proper folding of proteins. Their activity help to reduce the 
RpoE induced stress response to misfolded proteins and reduce formation of protein 
aggregates (Liu and Walsh, 1990; Ruiz-Perez et al., 2010). However, these proteins 
were observed to be down regulated in the P mutant when compared to N. Proteins 
involved in transcriptional regulation by causing folding and compaction of DNA 
and in so doing cause a global or specific reduction in transcription include 
integration host factors (alpha and beta), H-NS, HU (Dame, 2005b). These proteins 
even though differentially regulated in the same direction but were all observed to 
be down regulated inN+.compared to T. Similarly, the DNA protection during 
starvation protein (Dps) which binds to and protects DNA from toxic substances 
during starvation or stationary phaseand the single-stranded DNA-binding 
proteinwere observed to be relatively less in abundance in N+ compared to T. Taken 
together, this could mean that T is more starved with more reduction in the rate of 
transcription.  
In central carbon metabolism, several proteins were observed to be relatively more 
up regulated in N+ compared to T. These include malate dehydrogenase, pyruvate 
dehydrogenase E1 component, NAD-dependent malic enzyme, 2-oxoglutarate 
dehydrogenase, E2 subunit, transketolase, triosephosphate isomerase, extracellular 
solute-binding protein family 1 (MalE), pyruvate kinase, transaldolase, acetate 
kinase and phosphoglucomutase. This would indicate more or better energy source 
utilization in N+ strain.  
Lac repressor (LacI transcriptional repressor) levels are seen to be up regulated in 
N+ (2.28) and down regulated in T (-1.27). The lac repressor serves to regulate the 
lac operon and is involved in the efficient and selective use of carbon sources by E. 
coli and as such LacI will ensure the preferential use of glucose if available by 
binding to lacO and preventing the transcription of the lac operon. An up regulation 
of LacI will therefore signify availability and dependency of N+ on glucose and the 
repression of the utilization of other carbon sources such as glycerol, other 
hexoses/pentoses and polysaccharides such as maltodextrin. This process is usually 
achieved by the cAMP-CRP mediated catabolite repression.  As glucose levels fall, 
cAMP is up regulated and this subsequently binds and activates CRP, and in 
association induces lac operon.  CRP is up regulated in N+ in the presence of up 
regulated LacI. It is known that the presence of LacI dictates the preference of 
glucose over lactose and glycerol in that order but increasing the level of LacI 
would change the preference to glucose/glycerol/lactose (Blommel et al., 2007). 
However, elevated levels of CRP would favor the utilization of sources other than 
glucoseand the maltose/maltodextrin utilization operon is induced by cAMP-
CRP(Boos and Shuman, 1998; Dippel and Boos, 2005). The glucose specific PTS 
system crr is known to negatively regulate cAMP-CRP levels (Boos and Shuman, 
1998) and so a down regulation of crr would support increase in cAMP-CRP levels.  
This would therefore be responsible for the up regulation of the 
maltose/maltodextrin utilization operon and glycerol and other carbon sources such 
as mannose, trehalose, and galactitol in order to meet the increase demand for 
acetyl-CoA. The enhance level of cAMP-CRP is responsible for increased 
utilization of carbon sources through the activation of the rpoS regulon. Some of the 
enzymes in this regulon up regulated include, Acetate kinase (Acka), Phosphate 
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acetyltransferase (pta), Aldehyde Dehydrogenase (AldA), ArgT, subunit of 
lysine/arginine/ornithine ABC Transporter (Cationic amino acid ABC transporter, 
periplasmic binding protein), ATP synthase subunit alpha (AtpA), dipeptide 
transporter (DppA), D-tagatose-1,6-bisphosphate aldolase subunit GatY (gatY), 
glycerol-3-phosphate transporter (UgpB), Maltose-binding periplasmic protein 
(MalE), D-galactose-binding periplasmic protein (MglB), Extracellular solute-
binding protein family 1(Han and Lee, 2006; Xu and Johnson, 1995). These 
proteins are potentially responsible for the significant more expression of the 
terpene synthase precursors in N. 
The elements that are responsible for the low abundance of both IPP isomerase and 
FPP synthase and hence low terpene production are examined next. The P and T 
strains showed relatively low abundance of these proteins when compared to N and 
N+ respectively.  These elements would be due to the presence of P450 and 
ferrodoxin reductase in both P and T.  The most prominent common theme in these 
comparisons that were not observed in the N+ strain was the presence of the heat 
shock proteins which were all observed to be up regulated, while there was a 
relative down regulation of the cold shock proteins when compared to N+. of 
significance is the observation of two uncharacterized proteins that are significantly 
upregulated in these two strains, UPF0061 protein YdiU  with 18.57 fold in T and 
22.42 fold increase in P compared to N and putative uncharacterized protein 
(C6V8W6) with 16.84 and 14.44 fold increase in T and P respectively. 
 
6.5 Conclusions 
This chapter, the metabolic profile of a high yield terpene producing E. coli strain 
has been examined and compared to the baseline terpene strain. The cytochrome 
P450/ferrodoxin reductase strains with or without the FPP-overproducing pathway 
have also been examined and comparisons made. 
There is a proteomic evidence of an increase in glycolysis and pyruvate metabolism 
to yield acetyl-CoA for the synthesis of DMAPP and IPP in the N+ strain. Thelikely 
increase in the glycolysis leads to a flux of pyruvate which was partly converted to 
lactate by lactate dehydrogenase as well as to acetate by a combination of acetate 
kinase and phosphate acetyl transferase. The increase in the glycolytic pathway is 
from several sources: maltodextrin phosphorylase (malP) hydrolysis maltodextrin to 
glucose-1-phosphate and enters the glycolytic pathway. The up-regulation of the 
maltodextrin active transport system (malE) ensures supply of maltohexose for the 
glycolytic pathway. Additionally, mannose-6-phosphate isomerase (manA) converts 
mannose-6-phosphate to F6P and tagatose-1,6-bisphosphate aldolase (gatZ) 
converts tagatose-1,6-bisphosphate to DHAP and G3P. Trehalose hydrolase up-
regulation ensures the conversion of extracellular trehalose-6-phosphate to glucose-
6-phosphate. Crr, the Glucose-specific PTS system enzyme IIA component is down 
regulated possibly by CRP mediated catabolite repression of glucose transport. The 
presence of cytochrome P450 is thought to have led to the drastic reduction of the 
terpene synthetic pathway.enzymes. The over abundance of heat shock proteins, 
reduction of cold shock proteins and the Peptidyl-prolyl cis-trans isomerases are an 
indication of protein aggregation and the CCM is depressed as a metabolic 
consequence. This would be the probable cause of reduce terpene synthase and 
hence terpene in P and T. 
In the next chapter, these findings would be put into perspective with the rest of the 
results of this thesis. 
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 7.1 Introduction  
The aim of this thesis was to understand the metabolism of an E. coli strain engineered to 
produce a sesquiterpene from Nostoc sp.PCC7120 and the effect of other additional genes 
such as cytochrome P450 and a mevalonate pathway on sesquiterpene production. To 
achieve this goal, molecular biological techniques as well as bio-analytical and chemical 
analytical tools were employed. The major findings of this thesis are summarised in this 
chapter and the outlook for future work is also discussed.  
 
7.2 Quantification of terpene  
In order to improve any system, it is important to first ensure that the system is established 
and functionally tested. Once the productive efficiency of this system is tested subsequent 
refinement and improvement is measured. The sesquiterpene from Nostoc sp. PCC7120 
was functionally expressed in E. coli and the terpene product confirmed to be the 
anticancer compound β-elemene using GC-MS. Using the endogenous DXP pathway to 
supply IPP/DMAPP precursors, this single plasmid carrying strain produced a baseline 
value of 38 mg/L of the terpene.Qualitative assay of this metabolite produced from an E. 
coli host have been performed, but there is no known report of a quantitative assay. In view 
of adding an FPP-overproducing plasmid with or without the cytochrome P450/ferrodoxin 
reductase plasmids to this system, production was tested  with empty versions of these two 
plasmids. The product titres from the three plamid system showed more than a 7 fold 
reduction in the baseline titres of β-elemene from the single plasmid strain. This significant 
reduction is ascribed to the extra metabolic burden imposed by adding two additional 
plasmids. Since the IPP/DMAPP precursors are essential for cell wall metabolism, the 
shunting of these to terpene synthetic pathway had a negative effect on cell growth and 
survival. The addition of a codon optimized FPP- overproducing plasmid increased the 
terpene titres by more than 34 fold to 178 mg/L and the specific productivity per gram of 
cells increased by more than 40 fold. As a first pass yield without any optimisation, this 
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result compares well with other studies using same or similar FPP-overproducing system 
with a sesquiterpene synthase. Some notable examples include 500 mg/L of amorphadiene 
(Redding-Johanson et al., 2011a), 900 mg/L of bisabolene (Peralta-Yahya et al., 2011a),  
136 mg/L of farnesol (Wang et al., 2010) and 380 mg/L of α-farnesene  (Wang et al., 
2011). Using a codon optimised terpene synthase as employed in these studies, would 
possibly give yields within the same range. The cytochrome P450 was very poorly 
expressed but nonetheless, its effect on the terpene production was negative and profound, 
reducing the terpene output by almost 90 fold. 
 
7.3 Metabolism  
There is always some metabolic consequences accompanying the production of any 
foreign protein in E. coli which is evident in this thesis. The metabolic changes are 
usuallystress induced and the effect of the stress is the observed phenotypic 
changes. The stress in this case comes from the terpene synthase and the plasmid, 
and the effect is manifested in the rate of growth and changes in the relative 
abundance of proteins in terpene synthase carrying straincompared to the empty 
plasmid carrying E. coli strain. The growth retardation observed (as measured from 
OD values) in the terpene producing strain (N) could be attributed to reduction in 
the synthesis of the cell wall peptidoglycan. This is because the IPP/DMAPP 
precursors that are used for the synthesis of undecaprenyl pyrophosphate of lipid II 
are hijacked to make terpene by the terpene synthase to the detriment of the cell. 
The relative decrease in abundance of Tetrahydrodipicolinate N-succinyltransferase 
and Glutamine-fructose-6-phosphate aminotransferase are in support of this 
assertion as shown by the growth retardation. The apparent demand for both 
pyruvate and glyceraldehyde-3-phophate needed for IPP/DMAPP synthesis is likely 
to have triggered an increase channeling of resources by the organism to meet this 
demand. This adaptation strategy is likely to be through a combination of reduction 
of cell wall synthesis, catabolic degradation of the cell wall to release more 
IPP/DMAPP through colicin M as well as increase catabolism of tryptophan, 
cysteine and serine by tryptophanase to yield pyruvate. The increase in catabolism 
of tryptophan also produces the toxic indole which may have contributed to growth 
inhibition. Even though the central carbon metabolism seemed to have been 
activated to provide pyruvate and G3P, mobilization of all possible carbon sources 
available to the cell in this case did not seem to have been utilized when compared 
to the N+ strain. 
The addition of an exogenous precursor pathway appeared to have relieved the 
catabolism of the cell wall peptidoglycan, increased the efficiency of the carbon 
source utilization with up regulation of the central carbon metabolism, which led to 
increased titres of terpene.The effect of the FPP-overproducing plasmid led to a 
significant increase in the mobilization of several carbon sources with an increase in 
the activity of the glycolytic pathway, the pyruvate metabolism as well as the citric 
acid cycle which potentially increased the flux of acetyl-CoA needed for the 
synthesis of IPP/DMAPP sufficiently to meet the demand for both cell biosynthesis 
and as well as synthesis of the terpene. This increase in the CCM enzymes possibly 
caused an over-abundance of acetyl-CoA which was then shunted to produce acetic 
acid and lactic acid which are themselves not growth friendly (Zhou et al., 2003).  
So, while, the FPP-overproducing strain relieved the catabolic effect on the cell 
wall, it had its own negative consequence by inducing more significant acid stress. 
There is also the possibility that there was an additional membrane stress brought 
about by excessive production of HMG-CoA as seen by the increase in malonyl-
CoA and other fatty acid biosynthetic enzymes. HMG-CoA accumulation is known 
to be toxic to E. coli cells as reported by Kizer et al. (2008). These (acidosis and 
HMG-CoA) would be the probable explanations for the growth retardation seen in 
N+ compared to P. 
The FPP overproducing pathway theoretically increases the efficiency of carbon 
usage and mobilization through up regulation of cAMP-CRPincluding utilization of 
glycerol. The relative abundance of level of cAMP-CRP is thus likely responsible 
for the increased utilization of carbon sources through the activation of the rpoS 
regulon. These proteins are potentially responsible for the significant over 
expression of the terpene synthase precursors in N+(D. S.-W. Ow et al., 2009).The 
carbon scavenging seen in N+ which is not seen in N is attributable to growth on 
glycerol, as growth on a low carbon source such as glycerol is also known to induce 
this response (Martínez-Gómez et al., 2012). However, since both cells were grown 
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on exactly the same media, the exaggerated response in N+ is due primarily to the 
FPP pathway is which responsible for the much higher titres of terpene seen here. 
This is most likely mediated through cAMP-CRP catabolite de-repression. This 
cAMP-CRP mediated process was not seen in any of the mutants carrying the 
cytochrome P450 insert. There was also a significant increase in expression of heat 
shock proteins in cytochrome P450 containing strains (P and T), which was absent 
in the high yield N+ strain. This heat shock response is hypothetically incriminated 
in both the reduction of P450 synthesis and as well as terpene production (as seen in 
terpene titres of P and T). With the addition of P450 to the N strain (three plasmid 
system), titres for P reduced 5 fold. While the addition of P450 to N+ strain, titres 
for T reduced 90 fold. Cold shock response as seen in N+ seems to be favourable 
for terpene synthesis.The poor expression of cytochrome P450, is hypothesized to 
be the effect of increase in heat shock proteins.and a diminution or lack of the 
cAMP-CRP mediated carbon source scavenging capabilities of N+  As an effect, the 
P450 may be miss-folded or forming aggregates which could lead to over-
expression of the heat shock proteins and proteases needed for degradation of the 
protein or be due to a translational block (Kusano et al., 1999). 
 
7.4 Future work 
The work in this thesis has highlighted some areas that would require further studies for 
validation purposes and/or metabolic engineering or optimisation. 
 
7.4.1 Cytochrome P450 
The poor expression of cytochrome P450 was seen to have a huge negative effect on 
terpene production based on the hypothesis that the cytochrome P450 suffers post-
translational degradation or forms inclusion bodies. To investigate this would require the 
analysis of the mRNA transcript in those strains haboring the cytochrome P450 and a 
targeted proteomic method such as MRM analysis will show significant disparity between 
transcript level and expressed protein. Western blotting method would be used to probe the 
cell to see if the protein is forming inclusion body aggregates. It is also possible that the 
poor expression would be at the level of transcription, in which case the mRNA transcript 
is expected to be very low as well. In which case, a codon optimised insert would be 
expected to address thisand lowering the temperature of cultivation even further would also 
help to improve protein expression and proper folding. Using a bacterial cytochrome P450 
such as P450 BM-3 from Bacillus megaterium could also be another solution. P450 BM-3 
is the fastest known P450 enzyme with a very good expression in E. coli and is self-
contained with both P450 and reductase domains that can be engineered through site 
directed mutagenesis to use other short chain substrates such as monoterpenes and 
sesquiterpenes (Appel et al., 2001; Bernhardt, 2006).Knock out studies of the P450 gene 
through random mutagenesis using error-prone PCR (Park et al., 2010)/site directed 
mutagenesis which will also create a library of mutants for activity screening. This has the 
potential of changing the regio/sterio-selectivities of the P450 protein and producing 
mutants with specific or degenerate reactivities. More efficient and productive pathways 
could then be constructed by selecting appropriate mutants based on target product or 
substrate. 
 
7.4.2 Terpene 
As significant increases in terpene titres were achieved with the exogenous FPP over-
producing pathway, further increases may be achievable through the following steps: 
Use of a codon optimised terpene synthase could potentially increase the efficiency of 
transcription.  
Reduction of the metabolic burden of multiple plasmids on the host cell by reducing the 
number of plasmids to two would be helpful. This can be done by cloning the terpene 
synthase, P450 and the ferrodoxin reductase into a single plasmid or using a mutant of the 
self-contained P450 BM-3. Alternatively, a genomic integration of the genes into the host 
genome could bypass this impediment (Cs rgő and Pósfai, 2007  Datsenko and Wanner, 
2000; Peti and Page, 2007) 
Deletingthe genes that shunt acetyl-CoA from the mevalonate pathway into lactate, acetate 
and ethanol(Merlin et al., 2002) could increase the acetyl-CoA available to make precursors 
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and with a codon optimised terpene synthase; a even higher titres of the terpene may be 
achieved.  
Seeing that CRP is associated with an increase in carbon scavenging and with increase in 
the activity of the CCM, the gene of this protein could serve as a metabolic engineering 
prospect. Indeed efforts at expressing cAMP-independent CRP mutant strains have shown 
positive result in carbon utilisation (Clomburg and Gonzalez, 2010; Karimova et al., 2004; 
Khankal et al., 2009) 
 
7.4.3 Assay validation  
Despite the use of an exogenous pathway to supply IPP/DMAPP precursors for terpene 
synthesis, there was still some growth retardation. This growth retardation cannot be 
wholly attributed to the plasmid burden or protein production. The relative abundance of 
fatty acid biosynthetic proteins could be due to overabundance HMG-CoA, as reported by 
Kizer et al. (2008). To assess this, metabolite assay of the culture for malonyl-CoA and 
HMG-CoA should be carried out. Additionally, fatty acid methyl ester (FAME)analysis 
should(Cs rgő and Pósfai, 2007  Datsenko and Wanner, 2000  Peti and Page, 2007) be 
done to assess cell wall fatty acid profile.  
7.4.4 Uncharacterised proteins 
The four uncharacterised proteins that showed very high fold changes could possibly  have 
some significance in the expression or otherwise of  the terpene synthase or the P450. 
These genes can be explored using gene deletion methodologies (Merlin et al., 2002). 
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Fig A1. Annotated final plasmid maps of pCDFDuet and pETDuet with sesquiterpene 
synthase and cytochrome P450 genes in-frame with the N-terminal hexa-histidne 
sequence  
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Fig A2. Annotated final plasmid maps of pETDuet containing insert (NS1 and NS1-
P450) and cloned into NcoI and NotI of MCS1  
  
 
Fig A3. DNA sequence chromatogram of pCDFDuet-NStag showing the N-terminal 6-
histidine sequence tag and the ATG start site of the gene. 
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Fig A4. DNA sequence chromatogram of pCDFDuet-P450tag showing the N-terminal 6-
histidine sequence tag and the ATG start site of the gene. 
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